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Abstract
This work describes diﬀerent strategies for the detection of biologically relevant
analytes. The main goal was to achieve sensing in water, which is a prerequisite for
application to real biological samples. In several cases, we could demonstrate that our
systems were also working in blood serum, a notoriously complex medium containing
proteins, sugars and salts, which can potentially interfere with our sensors.
Our ﬁrst analyte of choice was the lithium cation. Owing to its therapeutic uses in
the ﬁeld of psychology, it represents an appealing target, and an eﬃcient chemosensor
for lithium ions may ﬁnd numerous uses in biomedical investigations. The ﬁrst strat-
egy that will be presented involves the use of organometallic macrocycles carrying
ﬂuorescent reporting units. These compounds were found to be potent ionophores
and display a very high selectivity for lithium ions. Upon careful choice of constituent
building blocks, a chemosensor displaying good aﬃnity, selectivity, and solubility was
obtained. The sensor allowed the detection of lithium ions in water and in human
serum by simple ﬂuorescence measurements (Chapter 2).
Other approaches for the detection of lithium ions will be presented in Chapter
3. Instead of covalently attaching ﬂuorescent dyes to the lithium binding unit, ﬂuo-
rophores that can bind in a non-covalent fashion were employed. Assays based on
easily available constituents were devised. They allowed the sensing of lithium ions in
the sub-millimolar concentration range.
In Chapter 4, the pattern-based sensing of micromolar concentrations of small
peptides in water will be described. Small peptides are ubiquitous in biology, and they
are involved in many essential processes such as neurotransmission, blood pressure
regulation or oxidative stress mitigation. It will be demonstrated that their selective
detection can be accomplished by arrays of diﬀerential sensors: instead of building a
selective sensor for a given analyte, a series of cross-reactive, unsophisticated sensors
could be employed. Their diﬀerential response (ﬁngerprint) for various analytes was
vii
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interpreted via statisticalmethods. As a result, lowmicromolar concentrations ofmany
short peptides (as well as mixtures thereof) could be measured in water and in human
serum samples.
In the last part (Chapter 5), the sensing properties of a sensor array will be com-
pared with those of a dynamic combinatorial library (DCL). The DCL contains the same
elements as the sensor array, but they are mixed in one pot. It is shown that the DCL
can outperform the sensor array in many situations, but that an excessive complexity
can be detrimental to its resolution.
Keywords
Sensors  Fluorescence spectroscopy Metallamacrocycles  Self-assembly 
Ruthenium  Lithium  Peptide  Indicator displacement assay  Combinatorial
chemistry  Sensor array
Résumé
Ce travail décrit diﬀérentes stratégies développées aﬁn de détecter diversesmolécules
importantes d'un point de vue biologique. L'un des objectifs est de parvenir à la
détection des molécules ciblées enmilieu aqueux, ce qui représente un passage obligé
dans la perspective d'aboutir à la détection en milieu biologique réel.
La première substance dont la détection sera présentée est le cation lithium. Son
emploi dans le traitement dedivers troubles psychologiques en fait un analyte de choix.
Un senseur simple et eﬃcace pour le lithium peut ouvrir d'intéressantes perspectives
pour la recherche biomédicale, notamment en ce qui concerne le développement
de médicaments à partir de lithium. Tout d'abord, des chémosenseurs ﬂuorescents
sélectifs pour le cation lithium seront décrits (Chapitre 2). Constituées de macrocy-
cles organométalliques auxquels des marqueurs ﬂuorescents ont été attachés, ces
molécules peuvent, sous certaines conditions, être la fois solubles dans l'eau, sélec-
tives pour le cation lithium, et donner une réponse sous forme d'une modulation
de l'intensité de ﬂuorescence. Comme il le sera démontré, ces macrocycles sont
également capables de détecter le lithium dans du sérum issu de sang humain.
Au Chapitre 3 seront présentées des approches simpliﬁées pour la détection de
lithium. En utilisant des colorants ﬂuorescents qui s'attachent de façon non-covalente
au récepteurmacrocyclique, de nombreuses étapes de synthèse sont évitées, et le sys-
tèmeobtenupermet la détection de lithiumenmilieu aqueux à des concentrations sub-
millimolaires. L'un des avantages de ces systèmes est qu'ils font usage de molécules
simples, généralement disponibles dans le commerce.
Au Chapitre 4, la détection de petits peptides de concentration micromolaire en
milieu aqueux sera présentée. Les peptides sont omniprésents dans tout système et
processus biologique. Par exemple, ils interviennent dans la régulation de la pression
sanguine, dans des phénomènes de neurotransmission, ou encore dans la gestion
du stress oxydant. Dans le cas que nous présentons, les senseurs sélectifs sont
ix
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abandonnés au proﬁt d'ensembles de senseurs diﬀérentiels. Une série de senseurs peu
sophistiqués, possédant une réactivité croisée pour les diﬀérents analytes d'intérêt
peut être employée. La discrimination entre diﬀérents peptides est eﬀectuée au
moyen d'algorithmes de reconnaissance de formes (pattern recognition) qui permet-
tent d'attribuer à chaque analyte sa propre empreinte. Au ﬁnal, la discrimination de
petits peptides (ainsi que demélanges de peptides) à des concentrations micromlaires
sera réalisée, en solution aqueuse tout commeen solution contenant du sérumhumain.
Finalement, le Chapitre 5 propose de comparer les capacités en termes de dis-
crimination d'un ensemble de senseurs et d'une bibliothèque combinatoire dynamique
(BCD). Une BCD contient les mêmes éléments qu'un ensemble de senseurs, à la
diﬀérence près que tous sont mélangés dans une même solution. Il en résulte un
systèmeplus simple à employer et analyser qu'un ensemble de senseurs. Il seramontré
que la librairie possède des capacités analytiques supérieures à l'ensemble de senseurs,
à condition qu'une trop grande complexité ne porte pas atteinte à sa résolution.
Mots Clefs
Senseurs  Spectroscopie de ﬂuorescence Métallamacrocycles  Auto-assemblage 
Ruthénium  Lithium  Peptide  Analyse par déplacement d'indicateur  Chimie
combinatoire  Ensemble de senseurs
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BODIPY 4,4-diﬂuoro-4-bora-3a,4a-diaza-s-indacene (boron-dipyrromethene)
br broad
nBu n-butyl
C degree Celsius
ca. circa, about
CAB calcein blue
CAL calcein
calcd calculated
cbz carbobenzyloxy
cf. confer, compare to
CHES 2-(cyclohexylamino)ethanesulfonic acid
Cp* η5-pentamethylcyclopentadienyl
cyclen 1,4,7,10-tetraazacyclododecane
cymene 1-methyl-4-(1-methylethyl)benzene
d doublet
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dansyl N,N-dimethylaminonaphthalene-1 sulfonyl
DCL dynamic combinatorial library
dd doublet of doublets
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DMF N,N-dimethylformamide
xv
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DMSO dimethyl sulfoxide
e.g. exempli gratia, for example
em emission
en ethylenediamine
ESI electrospray ionisation
Et ethyl
et al. et alia, and others
ex excitation
g gram
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HEPES 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid
HOMO highest-occupied molecular orbital
HPLC high performance liquid chromatography
HPTS 8-hydroxy-1,3,6-pyrenetrisulfonic acid
Hz Hertz (s-1)
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J coupling constant
Ka association constant
KD kallidin
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LUM lumazine
LUMO lowest-unoccupied molecular orbital
m multiplet
m meta
M molar (mol  L-1)
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MAA N-methylanthranilic acid
MCB methylcalcein blue
Me methyl
Mes mesityl (1,3,5-trimethylphenyl)
mg milligram
mL milliliter
mm millimeter
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xvii
mmol millimole
μm micrometer
μM micromolar (μmol  L-1)
μmol micromole
mV millivolt
NFR nuclear fast red
nm nanometer
NMR nuclear magnetic resonance
o ortho
OTf triﬂate, triﬂuoromethanesulfonate
p para
PCA principal component analysis
PET photoinduced electron transfer
Ph phenyl
PPi pyrophosphate
ppm parts per million
iPr isopropyl
quint quintet
rac racemate
ref reference
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s singlet
sept septuplet
t triplet
TEA triethyl amine
TFA triﬂuoroacetic acid
UV ultraviolet
UV/Vis UV/Visible
vol volume
vs. versus, against
wt weight
XO xylenol orange
Note: usual abbreviations are used for amino acids.

1 General Introduction
Synopsis
In this opening chapter, an elementary introduction to the concept of chemosensors is
presented. The sensing methodologies, which will be employed in the following chap-
ters, are described and illustrated with selected examples from the recent literature.
1

1.1 Deﬁnition of a Chemosensor
AĈčĊĒĔĘĊēĘĔė can be regarded as ‘‘a receptor that interacts with an analyteproducing a detectable change in a signal’’.[1] Optical reporters (for ﬂuorescence
or UV/Vis spectroscopy) have been widely used in this context,[2--14] owing to a usually
fast and convenient implementation. The instrumentation required for the use of
such techniques is relatively simple and cheap, which makes this type of sensors quite
appealing. In addition to optical methods, electrochemical techniques have also been
employed.[6, 9] In this introduction, we will focus on optical sensors, since they will be
extensively used and studied in the next chapters.
Chemosensors can be classiﬁed into three main categories, which are described in
the following sections.
1.2 Integrated Chemosensors
When the signalingunit is part of thebindingunit (andvice-versa), the sensor is referred
to as an integrated chemosensor.[11, 15] The most ancient examples of this class of
compounds are pH indicators, where a change in the protonation state of a colored
molecule results in a change in coloration.
Figure 1.1 – Representation of an integrated chemosensor: The binding unit (grey
cup) is also a ﬂuorophore, and the complexation of the substrate (ball) modiﬁes
the emission intensity (switching it on).
With the rise of supramolecular chemistry, compounds such as crown ethers, cryp-
tands and carcerands were developed,[6] which are able to capture various analytes in
a selective fashion. These receptors can be used as sensors when they simultaneously
behave as signaling units. Several sensors for cations were elaborated based on this
type of platform.[11] For example, boron-containing resorcinarene 1, which was very
recently described by Kubo et al., is able to indicate the presence of alkyltrimethylam-
monium ions by a change in its ﬂuorescence properties.[16] Compound 1 is selective for
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small ammonium salts and no response is observed for bulky tetraalkylammonium ions
such as NEt+4 or NnBu+4.
R1 R1
R1R1
O O
O
O
OO
O
O
NHB
HN NH
BHN
HN B
NHHN
B NH
R
 2 R2
R2R2
R
 1 = C11H23
O OC
 8 H 17
R
 2 =
1
Scheme 1.1 – Resorcinarene 1, which can act as a sensor for alkyltrimethylammo-
nium ions.[16]
Another example is the sensor 2, whichwas developed by Bell et al.[17] (Scheme 1.2),
and which is able to extract creatinine fromwater into organic solvents. Upon binding
of creatinine, receptor 2 undergoes a rearrangement (proton shift), which induces a
strong change in the UV/Vis spectrum.
Although some successes were reported with sensors of this type, their nature
makes them diﬃcult to modify. If one tries to improve the binding of analytes, it is
very likely one will simultaneously modify the photophysical properties of the dye, or
vice-versa. Therefore, optimization and customization of this type of sensor is diﬃcult
to achieve.[4]
NN
N
NO2
OH
O2N
N
N ON
NN
N
NO2
O
O2N
H
H H
2
creatinine
Scheme 1.2 – Binding of creatinine to the designed receptor 2.[17]
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1.3 Conjugated Chemosensors
These types of sensors are made of a binding unit, which is selective for the desired
analyte, and a reporting unit, which role is to signal the absence or presence of analyte
at the binding unit. A spacer physically connects the binding and the signalling units.
The signalling unit-spacer-receptor triad was extensively used in the context of supra-
molecular analytical chemistry. It makes the design of a sensor much more ﬂexible
than the ‘‘integrated sensor’’ approach, given that the various parts can be separately
optimized and tuned before being combined to form the desired sensor. In order to
work properly, a transduction mechanism must exist, which allows the reporting unit
to sense and indicate binding events occurring at the recepting unit (Figure 1.2).
Fluorescence appears to be a method of choice for the formation of conjugated
sensors, essentially because photoinduced electron transfer (PET) mechanisms oﬀer
the possibility to design oﬀ-to-on sensors for a large variety of analytes.
The mechanism of photoinduced electron transfer was extensively studied,[11, 15, 18]
and is depicted in Figure 1.2 for the casewhere a cation (ball) controls the ﬂuorescence
behaviour of a sensor. The binding site possesses an electron donating moiety (indi-
cated by a D), and the ﬂuorophore plays the role of an electron acceptor.
D D
e-
hν hν
hν'
E
hν'
Figure 1.2 – Working principle of a conjugate PET sensor. Bottom: The binding
subunit (grey cup) is separated from the ﬂuorescent subunit (red rectangle) by
a spacer (black line). The system also contains an electron donating moiety (D).
Binding of the substrate (ball) modiﬁes the energy of the electron donor, which
switches on the emission of the dye. Top: Representation of themolecular orbitals
involved in the PET process.
When the ﬂuorophore is irradiated at the appropriate wavelength, an electron of
its highest-occupied molecular orbital (HOMO) is promoted to the lowest-unoccupied
molecular orbital (LUMO).Whennoguest occupies thebinding site, PET canoccur from
the HOMO of the donor (indicated by D in Figure 1.2) to the one of the ﬂuorophore
(after excitation, and before emission takes place), thus quenching the ﬂuorescence.
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When a cation occupies the receptor, the redox potential of the donor is increased,
so that the relevant HOMO becomes lower in energy than that of the ﬂuorophore.
The PET process is no longer possible, and the ﬂuorescence is turned on. As will
be discussed in Chapter 2, 4d transition metals also exhibit redox activity, and can
therefore be involved in PET mechanisms.
Although many existing optical sensors work with the PET mechanism, numerous
other phenomena can be involved,[5] resulting in analyte-induced changes in ﬂuores-
cence or colorimetric properties (Table 1.1).
Table 1.1 – Optical response mechanism involving supramolecular interactions
between chemosensors and analytes.[5]
Mechanism Chromophore Fluorophore
Proton transfer X X
Tautomerism X X
Skeletal isomerism X X
Charge transfer X X
Polarization X X
Solvent displacement X
Conformational restriction X
Quenching by guest X
Internal charge transfer (ICT) X
Twisted internal charge transfer (TICT) X
Resonance energy transfer (RET) X
Photoinduced electron transfer (PET) X
Over the years, the signaling unit-spacer-receptor paradigmwas extensively studied
and applied,[2, 11--13, 18--21] with a particular emphasis on sensors for alkali or alkaline earth
metal cations,[22--29] transition metals,[28, 30--41] anions,[7, 8, 10, 42--44] sugars,[45] and neutral
organic species.[5, 46, 47]
Domaille et al. recently reported a ﬂuorescent PET sensor for Cu+ (3, Scheme 1.3).[31]
The selective detection of guests is performed by thioether-rich side-arms (binding
site) tethered to a boron-dipyrromethene ﬂuorophore (abbreviated BODIPY). In the
absence of any guest at the binding site, the ﬂuorescence of the BODIPY ﬂuorophore
is essentially quenched. This quenching is attributed to an electron transfer from the
amine bearing the BODIPY core. Upon cation binding (Cu+ in H2O, pH 7.0) by the
thioether side-arms, a dramatic increase in ﬂuorescence is observed. In this case, the
amino group is coordinated to the metal cation, and the lone pair formerly involved
in ﬂuorescence quenching is no longer available. The high selectivity observed for Cu+
1.3 Conjugated Chemosensors 7
is attributed to the soft-soft interactions between the thioether functions and the Cu+
cation.
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Scheme 1.3 – Fluorescent PET sensor 3 for Cu+.[31]
Live-cell experiments showed that chemosensor 3 is membrane-permeable and
that changes in the levels of Cu+within living cells canbe sensedby confocalmicroscopy
imaging. Applications such as studying intracellular redox chemistry of copper in brain
or immune systems can be envisioned, which is remarkable since the translation of a
sensor from a chemical system to a biological living one is a notoriously diﬃcult task to
achieve.
A ﬂuorescent PET sensor for the pyrophosphate anion was reported by the group
of Czarnik.[44] The design principle of sensor 4 is very similar to that of cation sensor 3
described above: the ﬂuorophore (anthracene) is linked to the binding site (made of
two tris(3-aminopropyl)amine residues) via a spacer (Scheme 1.4). Sensor 4 displays
good aﬃnity and selectivity for the pyrophosphate anion, as indicated by ﬂuorescence
titration experiments. Again, the ‘‘free’’ receptor is veryweakly ﬂuorescent, given that
the quenching of ﬂuorescence by the amino groups is very eﬃcient. In the presence of
pyrophosphate at the binding site, an enhancement of the ﬂuorescence is observed,
reﬂecting the electronic rearrangement induced by capturing the anion. Remarkably,
the preorganisation of the sensor allows for a good discrimination for pyrophosphate
towards phosphate anion.
Gawley et al. presented compound 5 as a selective, ﬂuorescent PET sensor for the
neurotoxin saxitoxin.[46] The typical features of a PET sensor are easily recognizable
(Scheme 1.5), although the interaction mechanism between the crown ether receptor
and the saxitoxin itself is much less straightforward. More complex interactions are
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Scheme 1.4 – Binding pattern of receptor 4 with pyrophosphate anion (PPi) by
means of hydrogen-bonding interactions.[44]
speculated to occur between the analyte and the ﬂuorophore, quenching the PET
process in the presence of saxitoxin.
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Scheme 1.5 – Saxitoxin, together with sensor 5, which is able to detect it down to
submillimolar concentrations.[46]
These examples and many others show that the very modulable receptor-spacer-
indicator scheme has been widely applied, and research in this area is still ﬂourishing.
However, these sensors can prove rather diﬃcult to develop. One canmention tedious
synthesis, solubility issues or poor selectivity, for instance, as recurrent problems
associated with this methodology. The next section presents a completely diﬀerent
approach to chemical sensing, which aims at overcoming these weaknesses.
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1.4 Sensing Ensembles
1.4.1 Deﬁnition and Examples
In contrast to the examples of chemosensors discussed so far, there is no requirement
of covalent bondingbetween thebinding and the signalingunits in the caseof a sensing
ensemble. More particularly, in the approach known as ‘‘indicator displacement assay’’
(IDA), a preliminary self-assembly of a receptor and an indicator is required. The
targeted analyte, possessing a higher aﬃnity for the receptor than the indicator, is able
to displace the latter from the binding site. This displacement event induces a change
in the colorimetric or ﬂuorescence properties of the indicator, as shown in Figure 1.3.
This method was ﬁrst applied by Inouye[48] and Shinkai,[49] who developed sensing
ensembles for acetylcholine. In the last 15 years, the ﬁeld was further developed and
numerous applications were found in the research groups of Eric Anslyn[1, 3, 50], of Luigi
Fabbrizzi,[51, 52] as well as in ours.[53]
+
Figure 1.3 – Working principle of an indicator displacement assay: upon binding
of the analyte (ball), the indicator (star) is expelled from the receptor (grey cup),
which translates into a change in color or ﬂuorescence.
The general strategy for the development of such a sensing ensemble is to build
a selective receptor for the analyte of interest. One then needs to ﬁnd an indicator
possessing approximately the same functional groups than the analyte. The indicator-
receptor interaction can be quantiﬁed, and the sensing conditions can be tuned, in
order to obtain the best response for the sensing of the analyte.[50] Anions have been
widely studied as targets for indicator displacement assays. Since many commercially
available dyes are anionic themselves, competitive binding with analytes is likely to
occur.
An example of sensing ensemble is provided by Piatek et al., who used compound
6 together with the dye alizarin complexone (7) to detect malate (hydroxybutane-
dioate) and tartrate (2,3-dihydroxybutanedioate) anions in beverages.[54, 55] The recep-
tor features a boronic acid moiety, which confers a good aﬃnity to vicinal diols, and
guanidinium groups which improve the aﬃnity for carboxylates (Scheme 1.6). It was
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observed that alizarin complexone (7) possesses some aﬃnity for receptor 6, but is
eﬃciently displaced by tartrate and malate anions.
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Scheme 1.6 – A chemosensing ensemble for tartrate and malate anions: the
receptor 6 and the alizarin complexone indicator (7).
Similar systems were developed for the detection of many diﬀerent analytes such
as inositol-1,4,5-triphosphate,[56] adenosine triphosphate,[57, 58] guanosine monophos-
phate[59] and triphosphate,[60] caﬀeine,[61] aspartate,[62] glutamate,[63] histidine,[64--66]
short peptides,[67] phosphates,[68--72] pyrophosphate,[52, 73, 74] phosphoesters,[75] 2,3-bis-
phosphoglycerate,[76] halides,[77] gluconic acid,[78, 79] α-hydroxyacids,[80, 81] (poly)carbo-
xylates,[54, 55, 82--85] carbonate,[86] heparin,[87] thiols,[88] nitric oxide,[89, 90] among others.
Enantioselective detection of amino acids was achieved,[91, 92] and high-throughput
screening was proposed to optimize sensing ensembles.[93]
The use of transition metals as receptors is of notable interest. This approach,
which was in particular pioneered by Fabbrizzi et al.,[10, 51, 52, 63, 66, 82, 83, 86] was exploited
in our group to build a sensor for histidine- ormethionine-containing short peptides.[65]
Here, the simpliﬁcation of the sensing ensemble goes a step further: both the indicator
and the rhodium-based receptor are commercially available. The colorimetric sensing
ensemble is made of the dye azophloxin (8) and organometallic complex [Cp*RhCl2]2
(C1). The addition of an analyte, which is able to bind to the Cp*Rh fragment, leads to
the replacement of the dye and to a change of color. In particular, it was observed that
short peptides containing histidine or methionine close to their N-terminus are able to
completely displace thedye: when thedipeptideHis-Ala is usedas analyte, the red color
of azophloxin is visible; however, if Val-Phe is used as analyte, the purple color of the
[Cp*Rh-azophloxin] adduct is visible. In summary, naked-eye detection of histidine or
methionine containing peptides could be achieved with this simple sensing ensemble
(Scheme 1.7).
The sensors or sensing ensembles described so far made successful use of Emil
Fischer's ‘‘lock-and-key’’ principle.[94] However, a conceptually diﬀerent approach was
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Scheme 1.7 – A chemosensing ensemble for sequence-selective detection of
histidine- and methionine-containing peptides in water.[65]
developed over the last decade, which aimed at abandoning the usually complicated
and sometimes serendipitous synthesis of highly selective receptors. This is the
principle behind the concept of sensor arrays, which is described in the next section.
1.4.2 Sensor Arrays
Inspiration for building arrays of diﬀerential sensorswas provided by the extraordinary
performances achievedby the sensesof taste and smell inmammals. Itwas established
that our olfactory and gustatory systems are made of several hundreds of cross
reactive sensors, which do not display high selectivity for speciﬁc analytes. Instead, the
composite response of the sensor array is interpreted and recorded as a given odor
or ﬂavor.[95] Pattern-based recognition of analytes was recognized as an interesting
alternative tomore classical detectionmethods.[96] Indeed, there are several classes of
analytes (including many bioanalytes such as peptides, nucleotides or sugars), which
proved to be tough targets for analyte-selective chemosensors, but which could be
eﬃciently analysed by sensor arrays.
A remarkable featureof pattern-based sensors is that the individual sensor units can
be rather unsophisticated as long as they give a diﬀerential response upon interaction
with the analyte. Furthermore, pattern-based sensors can be used for classes of
analytes, whereas normal chemosensors are generally used for one particular analyte.
Cross-reactive sensor arrays can be employed to detect analytes in the gas phase
or in solution. Gas-phase sensors are known as ‘‘electronic noses’’,[97] in analogy
to the pattern-based sensing of the olfactory system.[98--100] Research in the area
of electronic noses is quite advanced and sensors for diﬀerent applications such as
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food and beverages analyses, [101--105] follow-up of chemical processes,[106] or toxic gas
detection[107--109] have been developed and are commercially available.ƅ
These systems usually rely on arrays of diﬀerent materials that undergo modi-
ﬁcations of their properties when they are exposed to analytes. Cross-reactivity
arises from the variety of materials being used. Several types of sensors have been
developed,[98] which include sensors based on conducting polymers, metal oxide semi-
conductors, piezoelectric devices, optical ﬂuorescence and amperometric gas sensors.
The output signals are generally treated with pattern recognition algorithms.[110]
A remarkable ‘‘smell-seeing’’ device was proposed by Rakow and Suslick, which
allowsdetectionof variousgases andmixturesbyanarrayofmetalloporphyrin sensors.
Strong color changes occur upon exposure to various analytes, which make it possible
to visually interpret the response of the sensor.[111] The sensor array ismade of diﬀerent
metalloporphyrins ﬁxed in silica gel, and unique ‘‘color ﬁngerprints’’ of vapours down
to a few hundreds parts per billion can be obtained (Figure 1.4). This concept was
extended by the same group to the detection of toxic gases,[107, 108, 112, 113] as well as to
the analysis of coﬀee aromas.[101]
Figure 1.4 – Color ﬁngerprint for diﬀerent analytes (1.8 ppm): The response of a
minimal array of four metalloporphyrins is shown for n-octylamine, dodecanethiol
and tri-n-butylphosphine. (Reprinted by permission fromMacmillan Publishers Ltd:
Ref. [111], copyright 2000).
The pattern-based recognition of analytes in solution is less developed, but the
ﬁeld has advanced substantially over the last years. Sensors that display an electronic
signalling mechanism are referred to as ‘‘electronic tongues’’.[114--121] They have found
applications for the analyses of food and beverages, and of biological ﬂuids. The
construction of electronic tongues typically requires the fabrication of specialized
sensor hardware and electrode systems. This is in contrast to pattern-based sensors,
which arebasedonUV/Vis or ﬂuorescence spectroscopy.[95, 122--124] These techniques are
appealing because standard equipment can be used for the signal readout (e.g., plate
readers).
ƅFor example, see: www.osmetech.com
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Cross-reactive sensors with a colorimetric or a ﬂuorescence response have been
described for the solution-based detection of cations,[125--140] anions[141--145] and ion
pairs,[146] oforganic amines[147--153] andcarboxylates,[154--159] ofnitratedexplosives,[160--162]
nucleotides,[142, 163--167] steroids,[156, 168, 169] alkaloids,[170] carbohydrates,[165, 171--178] amino
acids,[179, 180] peptides,[181--188] and proteins,[184, 189--201] among others. It has also been
demonstrated that sensor arrays of this kind can be used for the classiﬁcation of
beverages.[127, 158, 159, 171, 175, 202] Furthermore, recent studies showed that cell classiﬁca-
tion into normal, cancerous and metastatic is achievable with conjugated polymer-
based sensor arrays.[203, 204]
For example, Palacios et al. reported a sensor array for the detection of metal
ions.[128] The array consists in a series of 8-hydroxyquinoline receptors linked to diﬀer-
ent conjugated ﬂuorophores 9 - 14 (Scheme 1.8).
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Scheme 1.8 – Hydroxyquinoline-based diﬀerential sensors 9 - 14. R = rac-2-
ethylhexyl, R' = n-hexyl. The extended conjugated chromophore is shown in red
color.[128]
Upon coordination of a metal cation to the hydroxyquinoline receptor, the ﬂuores-
cence of the conjugated ﬂuorophore is modiﬁed in a diﬀerential fashion (Figure 1.5).
Pattern recognitionmethods (see section 1.4.4) are used to estimate the discriminating
ability of the array, as well as the individual contribution of each sensor. This approach
allowsqualitativediscriminationbetween 10 cationswith high accuracy. As a real-world
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example, the capacity of the sensor array to discriminate between a series of enhanced
soft drinks, based on their Ca 2+, Mg 2+ and Zn 2+ contents, was presented.
9
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Figure 1.5 – Response patterns generated by the sensors (numbered 9 - 14)
displayed in Scheme 1.8 (λem = 525 nm) in the presence of 10 diﬀerentmetal cations.
The black tops in the graph indicate negative responses (Adapted with permission
from ref. [128]. Copyright 2008 American Chemical Society).
By examining Figure 1.5, it is clear that no individual sensor gives a selective
response towards a particular cation. On the other hand, it is also evident that the array
gives very diﬀerent responses for each analyte. This underlines the basic principle of a
sensor array: perfect selectivity is not required, but a diﬀerential response of a series
of sensors towards diﬀerent analytes is necessary.
1.4.3 Dynamic Combinatorial Libraries as Sensors
The use of dynamic combinatorial libraries (DCLs) as sensing systems is closely related
to the use of sensor arrays (roughly speaking, a DCL can be considered as the one-
pot version of an array). Assemblies can be formed in a reversible fashion when a
series of receptors and indicators are mixed. If there is cross-reactivity (i.e., each
receptor-indicator combination can theoretically be present), a dynamic combinatorial
library is obtained.[205--210] A DCL is a complex equilibrium between several interacting
species. Upon perturbation of the library (e.g., by addition of an analyte), a re-
equilibration process takes place and modiﬁes the composition of the library. If
this modiﬁcation can be transduced into a measurable signal, sensing of the analyte
becomes possible. Several studies have been published by our group, which take
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advantage of the properties of DCLs.[166, 183, 186, 188, 211, 212] The general protocol used in
these studies is quite simple: A DCL is constituted by mixing one or several metal
complexes (the receptor(s))with several dyes. After equilibration, theUV/Vis spectrum
reﬂects the composition of the library. When an analyte such as a peptide[180, 183, 186, 213]
or a nucleotide[166] is added, the DCL rearranges in an analyte-speciﬁc fashion, which
results in a change in theUV/Vis spectrum (Figure 1.6). In this case, thewhole spectrum
represents a ﬁngerprint for a given analyte, and can be analyzed by pattern recognition
procedures.
A A
Analyte
Figure 1.6 – Principle of a DCL sensor: a dynamicmixture of colored (or ﬂuorescent)
compounds undergoes an analyte-induced re-equilibration. The change in color (or
in ﬂuorescence) canbe related to thepresenceof an analyte, its concentration, and
its nature. Here, the absorbances measured at 6 wavelengths are represented by
the 6 colored bars.
Other research groups applied this sensing principle to the simultaneous detection
of tartrate and malate in solution,[157] citrate and Ca 2+ in ﬂavored vodkas,[158] or to the
sensing of analytes such as diamines,[150] histamine,[148] and proteins.[192]
In a recent publication, Margulies and Hamilton presented a sensing ensemble
based on G-quadruplexes.[192] A library of compounds is obtained when guanine-rich
DNA single strands tagged with diﬀerent ﬂuorophores are mixed together: using DNA
strands carrying 3 diﬀerent ﬂuorophores, an ensemble of 21 diﬀerent G-quadruplexes
can be generated, each one of thempossessing distinct ﬂuorescence properties. Upon
addition of a protein, its non-speciﬁc interactions with the various G-quadruplexes
result in a unique ﬂuorescence signature. With this method, it was demonstrated that
ﬁve diﬀerent proteins could be detected owing to the speciﬁc change they induce to
the emission response of the sensing ensemble.
1.4.4 Chemometrics
When sensor arrays or dynamic combinatorial libraries are employed as chemosensors,
they usually provide high-dimensionality data sets, which are diﬃcult to interpret quan-
titatively. Chemometrics is the application of statistical and mathematical methods to
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interpretmultivariate data and extract useful information.[110, 214] The twomethods that
our groupuses routinely are principal component analysis (PCA) and linear discriminant
analysis (LDA).[215]
Principal component analysis is a non-supervised method used to reduce the
dimensionality of a data set in order to make it easier to interpret. The non-supervised
character of the method implies that it does not ‘‘know’’ which data points should
belong to the same cluster, but it tries to classify them according to their similarities.
The fact that analyte-clusters naturally arise is evidence of the discriminating eﬃciency
of the data set, and allows to qualitatively diﬀerenciate one sample from another.
The data analysis consists in calculating orthogonal eigenvectors (the principal com-
ponents) lying in the direction of the maximum variance in the data set. Principal
components are generated in such away that the ﬁrst one contains the highest degree
of variance, and theother principal components followbyorder of decreasing variance.
In most of the cases that will be developed in the following chapters, two or three
principal components were enough to concentrate 95% of the total variance, thus
considerably reducing the dimensionality of the data set, while ensuring aminimal loss
of information.
Linear discriminant analysis is a supervised method, which implies that there is
a prior knowledge on which data points belong together. The routine tries to form
clusters of similar analytes, and tomaximize the separation between these clusters. As
for PCA, the analysis is performedbyﬁnding the linear combinationof sensor responses
that best describe similarities and diﬀerences between analytes. Functions that are
linear combinations of discriminating variables are created and used to describe the
existing data set. They are of the general form:
Fz = A+
pX
b=1
cb  Zb (1.1)
WhereA represents a constant, c the classiﬁcation coeﬃcients andZ the variables
(in the casewhere p variables are used). TheFz's are the discriminant scores, which are
used to predict group membership. The generated scores (or factors) are classiﬁed by
order of importance, and 2 or 3 scores are usually enough to describe 95% of the total
variance.
LDA is frequently considered as giving overly optimistic classiﬁcation results. In
order to obtainmore realistic evaluation of a system, one can use a jack-knife validation.
This routine excludes one observation from the original set, and uses the remaining
(n - 1) observations to estimate the discriminant functions. The group membership of
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the omitted observation is determined based on these functions, and the method is
repeated, successively excluding each observation. The proportion of correct classiﬁ-
cation of excludedobservations gives an estimate for the success of the discrimination.
Going a step further, it is alsopossible to exclude several observations fromthedata set
(the hold-out sample), and then calculate the discriminant functionswith the remaining
observations (the training sample). The observations belonging to the hold-out sample
can then be classiﬁed. A successful classiﬁcation of the unknown samples within
the proper clusters ensures the predictability and quality of a statistical model and,
consequently, of a sensing system.

2 Conjugate 12-Metallacrown-3Complexes for the SelectiveDetection of Lithium Ions
Synopsis
In this chapter are introduced the pharmacology of the lithium ion, as well as some
of the properties, that make it so challenging to detect. The chemosensors that
were developed by other research groups are reviewed, and our approach based
on metallacrown complexes is introduced. The syntheses of a series of ﬂuorescent
dihydroxypyridine ligands are described, as well as the reactions of these ligands with
[(p-cymene)RuCl2]2 or [(C6H5CH2NMe2H)RuCl2]2Cl2, which resulted in the formation of
12-metallacrown-3 complexes. These complexes were found to possess strong aﬃnity
and selectivity for lithium ions. By a judicious choice of the ﬂuorophore and the
arene π-ligand, a macrocycle was obtained that could be used in aqueous solution to
selectively and quantitatively detect lithium ions by ﬂuorescence spectroscopy.
Part of the work presented in this chapter was published in: S. Rochat, Z. Grote,
K. Severin, Org. Biomol. Chem. 2009, 7, 1147-1153, and in: S. Rochat, K. Severin, Chimia
2010, 64, 150-152.
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2.1 Pharmacology of Lithium Ions
AĚĘęėĆđĎĆē ĕĘĞĈčĎĆęėĎĘę John Cade is referred to as the father of the use of lithiumsalts in the treatment of psychotic excitement.[216] In 1949, he reported the
calming eﬀects of lithiumsalts onpatients suﬀering fromacutemania.[217] Thepotential
value in psychiatry was rapidly acknowledged and since the mid-1960s, lithium drugs
have been widely used for patients suﬀering from bipolar disorders. It must be
noted, however, that the use of lithium was delayed due to accounts from the USA
of deaths caused by lithium toxicity in cardiac patients.[218] Therefore, it was only in
1970 that the US Food and Drug Administration approved lithium for the treatment of
mania.[219] Since then, and despite the development of alternative drugs, lithium has
remained the gold standard for the treatment of acute episodes and the prevention
of relapses.[220--223] Recent studies suggest that lithium salts could also be of interest
for the treatment of amyotrophic lateral sclerosis (ALS)[224, 225] and of Alzheimer’s
disease.[226--228] It was even speculated whether lithium could become the ‘‘aspirin of
the brain’’.[229] Apart from applications in the ﬁeld of neurology and psychiatry, lithium
salts have been proposed to treat skin diseases and certain viral infections.[220, 222]
An important problem occuring with lithium treatment comes from the fact that
the eﬃcient concentrations in blood range from 0.5 mM to 1.5 mM, which is very
close to the concentrations where side-eﬀects and toxicity arise.[230--232] Furthermore,
a concentration of 5.0 mM can result in death. This potential toxicity makes the
control of concentration of prime importance during treatment periods. In view of
their pharmacological relevance, it is not surprising that considerable eﬀorts have been
devoted towards the development of sensors for lithium ions.[230, 232] In fact, a recent
review about the pharmacological action of lithium salts concludes that ‘‘...progress in
lithium research has been hampered by the unavailability of a sensitive and speciﬁc Li+
spectroscopic tool.’’[233]
2.2 Chemosensors for Lithium Ions
The lithium ion represents a challenging analyte. First, it is very well solvated, and a
potent ionophore is required in order to extract it fromwater (the hydration energy of
Li+ is -519 kJ mol-1).[234] Second, lithium usually appears in environments where poten-
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tially competing ions such as Na+, K+ orMg 2+ are present in high concentrations.[230, 235]
A good selectivity for Li+ is therefore required. Finally, if the goal is to detect lithium in
a homogeneous aqueous solution, a water soluble sensor is necessary, which strongly
limits the number of potential candidates. Many of the receptors and sensors, which
were reported in the past, are based on organic macrocycles, and were used in
organic solvents.[23, 25, 26, 230, 232, 236--255] Furthermore, although there are several publica-
tions about ﬂuoroionophores for Li+ in organic solvents,[23, 25, 26, 230, 237--240, 243, 244, 247--249]
only a few studies - summarized thereafter - report sensors working in homogeneous
aqueous solution.[24, 256, 257]
Caballero et al. have developed the ferrocene-anthracene dyad 15,[257] which can be
used in mixtures of acetonitrile and water (70:30) at pH 5.0 to detect lithium ions with
good selectivity over other cations (Figure 2.1). A ﬂuorescence enhancement could
be observed in the presence of Li+, which was attributed to the concomitant eﬀect of
protons on the imine bridge, and of Li+ captured by the ferrocene fragment.
N
Fe
15
Figure 2.1 – Fluorescence spectra of 15 (2.5  10-5 M, in CH3CN/H2O, 70:30) at: pH =
7.0 (red), pH = 5 .0 (black), pH = 7.0 in the presence of Li+ (blue), and pH = 5.0 in the
presence of Li+ (green). (Adapted with permission from ref. [257]. Copyright 2004
American Chemical Society).
Liu et al. presented crown ether derivative 16 (Scheme 2.1), which acts as a dual
sensor for Li+ ions and singlet oxygen (1O2).[256] Fluorescence measurements showed
that the emission intensity of compound 16 was very weak, due to eﬃcient PET from
the tetrathiafulvalene unit to the anthracene ﬂuorophore. In the presence of singlet
oxygen, an enhancement of the emission intensity was observed. Oxidation of the
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tetrathiafulvalene was assumed to inhibit the PET process, and to result in an emission
increase. After subsequent addition of Li+ to the system, ﬂuorescence was further
enhanced, which can be explained by additional restriction of PET by the presence of
the cation in the crown receptor. Interestingly, addition of Li+ alone does not aﬀect the
ﬂuorescence of compound 16. The presence of 1O2 is therefore required to trigger the
detection of Li+. This systemwas used inmixtures ofwater and tetrahydrofuran (20:80,
pH 7.0) and alkali metals other than lithium did not induce any measurable change in
ﬂuorescence.
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Scheme 2.1 – Crown ether annelated tetrathiafulvalene derivative with anthracene
moiety 16, which was used for the simultaneous sensing of 1O2 and Li+.[256]
Fluorescent probe 17 was presented by Citterio et al. as a sensor for Li+ ions in
water.[24] The use of a coumarin ﬂuorophore rendered the probe pH-insensitive over a
broad pH range. In addition to that, it was found that the tetramethyl 14-crown-4 bind-
ing site possessed a good selectivity for Li+ over other cations. The fused compound
17 was therefore quite successful in detecting Li+ in aqueous solutions. Nevertheless,
a small quantity of MeOH (1%) was required in order to solubilize the sensor, and its
synthesis was aﬀected by poor yields. The analogous compound 18 was immobilized
on a membrane, allowing the formation of a so-called optode (optical sensor), which
was able to detect lithium ions in aqueous solutions with high accuracy.
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17: R = CH3
18: R = (CH2)4-CH=CH2
Scheme 2.2 – Chemical structures of the Li+-selective ﬂuoroionophores 17 and 18.[24]
The same group recently reported ﬂuoroionophore 19 (Scheme 2.3), which can be
covalently immobilized on a porous glass support.[258] The recognition unit is again a
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14-crown-4 ether, and the ﬂuorophore is a BODIPY derivative. Compound 19 allows
measuring therapeutically relevant concentrations of Li+ in aqueous solutions with an
improved sensitivity and selectivity compared to sensor 18.
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Scheme 2.3 – Chemical structure of ﬂuoroionophore 19.[258]
None of the above-mentioned examples features a chemosensor, which is soluble
in 100%water. Regarding the numerous clinical applicationsmentioned earlier (section
2.1, p.21), as well as the widespread use of lithium in industrial ﬁelds (particularly
in batteries),[259] we expect that the needs for monitoring Li+ levels in biological or
environmental samples will be constantly increasing. In the following sections, we
report eﬀorts to address the triple challenge of solubility, selectivity, and sensitivity.
In particular, we will describe a ﬂuorescent conjugated chemosensor, that allows the
detection of low millimolar concentrations of lithium in water or serum with excellent
selectivity over Na+ or Mg 2+.[22, 260]
2.3 Design Strategy: Metallacrown Complexes
As recognition units for our lithium sensor, we decided to use 12-metallacrown-3
complexes.[53, 261--264] This class of compounds has been investigated extensively by
our group,[265--275] and by others.[276--279] They can easily be obtained by self-assembly
of half-sandwich complexes of Ru(II), Rh(III), or Ir(III) with organic ligands featuring
the 2,3-dihydroxypyridine motif.[263, 264] Organometallic half-sandwich complexes such
as [(p-cymene)RuCl2]2 (C2) or [Cp*RhCl2]2 (C1) are commercially available or easily
accessible, either by reaction of cyclohexa- or cyclopentadienes with MCl3  xH2O
(M = Ru, Rh, Ir),[280, 281] or by arene exchange.[282] Dimeric compounds of this type
are remarkably stable: solids can be handled without a protective atmosphere, and
solutions are only moderately air sensitive. They are soluble in many organic solvents,
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as well as in water, by formation of monomeric aqua complexes. The π-ligands usually
act as ancillary ligands, and the remaining three coordination sites can be used for the
coordination of anionic or neutral ligands. The fact that these coordination sites are
very labile[283, 284] is decisive, since lability is required for the systems to undergo error
correction during self-assembly processes.
Formation of trinuclearmacrocycles proceedswhen chloro-bridged organometallic
dimers react with 2,3-dihydroxypyridine ligands (DHP, L1) in the presence of a base
(Scheme 2.4). The macrocycles are usually well soluble in organic solvents, and
they display characteristic 1H NMR signatures: since the complexes possess a high
symmetry, only one set of signals is observed for the bridging ligands as well as for
the π-ligands. When p-cymene is used as π-ligand, one observes two signals for the
methyl protons of the isopropyl side chain. This indicates that the methyl groups are
diastereotopic. The metal centers are thus chiral and epimerization is slow compared
to the NMR time scale. Since only one set of signals is observed, the self-assembly
process is completely diastereoselective (a racemic mixture of MRMRMR and MSMSMS
is obtained).
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Scheme 2.4 – Top: Self-assembly of organometallic complexes of the general
formula [(π-ligand)M(L1)]3 and their 12-metallacrown-3 scaﬀold. Bottom: Ex-
amples of metal fragments, which can be used for the formation of trinuclear
metallamacrocycles.
Complexes of the general formula [(π-ligand)M(L1)]3 represent analogues of or-
ganic 12-crown-3 ethers. The ﬁrst examples of organometallic analogues of crown
ethers were published in 1989, and consisted of a manganese-based mimic of 12-
crown-4,[285] and of an iron-based mimic of 9-crown-3, respectively.[286] Since then,
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numerousmetallacrowns have been reported, from small 8-membermolecular wheels
up to 60-metallacrown-20 complexes.[262] Not surprisingly, 12-metallacrown-3 com-
plexes (Scheme 2.4) can accomodate small cations next to the three adjacent oxygen
atoms, similarly to their organic counterparts. Several lithium and sodium adducts
have been isolated, and the selectivity for these small cations was found to be largely
dependent on the steric requirements of π-ligands. Furthermore, certain conditions
were found to enable accomodation of Li+ only.[273] Competition experiments revealed
that the host-guest complexes are extremely stable, and that association constants
are comparable to that of cryptands.[274, 275] Several reasons were cited in order to
explain this exceptional aﬃnity:[274, 275] (a) The receptors are highly preorganized and
rigid. (b) The energetic costs for desolvation of the donor atoms is very small because
the binding site is well shielded by the π-ligands. (c) The salts are bound as ion pairs,
with the anion occupying the fourth coordination site of the Li+ or Na+ ion. In addition
to that, theoretical data show that the partial negative charges on the O-donor atoms
of the metallamacrocycle are larger than those on the O-donor atoms of 12-crown-3
(-0.88 versus -0.59).[269] Electrostatic reasons can therefore also be invoked to explain
the strikingly high aﬃnity of 12-metallacrown-3 complexes for small cations.
Coordination of guest molecules to the binding site of macrocycles is fairly easy to
detect by 1H NMR spectroscopy: upon binding of Li+ or Na+, the aromatic signals of
pyridine and arene are shifted towards higher chemical shifts. If all the macrocycles
in solution are not occupied by a cationic guest, two sets of signals can be observed,
one corresponding to the ‘‘free’’ receptor, and the other one corresponding to the
adduct. The fact that the cation exchange is slow on the NMR time scale makes the
quantiﬁcation of adduct formation (i.e., determination of the association constant)
very easy. Interestingly, the presence of a cation at the binding site can also be
detected electrochemically: in the presence of Li+, the metal centers are more diﬃcult
to oxidize, which can be measured by cyclic voltammetry experiments.[273, 274]
The fact that ion pairs are captured in organic apolar solventswas exploited to build
a sensor for the ﬂuoride anion:[270] a macrocycle was designed, which could accomo-
date only the small F  anion together with Li+ in its binding pocket. The presence of
ﬂuoride can be followed by electrochemical measurements (in the presence of F , the
macrocycle is signiﬁcantly easier to oxidize).
Water-soluble 12-metallacrown-3 complexes were obtained by using modiﬁed di-
hydroxypyridine ligands (Scheme 2.5).[267, 268] The solubility is conferred by appended
amino groups, which can be easily added to dihydroxypyridine ligands by Mannich
reactions.[287--290] Protonation of these groups inwater at neutral pH enhances the solu-
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bility of the trimeric macrocycles. Synthesis of water soluble metallacrown complexes
is remarkably simple: all that is required is tomix the organometallic dimeric complexes
and bridging ligands inwater at neutral pH in the presence of a buﬀer, or inmethanol in
the presence of a base. When performed in water, self-assembly aﬀords quantitative
yields of the desired trimeric species.[267, 268] Strong aﬃnity for Li+ ions persists even
in a polar solvent such as water, and still depends on the π-ligands. Complex M1, for
example, is able to bind lithium ions in aqueous solutionwith a binding constant of Ka =
5.8 ( 1.0)  104 M−1 (Scheme 2.5),[267] whereas sodium ions are boundwithmuch lower
aﬃnity (Ka = 5.0 ( 1.0) M−1).
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Scheme 2.5 – Representation of the Li+ adduct of complexM1with view along the
C3 symmetry axis.
A simple ‘‘naked-eye’’ chemosensor for low millimolar concentrations of Li+ was
devised:[267] When FeCl3 was added to an aqueous solution of receptorM1, fast decom-
position of the macrocycle occured, and resulted in an immediate color change from
orange to dark brown. In the presence of Li+ ions, this reactionwas kinetically inhibited
and addition of FeCl3 led to no immediate color change (Figure 2.2).
In order to convert macrocyclic receptors into ﬂuoroionophores, our strategy was
to attach a ﬂuorophore to the 2,3-dihydroxypyridine ligands. Upon formation of a
macrocycle, the ﬂuorescence is expected to be quenched due to electron transfer
from the transition metals. In the presence of lithium ions, however, the transition
metals are more diﬃcult to oxidize (ΔE  300 mV),[273, 274] and the quenching eﬀect is
expected to be reduced (Scheme 2.6). The detection of Li+ can therefore be performed
by a simple ﬂuorescencemeasurement. Themodular nature of themacrocycles allows
for the organic ligand and organometallic complex to be separately modiﬁed until an
optimal combination is found.
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Figure 2.2 – Photos of aqueous solutions containing diﬀerent concentrations of
macrocycle M1 (0.5, 1.0, and 1.6 mM) and diﬀerent lithium concentrations (0.1,
1.0, and 1.6 mM) after addition of an excess of FeCl3. A brown color is observed
for solutions in which receptor M1 is not saturated with Li+. (Reproduced with
permission from ref. [267]. Copyright 2004 American Chemical Society).
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Scheme 2.6 – Sensing of Li+ ions by a 12-metallacrown-3 based sensor. The
ﬂuorescence is turned on upon coordination of lithium at the binding site. M =
transition metal.
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2.4 Towards Water-Soluble Fluoroionophores
2.4.1 Macrocycles Based on (p-cymene)Ru Fragments
The ﬁrst ﬂuorescent 12-metallacrown-3 complex that was prepared was tagged with
pyrene ﬂuorophores. The organic bridging ligand L5, carrying the pyrene moiety was
obtained by reductive amination of 1-pyrenecarboxaldehyde with 4-aminomethyl-2,3-
dihydroxypyridine (L4). The latter was prepared by a Mannich reaction of commercial
2,3-dihydroxypyridine (L1) with dibenzylamine, followed by hydrogenolysis over Pd/C
(Scheme 2.7).
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Scheme 2.7 – Synthesis of organic bridging ligand L5, followed by self-assembly of
macrocycleM2.
Complex M2 was then obtained by reaction of bridging ligand L5 with the chloro
dimer [(p-cymene)RuCl2]2 (C2) in methanol in the presence of a base (CsOH). After
ﬁltration, the productwas separated from the residual salts bywashingwithmethanol.
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MacrocycleM2, which contains the highly hydrophobic pyrene ﬂuorophore, was only
moderately soluble in benzene and in dichloromethane. To evaluate the aﬃnity ofM2
for lithium cations, the complexation of Li+ was studied using 1H NMR spectroscopy.
12.5 μL of a 100 mM LiCl stock solution in CD3OD were added to 487.5 μL of a solution
of complex M2 in C6D6. (Final concentrations: [M2] = 5.0 mM; [Li+] = 2.5 mM). After
stirring for 5 minutes, the 1H NMR spectrum of the solution was examined. It showed
that macrocycle M2 was still present, but it also displayed a new set of signals. The
two sets of signals had the same intensity, and we attributed the new set to the Li+
adduct (Figure 2.3).ƅ The peaks of the Li+ adductwere slightly shifted and in some cases
strongly broadened (aromatic p-cymene signals) compared to those of complex M2.
More detailed complexation studies were not performed due to the poor solubility
of the macrocycle in polar solvents. However, it was concluded that the presence
of sterically demanding ﬂuorophores on the macrocycle does not prevent Li+ from
reaching the binding site.
2.53.03.54.04.55.05.56.06.57.07.58.08.5
(ppm)
* *
Figure 2.3 – Bottom: region of the 1H NMR spectrum of the receptor M2 (5.0
mM) in C6D6 containing 2.5 vol% CD3OD. Top: receptor M2 in the presence of
0.5 equivalent (2.5 mM) of LiCl. The peaks labeled with n indicate the presence
of signals corresponding to the pyridine and/or p-cymene of the macrocycle–Li+
adduct. The asterisks indicate the solvents peaks.
ƅThe fact that two sets of signals are observed indicates that the exchange of Li+ is slow compared
to the NMR time scale, as reported in previous studies (see for example ref. [264]).
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Two approaches were pursued in order to obtain more soluble complexes. First,
a series of ligands bearing less lipophilic ﬂuorophores was synthesized. In all cases,
ligand L4 was used as starting material: ligand L6 was obtained by reaction between
L4 and N-methylisatoic anhydride, resulting in the formation of an amide bond; L7was
formed by reaction of L4with dansyl chloride (dansyl = 5-dimethylaminonaphthalene-1
sulfonyl), resulting in a sulfonamide linkage; ligands L8 - L10 were formed in two
stepsby reductive aminationbetween L4 and the respective formylcoumarin derivative
(Scheme 2.8).
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Conjointly, a modiﬁed π-ligand was used in order to enhance the solubility of the
macrocycle in water. Together with standard [(p-cymene)RuCl2]2 (C2), we synthe-
sized amino-substituted [(C6H5CH2NMe2H)RuCl2]2Cl2 (C3, scheme Scheme 2.9).[291] The
tertiary amino groups of the arene π-ligand were expected to enhance the solubility
of the resulting macrocycles in water. Chloro dimer C3 was obtained by reaction
of the corresponding diene ammonium salt with hydrated RuCl3. The diene itself
was obtained by a Birch reduction of commercially availableN,N-dimethylbenzylamine,
followed by protonation of the amino group.
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Scheme 2.9 – Representation of the dimeric complex C3.
As described below, organic ligands L6 - L10were combined with ruthenium arene
chloro dimers C2 and C3 in order to form 12-metallacrown-3 complexes. Their solubility
properties and lithium aﬃnity depend on both the π-ligand and the ﬂuorophore (as
summarized in Table 2.1)
Table 2.1 –Macrocycles that were obtained by combination between organometal-
lic chloro complexes C2 or C3with various organic ligands. The most polar solvent
(or combination) able todissolve signiﬁcant amounts of themacrocycle is indicated
(H2O refers to buﬀer solutions at pH 7.0 or 8.0).
Macrocycle Ru fragment Bridging ligand Solubility
M1ƅ C2 L2 H2O
M2 C2 L5 C6H6
M3 C2 L6 MeOH
M4 C3 L1 H2O
M5 C3 L2 H2O
M6 C3 L5 CH2Cl2
M7 C3 L6 MeOH/H2O 1:1
M8 C3 L7 MeOH/H2O 7:3
M9 C3 L8 H2O
M10 C3 L10 H2O
ƅThe use of the non-ﬂuorescent receptorM1will be presented in Chapter 3.
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ComplexM3was synthesized by the reaction of ligand L6with [(p-cymene)RuCl2]2
(C2) in methanol in the presence of CsOH. After removal of the solvent, the complex
was extracted from the residual salts with chloroform, and isolated by precipitation
upon addition of hexane (Scheme 2.10).
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Scheme 2.10 – MacrocycleM3.
It was observed that macrocycle M3 was soluble in methanol (unlike M2), but
that its solubility was considerably reduced upon addition of water to the solution.
Therefore, investigations on complex M3 were not pursued further, and from this
point, our eﬀorts focused on using themodiﬁed ruthenium chloro dimer C3 as building
block for our sensors.
2.4.2 Macrocycles Based on Modiﬁed Ru Fragments
Self-Assembly with Non-Fluorescent Ligands
In order to verify that 12-metallacrown-3 complexes could be formed with modiﬁed
ruthenium fragment [(C6H5CH2NMe2H)RuCl2]2Cl2 (C3), the syntheses of simple macro-
cycles M4 and M5 were performed (Scheme 2.11). Analogous complexes made from
widely used [(p-cymene)RuCl2]2 had been synthesized and extensively studied in our
laboratory,[53, 264, 267, 269, 271, 272, 274, 275] and similar procedureswere developed for synthe-
sis with complex [(C6H5CH2NMe2H)RuCl2]2Cl2. For the preparation of complex M4,
commercially available 2,3-dihydroxypyridine (L1)was stirred inmethanolwith complex
C3 in the presence of CsOH. After evaporation of the solvent, the macrocycle was
extractedwith dichloromethane and precipitated by addition of hexane. Interestingly,
complex M4 was found to be soluble in water at neutral pH, which was not the case
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for the similar macrocycle based on the (p-cymene)Ru fragment.[274, 275] The synthesis
of complexM5 was performed in the same manner, using organic ligand L2, that had
been prepared by a Mannich reaction of 2,3-dihydroxypyridine, formaldehyde and N-
methylpiperazine.[267] As in the case of complexM4, macrocycle M5 was found to be
well soluble in water at neutral pH. This was expected since themethylpiperazine side-
chains can be protonated, enhancing the solubility of the macrocycle.
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Scheme 2.11 – MacrocycleM4 andM5 (neutral forms).
Furthermore, macrocyclesM4 andM5 could be obtained by self-assembly directly
in water (in the presence of a buﬀer) by mixing appropriate amounts of the building
blocks (ligands L1 or L2 with chloro dimer C3 in H2O pH 8.0, 100 mM phosphate).
In this case, the reaction is essentially quantitative and can be followed by 1H NMR
if it is performed in deuterated solvent. NMR also allowed to study the aﬃnity of
receptors M4 and M5 for Li+ ions. When the macrocycles were dissolved in water
(phosphate buﬀer, pH 8.0) in the presence of an excess of Li+, a new set of signals
appeared, which was attributed to the adduct. Smaller signals corresponding to
the uncomplexed receptors M4 and M5 were also visible, which made it possible to
estimate the association constants as Ka(Li+) = 3.2 ( 0.3)  103 M-1 for receptorM4, and
Ka(Li+) = 1.2 ( 0.6)  103 M-1 for receptorM5. The error on the second value is relatively
important, since the 1H NMR spectrum was considerabely broadened after addition
of LiCl, and therefore contained few suitable signals. Still, these results are important
since they indicate that complex [(C6H5CH2NMe2H)RuCl2]2Cl2 (C3) iswell adapted to the
self-assembly of 12-metallacrown-3 complexes, and that in spite of additional positive
charges, the corresponding receptors still possess a good aﬃnity for Li+ ions.
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Self-Assembly with Fluorescent Ligands
A series of syntheses was undertaken, the goal of which was the formation of macro-
cyclesM6 -M10. These were obtained by reaction of organic bridging ligands L5 - L10
with ruthenium complex [(C6H5CH2NMe2H)RuCl2]2Cl2 (C3) inmethanol, in the presence
of CsOH or Cs2CO3 (Scheme 2.12).
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Scheme 2.12 – Synthesis ofmacrocyclesM6 -M10. The corresponding ﬂuorophores
are indicated.
MacrocycleM6, which contains the pyrene ﬂuorophore, was prepared in the same
manner as macrocycle M2 described in Scheme 2.7. No signiﬁcant improvement in
terms of solubility was observed compared to the analogous complex M2, which
features p-cymene as π-ligand.
We then decided to focus on the less lipophilic ligands L6 - L10. When ligand L6
was mixed with [(C6H5CH2NMe2H)RuCl2]2Cl2 in methanol in the presence of CsOH,
macrocycle M7 was formed. After evaporation of the solvent, the complex was
extracted with dichloromethane and isolated by precipitation. Macrocycle M7 was
found to be soluble in organic solvents (MeOH, CH2Cl2, CHCl3), aswell as in a 1:1 mixture
of methanol and buﬀered water (pH 7.0 - 8.0, 50 mM phosphate). 1H NMR studies
for this complex were made diﬃcult by a considerable broadening of the signal upon
additionof lithiumsalts, andby several overlaps between the signals of themacrocycle,
and those of the lithium adduct. However, the fact that the spectrum undergoes
important changes (broadening, shift of the signals) led us to be conﬁdent that a
good aﬃnity between compoundM7 and Li+ exists. Taking advantage of the relatively
good solubility properties of the complex, a series of ﬂuorescence experiments was
performed. First, we observed that the ﬂuorescence of the N-methylanthranilic acid
dye was almost completely quenched upon formation of the macrocyclic receptor.
This was an expected eﬀect of the Ru(II) centers, which are able to quench the
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ﬂuorescence by electron transfer. However, the quenching seemed particularly strong
in the present case: at the maximum intensity, the ﬂuorescence decreased by a factor
of approximately 3000. Second, a small but signiﬁcant recovery of the ﬂuorescence
was observed when Li+ was present in solution. This turn-on was very weak: When
4.0 mM Li+ was added to a 2.0 mM solution of M7 in a 1:1 mixture of methanol and
water (ﬁnal phosphate concentration: 50mM), the ﬂuorescence intensity increased by
a factor of 1.3 (λex = 350 nm, λem = 507 nm, Figure 2.4). We propose that the ‘‘turn-on’’
response of receptorM7 upon the binding of Li+ is due to the reduced ability of the Ru
centers to quench the ﬂuorescence of the ﬂuorophores. This assumption is supported
by electrochemical measurements, which have shown that Ru-based metallacrown
complexes are signiﬁcantly more diﬃcult to oxidize in the presence of Li+.[273, 274]
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Figure 2.4 – Emission spectra ofmacrocycleM7 (2.0mM) inmethanol/water (1:1, pH
7.0, 50 mM phosphate buﬀer) in absence of Li+ (solid line), and after equilibration
with 4.0 mM Li+ (dashed line). Excitation wavelength: 350 nm.
ComplexM8, bearing dansyl ﬂuorophores, was synthesized by reaction of L7 with
[(C6H5CH2NMe2H)RuCl2]2Cl2 in methanol in the presence of Cs2CO3. After removal of
the solvent, the complex was extracted from the residual salts with dichloromethane
and isolated by precipitation. Macrocycle M8 turned out to be soluble in aqueous
methanol (containing up to 30%H2O)but not in purewater. The 1HNMRspectra of solu-
tions containingM8 and various concentrations of LiCl unequivocally indicated a strong
aﬃnity between the macrocycle and Li+. The association constant was determined
by NMR measurements: a 1.5-fold excess of LiCl (3.0 mM) was added to a solution
of macrocycle M8 (2.0 mM) in CD3OD/D2O (9:1, pD 7.0, 10 mM phosphate buﬀer).
After stirring for 5 minutes, the 1H NMR spectrum was recorded. A new set of signals,
corresponding to the Li+ adduct, was visible togetherwith the signals corresponding to
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uncomplexed receptorM8. The ratio of the two specieswas determinedby integration
of selected signals. From that, the association constant was calculated as Ka(Li+) = 6.4
( 0.6) 103 M-1. The water content of the solution could be increased to 30% if HEPES
buﬀer was used, since phosphate salts show a limited solubility in MeOH/H2O. The
ﬂuorescence of complexM8was again strongly reduced compared to that of the free
ligand L7. Still, solutions of complex M8 displayed a pronounced ﬂuorescence signal
centered at 547 nm when excited at 360 nm. This signal increased in intensity when
LiCl was added to the solution (Figure 2.5), as was reported in the case of M7. This
time, however, the increase in emission intensity was more pronounced.
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Figure 2.5 – Increase of the emission signal of macrocycle M8 (2.0 mM) in
methanol/water (9:1, pH 7.0, 10 mM phosphate buﬀer) upon the addition of LiCl
(0.0, 0.5, 1.5 and 3.0 mM). Excitation wavelength: 360 nm.
The next series of ﬂuorescent ligands that were investigated are based on the
coumarin ﬂuorophore. Commercially available coumarin was formylated in basic
solution in the presence of chloroform.[292] Ligand L8 was prepared by reductive
amination of amino-substituted dihydroxypyridine L4 with 6-formylcoumarin. Ligand
L8 proved diﬃcult to purify with standard techniques, and semi-preparative reversed-
phase HPLC was used. Since only small quantities of puriﬁed product were available,
synthesis of macrocycles in methanol in the presence of base was not attempted.
However, macrocycle M9 could be formed by self-assembly of ruthenium complex
C3 with ligand L8 directly in water in the presence of a buﬀer (pH 8.0, 100 mM
phosphate). The formation of macrocycleM9 could be observed by 1H NMRwhen the
self-assembly was performed in D2O. It has to be noted, however, that the 1H NMR
spectrum displayed several extra peaks in addition to the expected signals of M9. It
appears likely that the reaction leads to side products. Nevertheless, when lithium
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ions were present in solution, the 1H NMR spectrum displayed a new set of signals,
corresponding to the adduct. Having this ﬁrst water soluble macrocycle in hands, we
investigated its ﬂuorescence properties. The overall ﬂuorescencewas extremely weak
  although still detectable  in the absence of Li+ in solution. Upon stepwise addition
of LiCl, an increase in the ﬂuorescence signal was observed. This increase was not
very pronounced: the increase factor estimated for the situation where the receptor is
saturated with Li+ is 1.35 (Figure 2.6).
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Figure 2.6 – Relative emission intensity of [(C6H5CH2NMe2)Ru(L8)]3 (2.0mM in H2O
(pH 7.0)) as a function of Li+ concentration. The curve was obtained by ﬁtting the
data to a 1:1 binding model. λex = 495 nm, λem = 523 nm.
The titration data were ﬁtted with the nonlinear least square curve-ﬁtting program
WinEQNMR[293] using a 1:1 bindingmodelƆ to calculate the association constant: Ka(Li+)
= 3.5 ( 1.0)  102 M-1.
Macrocycle M9 represents a ﬁrst success towards a sensor for Li+ in water. How-
ever, the fact that the 1H NMR spectrum was not perfect, the weak ﬂuorescence,
and the limited emission intensity increase upon Li+ coordination encouraged us to
search for diﬀerent ligands. Based on the results obtained with complexM9, several
important conclusions could be drawn: 1) coumarin-based ﬂuorophores represent a
suitable option; 2) an amino groupbetween the ﬂuorophore and the dihydroxypyridine
confers additional solubility in water, and 3) the modiﬁed π-ligand carrying additional
amino groups is necessary to ensure a good solubility.
Ligand L9 was synthesized by reductive amination of dihydroxypyridine derivative
L4 and 8-formyl-7-hydroxycoumarin. The puriﬁcation was the most problematic step,
ƆDue to steric reasons, the binding site of a 12-metallacrown-3 complex can only accommodate one
cation.
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and it required the use of semi-preparative HPLC. When self-assembly of ligand L9
and organometallic complexes C2 or C3 was attempted in water or in methanol,
the resulting solution contained a mixture of species (as observed by 1H NMR). The
complicated mixtures could not be separated, and no corresponding macrocycle was
isolated. We attributed these problems to the hydroxycoumarin moiety, which is
likely to interact with Ru centers during the self-assembly process. This led us to
synthesize ligand L10, which is theO-methylated equivalent of L9. Reductive amination
ofdihydroxypyridinederivative L4and8-formyl-7-methoxycoumarin formed ligandL10,
which was puriﬁed by reversed phase HPLC. In the next section, we show how ligand
L10was used to build a selective ﬂuorescent sensor for Li+, which was used in buﬀered
aqueous solutions and in human serum.
2.5 A Fluorescence Sensor for Lithium Ions in Water and
Serum
Complex M10 was synthesized by the base-assisted reaction of bridging ligand L10
with [(C6H5CH2NMe2H)RuCl2]2Cl2 (C3) in methanol, followed by extraction with di-
chloromethane. The complex is soluble in water at neutral pH. It was therefore
possible to generate macrocycle M10 by simply mixing two equivalents of ligand L10
with complex C3 in water (pH 8.0, 100 mM phosphate buﬀer). The in situ reaction is
essentially quantitative and further host-guest experiments were performed without
prior isolation of macrocycleM10 (Scheme 2.13).
When 2 equivalents of LiCl were added to an aqueous solution of complex M10,
the 1H NMR spectrum showed new signals for the Li+ adduct along with small sig-
nals for remaining M10 (Figure 2.7). From the ratio of the two species, a value of
Ka(Li+) = 8.3 ( 0.3)  102 M-1 was calculated. This value is similar to what had been
observed for water-soluble (p-cymene)Ru-derived metallacrown complexes.[267] The
same experiment performed with a large excess of NaCl instead of LiCl allowed us to
estimate the binding constant for sodium as Ka(Na+) = 6 ( 3)  10-1 M-1, thus indicating
a remarkable Li+:Na+ selectivity of 3 orders of magnitude. Previous investigations
had shown that organometallic 12-metallacrown-3 complexes have a negligible aﬃnity
for K+. Binding studies with K+ were therefore not performed. Due to its solubility
in water, complex M10 was selected for more detailed ﬂuorescence investigations.
Solutions of complexM10 displayed a ﬂuorescence signal at 480 nm when excited at
382 nm. Upon incremental addition of LiCl to an aqueous solution ofM10, an increase
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Scheme 2.13 – FluoroionophoreM10 (neutral form).
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Figure 2.7 – Bottom: 1H NMR spectrum of receptorM10 (5.0 mM) in D2O (pD 8.0,
100 mM phosphate buﬀer). Top: receptorM10 in the presence of 2 equivalents of
LiCl. The arrows indicate signals of the pyridine ring; in the presence of Li+, these
signals are slightly downﬁeld shifted, and some ‘‘empty’’ receptor is still visible.
The asterisk indicates the water peak.
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in the ﬂuorescence was observed (Figure 2.8). Kinetic measurements showed that the
responsewas very quick and that a stable signal was obtained after 1 minute.Ƈ The data
were ﬁtted to a 1:1 binding model with the help of the non-linear least square curve-
ﬁtting programWinEQNMR.[293] The obtained value of Ka(Li+) = 7.4 ( 0.6)  102 M-1 was
in good agreement with the NMR studies.
0 2 4 6 8 10
1.0
1.5
2.0
2.5
I/I
0
cation concentration / mM
Figure 2.8 – Relative ﬂuorescence intensity at 480 nm (excitation at 382 nm) for
solutions containing metallacrown complex M10 (2.0 mM) and variable amounts
of LiCl (s and n) or NaCl (l). The data labeled with n and l were obtained in
water (100 mM phosphate buﬀer, pH 8.0), whereas the data labeled withs were
obtained in serum after removal of proteins.
In biological samples such as serum, the Na+ concentration can be more than 100
times higher than the pharmacologically relevant Li+ concentration of around 1.0 mM.
For potential applications, it is therefore of prime importance that the sensor displays
a very good selectivity for Li+ over Na+. Fluorescence titration experiments with NaCl
instead of LiCl showed that complexM10 is indeed highly speciﬁc (Figure 2.8). Only a
minor increase (less than 15%) in ﬂuorescence was observed for Na+ concentrations of
up to 140mM.Mg 2+ is another potentially interfering ion,[233] but sensorM10 showed a
negligible response for concentrations of up to 3.0 mM, which is much higher than the
biological relevant concentration.
Encouraged by the results obtained in water, we investigated whether metal-
lacrown sensor M10 could be used in a more complex environment such as human
serum. Blood serum contains numerous salts, glucose, hormones, and proteins (with
albumin, transferrin and immunoglobulins representing 90% of the total weight).[235]
ƇDependingon thenatureof the (π-ligand)M fragment and its steric requirements, 12-metallacrown-3
complexes may display very slow Li+ binding kinetics. See for example ref. [265] and ref. [269].
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The latter were expected to interfere with our sensor due to autoﬂuorescence and
competitive coordination to the (arene)Ru complexes. Consequently, large proteins
were removed prior to analysis by a simple precipitation procedure.[294] Fluorescence
measurementswere then performedwith samples that contained diﬀerent concentra-
tions of LiCl. The results were similar to what was observed for water: the presence
of Li+ resulted in a concentration-dependent increase in ﬂuorescence (Figure 2.8). The
signal to noise ratio was suﬃcient for quantitative measurements in the biologically
interesting concentration range of 0.5 – 3.0 mM. Fitting of the binding isotherm gave
an association constant ofKa(Li+) = 8.3 (0.6)  102M-1, and the increase in ﬂuorescence
was slightly more pronounced than for the measurements performed in water.
2.6 Conclusions
In this chapter are reported the syntheses and host-guest properties of ﬂuorescent
(arene)Ru-based 12-metallacrown-3 complexes. The solubility of the complexes was
found to depend strongly on the arene π-ligand, as well as on the appended ﬂu-
orophore. In order to obtain water soluble complexes, several solubilizing amino
groups were needed: both on the arene π-ligand and in the spacer connecting the
dihydroxypyridine to the ﬂuorophore. Moreover, the appended ﬂuorophores could
not be too lipophilic, to avoid compromising the solubility of the macrocycles.
Two water soluble complexes (M9 and M10) were obtained by combining a Ru
complex carrying an amino-substituted π-ligand with coumarin and methoxycoumarin
ﬂuorophores, respectively. Although both complexes act as ‘‘turn-on’’ ﬂuorescence
sensors,M10was the most interesting one for the following reasons: its ﬂuorescence
wasmore intense than that ofM9 (even if thequenchingby theRu centerswas still very
eﬃcient); its emission intensity nearly doubles in the presence of Li+; its association
constant Ka(Li+) is higher than that ofM9; and the self-assembly process allows the in
situ formation of pureM10, which was not the case for complexM9.
ComplexM10 can be used to quantify lowmillimolar concentrations of the pharma-
cologically important lithium ion. The sensor can be formed in situ from ligand L10 and
[(C6H5CH2NMe2H)RuCl2]2Cl2 (C3), both of which are straightforward to synthesize. A
key advantage ofM10 is the high aﬃnity and selectivity for Li+, which allows working in
purely aqueous solution in thepresenceof anexcess ofNa+, or in a complexmatrix such
as serum. A current limitation is the modest increase in signal intensity (up to 2.5-fold)
and the low overall ﬂuorescence. It should be possible, however, to overcome these
limitations by changing the nature of the (π-ligand)M fragment and the ﬂuorophore.
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Nevertheless, as was shown by the examples presented above, the solubility of the
sensors remains the main issue, which must be kept in mind when modiﬁcations are
considered.

3 Simple Assays for the FluorometricDetection of Lithium Ions inAqueous Solution
Synopsis
In this chapter are presented simple ruthenium-based assays for the selective detection
of lithium ions in buﬀered aqueous solution or in deproteinized serum by ﬂuorescence
spectroscopy. Awater-solublemetallacrown complex served as the recognition unit of
the sensing ensembles. Themetallacrown complex could be obtained in situ bymixing
solutions of complex [(p-cymene)RuCl2]2 with a dihydroxypyridine bridging ligand.
The addition of the ﬂuorescent dyes 1-hydroxypyrene-3,6,8-trisulfonic acid (HPTS) or
Calcein Blue (CAB) to the metallacrown complex resulted in a quenching of the ﬂuo-
rescence, either by formation of a non-covalent aggregate (HPTS) or by destruction of
the metallacrown structure (CAB). Signiﬁcantly increased ﬂuorescence was observed
for solutions containing lithium ions. Mixtures containing [(p-cymene)RuCl2]2, the
dihydroxypyridine ligand, and either HPTS or CAB could therefore be used as turn-on
ﬂuorescence sensors for lithium ions.
The work presented in this chapter was a collaboration between Jie Gao and the
author (equal contribution from both sides), and part of it was published in: J. Gao, S.
Rochat, X. Qian, K. Severin, Chem. Eur. J. 2010, 16, 5013-5017.
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3.1 Introduction
FĎėĘę ĘĚĈĈĊĘĘ towards the development of ﬂuorescent sensors, which are able todetect lithium ions in water, is reported in Chapter 2. In particular, complexM10,
carrying themethoxycoumarin ﬂuorophore, displays a very good selectivity for Li+, and
could also be used in the presence of numerous potentially interfering species present
in human blood serum (cf. section 2.5, p. 39). However, ﬂuoroionophoreM10 has two
disadvantages. First of all, the synthesis of the functionalized dihydroxypyridine ligand
L10 (six steps) and the Ru complex with an amine side chain C3 (three steps) requires
substantial synthetic eﬀorts. Second, the overall ﬂuorescence of the sensor is very
weak, and the Li+-induced turn-on is not highly pronounced.
In this chapter, we describe two conceptually diﬀerent approaches to sense lithium
ions with a metallacrown complex. We will show that it is possible to obtain turn-
on ﬂuorescence sensors for lithium ions by simply mixing readily available starting
materials in buﬀered aqueous solution. The sensors display a signiﬁcantly improved
sensitivity, which allows sensing Li+ in the submillimolar concentration range.
3.2 A Ditopic Receptor for Lithium and HPTS
The functionalization of a 12-metallacrown-3 complex with a covalently bound ﬂuo-
rophore while maintaining its solubility in water turned out to be a diﬃcult and time-
consuming task (see Chapter 2).[22] We therefore considered the possibility of using
a ﬂuorescent dye bound to the macrocyclic receptor in a noncovalent fashion. In
principle, such a sensing ensemble can operate by two diﬀerent mechanisms. If the
dye is bound at — or close to — the binding site of the lithium ion, the addition of
Li+ would lead to a displacement of the dye and to a change of its optical properties
(Scheme 3.1a). Sensors of this kind are typically referred to as indicator displacement
assays (IDAs) and many examples have been described in the literature (see section
1.4). Alternatively, the metallacrown can act as a ditopic receptor for the dye and the
metal ion (Scheme 3.1b). If there is some type of ‘‘communication’’ between the two
guests, a modulation of the ﬂuorescence properties is possible.
To implement such a sensing scheme, we decided to focus on receptor M1. It
had been extensively studied in our laboratory, and it is able to bind lithium ions in
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Scheme 3.1 – A dye is bound to a Li+ receptor through noncovalent interactions,
resulting in partial quenching of its ﬂuorescence. A change in ﬂuorescence may
be observed if Li+ displaces the dye (a), or if the ternary complex between the
receptor, Li+, and the dye has diﬀerent optical properties than the receptor–dye
complex (b).
aqueous solution with a binding constant of Ka = 5.8 ( 1.0)  104 M-1 (Figure 3.1),[267]
whereas sodium ions are boundwithmuch lower aﬃnity (Ka = 5.0 ( 1.0)M-1). Another
interesting feature of complexM1 is that its synthesis is very easy, and can be done by
dissolving the corresponding dihydroxypyridine ligand L2 and commercially available
[(p-cymene)RuCl2]2 (C2) in a buﬀer at neutral pH. The macrocycle is then formed by
self-assembly in nearly quantitative yield.[267]
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Figure 3.1 – Left: representation of the Li+ adduct of complex M1 with view
along the C3 symmetry axis; right: ball-and-stick representation of the molecular
structure of complexM1 in the crystal with view from the side (based on data from
reference [267]).
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We then had to ﬁnd a ﬂuorescent dye, which binds to the receptor in a noncovalent
fashion. ComplexM1was expected to exist as a polycation at neutral pH (protonation
of the piperazine side chains). To maximize electrostatic interactions, a polyanionic
ﬂuorescent dye seemed to be best suited. Furthermore, the dye could not contain
strong metal binding groups, which could lead to the destruction of the metallacrown
receptor. Finally, the dyeneeded tobe commercially available tomake the assay as sim-
ple aspossible. The commonlyusedﬂuorescentdye8-hydroxy-1,3,6-pyrenetrisulfonate
(HPTS) meets the above-mentioned criteria. In addition, it possesses a high quantum
yield and its ﬂuorescence is not sensitive to oxygen.[295] When a buﬀered aqueous
solution of complexM1was mixed with a solution of HPTS, the ﬂuorescence emission
intensity at 520 nm (λex = 462 nm) was strongly reduced. The change in ﬂuorescence
was a ﬁrst indication that a complex between the trimeric receptor and HPTS was
formed. To quantify the interaction between complex M1 and HPTS, a ﬂuorescence
titration experiment was performed (Figure 3.2).
Complex M1 + [(Complex M1)(HPTS)]
[Complex M1] (µM)
Figure 3.2 – Fluorescence emission intensity at 520 nm (λex = 462 nm) of a solution
of HPTS (50 μM) upon addition of complex M1 (0 – 1000 μM). The curve was
obtained by ﬁtting the data to a 1:1 binding model.
Fitting of the data to a 1:1 binding algorithm resulted in an association constant of
Ka = 3.4 ( 0.3)  104 M-1, and the 1:1 stoichiometry of the aggregate was conﬁrmed by
a Job plot.
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Neither the sulfonate groups nor the hydroxy group of HPTS were expected to
show a strong aﬃnity to the Ru centers. It therefore seemed unlikely that HPTS
would destroy the metallacrown complex. This assumption was supported by 1H
NMR spectroscopy. When increasing amounts of HPTS were added to a buﬀered
D2O solution of complexM1, the signals of trimerM1 shifted but the number and the
multiplicity of the signals remained the same (Figure 3.3). The data of the 1H NMR
titration also gave a clear indication of the binding mode. Strong diﬀerences in the
chemical shifts were observed for the signals of the protons of the p-cymene π-ligand,
whereas much smaller changes were found for the N-CH2 protons, and a negligible
shift for the N-CH3 protons (Figure 3.4). These results suggest that HPTS is bound
to the aromatic π-ligand(s) of complex M1, and not to the piperazine side chains.
The interaction between HPTS and the π-ligands is likely mediated by hydrophobic
eﬀects. We have not attempted to derive a binding constant by ﬁtting of the NMR
data because a precipitate was observed at higher concentrations (starting for [HPTS]
= [M1] 1 mM).
Figure 3.3 – Part of the 1H NMR spectrum of complexM1 (1.0 mM) in D2O (20 mM
phosphate buﬀer, pD 7.0) in the absence (top), in the presence of 0.5 mM HPTS
(middle), or in the presence of 1.0mMHPTS (bottom). The solvent peak is denoted
by an asterisk. ComplexM1was prepared in situ bymixing appropriate amounts of
[(p-cymene)RuCl2]2 and ligand L2.
Next, we investigated whether the addition of lithium ions to the aggregate be-
tween complexM1 andHPTSwould result in a change of ﬂuorescence. This was indeed
the case. Addition of LiCl (0 – 20 mM) to a buﬀered aqueous solution containing
the metallacrown complexM1 (1.0 mM) and HPTS (0.5 mM) resulted in a pronounced
recovery of the ﬂuorescence signal with I/I0 = 6.6 at [Li+] = 20 mM (Figure 3.5). The
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Figure 3.4 – Top: changes of the chemical shifts of selected 1H NMR signals of
complexM1 (1.0 mM) in D2O (20 mM phosphate buﬀer, pD 7.0) in the presence of
various amounts of HPTS. Bottom: 1HNMR spectrumof complexM1 in the absence
of HPTS and a drawing of the structure showing the assignment of the respective
signals (the annotation of the three aromatic CH protons of the cymene π-ligand is
arbitrary).
data could be ﬁtted to a 1:1 binding model, which is in line with the known ability of 12-
metallacrown-3 complexes to formmonoadductswith Li+.[267--279] The apparent binding
constant derived from the ﬁtting procedure was Ka = 2.3 ( 0.2)  103 M-1. This value
is only slightly lower than what has been observed for complex M1 in the absence of
buﬀer and dye.[267] The strong binding of Li+ suggests that complex M1 is able to act
as a ditopic receptor for HPTS and Li+, and that the complexation of the two guests is
largely independent of each other.
The assumption that Li+ and HPTS are bound independently was supported by the
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following control experiment: First, receptor M1 was saturated with Li+ by addition
of an excess of LiCl. Subsequently, a ﬂuorescence titration experiment with HPTS
was performed. As expected, the decrease in ﬂuorescence was less pronounced than
in experiments with free receptor M1, but the binding constant of HPTS obtained by
ﬁtting of the resulting isotherm (Ka = 1.9 ( 0.2)  104 M-1) was similar to that obtained
without Li+ (Ka = 3.4 ( 0.3)  104 M-1) (Figure 3.6). The presence of bound Li+ was thus
not detrimental to the complexation of HPTS.
Taken together, these experiments indicate that the sensing ensemble operates
according to the mechanism depicted in Scheme 3.1b and not via a Li+-induced dye
displacement as shown in Scheme 3.1a. The ‘‘communication’’ between HPTS and
Li+ must be mediated via the macrocyclic receptor since LiCl alone did not aﬀect the
ﬂuorescence of HPTS. Cyclic voltammetry studies showed that complexM1 was more
diﬃcult to oxidize if bound to a Li+ ion (Figure 3.7): For the ‘‘free’’ receptorM1, a ﬁrst
oxidation was observed at around E1/2 = 380 mV. Upon saturation with Li+, Ru complex
M1 is more diﬃcult to oxidize. Precise values for the diﬀerence in half potentials (ΔE1/2)
were not measured due to the irreversible nature of the redox transitions. As a result,
ﬂuorescence quenching by electron transfer from the metallacrown complex to HPTS
is more diﬃcult in the presence of Li+, which is in line with the observed increase in
ﬂuorescence upon addition of Li+. Inner ﬁlter eﬀects do not contribute to the observed
ﬂuorescence changes since receptor M1 and its lithium adduct show identical UV/Vis
spectra.
Based on the results summarized above, we were able to devise a simple assay for
the detection of lithium ions by ﬂuorescence spectroscopy.[296] The sensor was assem-
bled in situbymixing dihydroxypyridine ligand L2[287--290]with dimer [(p-cymene)RuCl2]2
(C2) and the dye HPTS in buﬀered aqueous solution (Scheme 3.2). The addition of LiClƅ
to this sensing ensemble resulted in a signiﬁcant increase in ﬂuorescence intensity.
The sensitivity of the assay was suﬃcient for the sensing of Li+ in the submillimolar
concentration range with very good selectivity over competing metal ions such as Na+
and Mg 2+ (Figure 3.8).
Subsequently, we have explored the possibility of using the sensing ensemble
in a complex biological ﬂuid such as human blood serum. Proteins were expected
to interfere with the self-assembly of receptor M1, notably because histidine and
methionine residues have a high aﬃnity for the (p-cymene)Ru fragment.[181] Therefore,
larger proteins were removed from the serum by a simple precipitation procedure.
ƅPrevious results with receptorM1 and diﬀerent LinX salts had shown that the nature of the anion Xn-
does not aﬀect the binding of Li+ in an aqueous solution (see ref. [267]).
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Figure 3.5 – Fluorescence emission intensity at 520 nm (λex = 462 nm) of a solution
of HPTS (0.5 mM) and complex M1 (1.0 mM) upon addition of Li+ (0 – 20 mM)
in HEPES buﬀer (100 mM, pH 7.0). Complex M1 was prepared in situ by mixing
appropriate amounts of [(p-cymene)RuCl2]2 and ligand L2. The curvewas obtained
by ﬁtting the data to a 1:1 binding model.
Figure 3.6 – Fluorescence emission intensity at 520 nm (λex = 462 nm) of a solution
of HPTS (25 μM) upon addition of complexM1 (0 - 750 μM) saturated with Li+. The
data were recorded in HEPES buﬀer (20 mM, pH 7.0) containing 5.0 mM LiCl. The
curve was obtained by ﬁtting the data to a 1:1 binding model.
Fluorescence measurements with 3:1 mixtures of deproteinized serum and buﬀered
water containing the sensing ensemble and variable amounts of Li+ showed an en-
hancement of the ﬂuorescencewith increasing amounts of Li+ (Figure 3.9). The derived
binding constant of Ka = 1.2 ( 0.1)  103 M-1 was similar to that obtained for plain buﬀer.
However, the maximum signal intensity was reduced (I/I0 = 3.2 at [Li+] = 20 mM). Still,
54 Simple Assays for the Detection of Li+
Figure 3.7 – Cyclic voltammogram of a solution of complexM1 (‘‘Ru trimer’’) in the
absence and in the presence of LiCl ([M1] = 1.0 mM, [LiCl] = 0 and 10 mM, [HEPES]
= 50 mM, pH 7.0).
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Scheme 3.2 – A turn-on ﬂuorescence sensor for Li+ is generated in situ by reaction
of [(p-cymene)RuCl2]2 with ligand L2 and dye HPTS.
the sensing ensemble could be used to sense Li+ in the pharmacologically important
concentration range of 0.5 to 1.5 mM.
In summary, the presented assay overcomes several limitations, which are often
associated with chemosensors for lithium ions. The assay utilizes the known Li+
receptorM1, but it is basedonaconceptually novel signal transductionmechanism. The
key to success was the realization that complexM1 is able to act as a ditopic receptor
for Li+ and the ﬂuorescent dyeHPTS. Consequently, it was possible to obtain the sensor
by self-assembly, circumventing the need for the time-consuming modiﬁcation of the
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Figure 3.8 – Relative ﬂuorescence intensity at 520 nm (λex = 462 nm) for solutions
containing [(p-cymene)RuCl2]2 (1.5 mM), ligand L2 (3.0 mM), and HPTS (0.5 mM) in
the presence of variable amounts of Li+ (J), Mg 2+ (n) and Na+ (l) in H2O (100 mM
HEPES, pH 7.0).
Figure 3.9 – Relative ﬂuorescence intensity at 520 nm (λex = 462 nm) for solutions
containing [(p-cymene)RuCl2]2 (1.5 mM), ligand L2 (3.0 mM), and HPTS (0.5 mM)
in the presence of variable amounts of Li+ in a mixture of H2O (100 mM HEPES, pH
7.0) and deproteinized serum (1:3). The curve was obtained by ﬁtting the data to a
1:1 binding model.
receptor scaﬀold. The assay allows the sensing of sub-millimolar concentrations of Li+
in buﬀered aqueous solution with high selectivity. It should also be pointed out that
minimal synthetic eﬀorts are required. Apart from the dihydroxypyridine ligand L2, all
reagents for the assay are commercially available. Ligand L2, on the other hand, can be
obtained in one step by a simple Mannich reaction.[287--290] One drawback of the assay
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is its response time: due to the slow binding kinetics of receptor M1, several hours
at room temperature are required until equilibration.Ɔ Furthermore, large amounts
of proteins should be avoided because they can decompose the metallamacrocyclic
receptor. Despite these restrictions, the assay[296] represents a simple but powerful
analytical tool for sensing lithium ions in an aqueous solution.
ƆThe equilibration time depends on the concentrations. With a receptor concentration of [M1] =
1.0 mM and a LiCl concentration of 1.0 mM, 3 h are required until equilibration, as shown by kinetic
experiments.
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3.3 Sensing of Lithium through its Stabilizing Eﬀect on
Macrocyclic Receptors
A diﬀerent approach for sensing of Li+ is depicted in Scheme 3.3. The samemacrocyclic
receptor M1, which was used in the former section, is employed. The addition of
a ﬂuorescent dye with a high aﬃnity for ruthenium leads to partial destruction of
the metallacrown complex accompanied by a quenching of the ﬂuorescence. In the
presence of Li+, a stable adduct [M1 + Li+] is formed. If the adduct [M1 + Li+] is less
prone to destruction by the ﬂuorescent dye than the ‘‘free’’ receptorM1, a diﬀerence
in ﬂuorescence should be observed.
+
Scheme 3.3 – The addition of a ﬂuorescent dye to a trimeric receptor leads to a
partial destruction of the trimer and to a quenching of the ﬂuorescence. In the
presence of lithium ions, the destruction of the receptor is less pronounced and an
increased ﬂuorescence is observed.
To implement such a sensing scheme, we have used the metallacrown complexM1
as the receptor. This complex can be formed either in situ by mixing commercially
available [(p-cymene)RuCl2]2 with dihydroxypyridine ligand L2 in aqueous buﬀer, or in
methanol in the presence of a base (Scheme 3.4).[267] Organic ligand L2 is accessible
by a simple Mannich reaction between dihydroxypyridine and N-methylpiperazine.
As ﬂuorescent dye, we have decided to employ commercially available Calcein Blue
(CAB). Previous studies in our group had shown that this dye has a high aﬃnity for
organometallic halfsandwich complexes such as the (p-cymene)Ru(II) fragment, and
that its ﬂuorescence is nearly completely quenched upon coordination to themetal.[181]
In order to study the interaction of macrocycle M1 with CAB, we performed a
ﬂuorescence titration experiment, in which a variable amount ofM1 (0 – 130 μM) was
added to a ﬁxed quantity of CAB (30 μM) in water (20 mM phosphate buﬀer, pH 7.0).
A quenching of the ﬂuorescence was observed as the concentration ofM1 increased,
which we attribute to binding of CAB to the ruthenium centers and simultaneous
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Scheme 3.4 – Synthesis of trimeric receptorM1 and structure of the ﬂuorescent dye
Calcein Blue.
destruction of M1 (Figure 3.10). Fitting the data to a 1:1 binding model aﬀorded an
equilibrium constant of K = 8.2 ( 0.8)  105.
Figure 3.10 – Relative ﬂuorescence intensity at 443 nm of a solution of Calcein
Blue (30 μM) in the presence of various amounts of macrocycleM1. The indicated
Ru concentration refers to the actual concentration of Ru(II) (i.e., 3 times the
concentration ofM1). The solutions were equilibrated 24 hours at 25C in H2O (pH
7.0, 20 mM phosphate buﬀer), and the excitation wavelength was 364 nm. The
curve was obtained by ﬁtting the data to a 1:1 binding model.
The assumption that CAB binds to the ruthenium centers and destroys macrocycle
M1 is supported by analyses of 1H NMR spectra recorded during a similar experiment.
When a solution containing M1 (2.0 mM) and CAB (6.0 mM) was stirred at room
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temperature, 1HNMRspectra recorded after diﬀerent time intervals showed aprogres-
sive disappearance of the signals corresponding to M1 and the appearance of peaks
corresponding to pyridone ligand L2, which is released by the reaction (Figure 3.11).
Signals corresponding to species formed by interaction between the Ru half-sandwich
complex and CAB were also observed. It appears that several new species are formed
bymixingM1 and CAB,which is not surprising since CABpossesses several coordinating
sites.
Figure 3.11 – Part of time-dependant 1H NMR spectra of a mixture containing
macrocycleM1 (2.0 mM) and ﬂuorescent dye Calcein Blue (6.0 mM) in D2O (20mM
phosphate buﬀer, pD = 7.0). Asterisks indicate signals corresponding to pyridone
ligand L2, and the circle indicates a peak corresponding toM1.
Next, we investigated whether the presence of Li+ in solution would inﬂuence the
stability of the macrocycle towards CAB-induced degradation. The following two-step
experiment was performed: First, an aqueous solution (20 mM phosphate buﬀer, pH
7.0) containing macrocycle M1 (4.0 mM) and excess LiCl (8.0 mM) was equilibrated
at room temperature for 2 hours. At this point, 1H NMR measurement revealed a
quantitative formation of the adduct [M1+Li+], whose spectrum is well distinguishable
from the one corresponding to M1. Second, an equivalent volume of an aqueous
solution of CAB (12.0 mM) was added to this solution, and the reaction was monitored
by 1H NMR (Figure 3.12). From the time-dependant 1H NMR spectra it is clear that the
host-guest complex [M1+Li+] is considerably more stable in the presence of CAB than
macrocycleM1. Even after a reaction time of 12 h, a very large amount of [M1+Li+] was
still visible (about 85% of the initial quantity), whereas in the case where no lithium
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was present (Figure 3.11), the signals corresponding to M1 had almost completely
disappeared. It was found that a reaction time of several days was necessary to obtain
a complete disappearance of the peaks corresponding to [M1+Li+].
Figure 3.12 – Part of time-dependant 1H NMR spectra of a sample prepared by
mixing equivalent volumes of a solution containingM1 (4.0 mM) and LiCl (8.0 mM)
with a solution containing CAB (12mM). Asterisks indicate signals corresponding to
the pyridone ligand L2, and the circle indicates a peak corresponding to [M1+Li+].
No peak corresponding toM1 is visible. The spectra were recorded in D2O (20 mM
phosphate buﬀer, pD = 7.0).
Hoping that the Li+-induced diﬀerence in reactivity would be translated into a
diﬀerence in ﬂuorescence, we studied the ﬂuorescence response of our systems. A
preliminary control experiment showed that the ﬂuorescence of CAB was not inﬂu-
enced by the presence of LiCl. Then, a two-step experimental setup with various
concentrations of LiCl and ﬁxed concentrations ofM1 and CAB was devised as follows:
a water solution (pH 7.0, 20 mM phosphate buﬀer) containing 2.0 mM ofM1 and LiCl
(0, 1.0, 2.0 or 4.0 mM, respectively) was equilibrated at room temperature for 2 hours.
A portion of this solution (50 µL) was then poured into a water solution containing
CAB (2950 µL, 76.1 µM) to initiate the degradation reaction. The ﬂuorescence intensity
was measured in a time-resolved fashion for 12 hours (λex = 364 nm, λem = 443 nm).
As expected, the assay performed in the absence of Li+ resulted in a relatively fast
quenching of the ﬂuorescence, reﬂecting the complexation of CAB to the ruthenium
centers. An abrupt decrease of the ﬂuorescence of about 20% directly after both
solutions were mixed is attributed to an inner ﬁlter eﬀect: UV/Vis measurements
revealed that a solution of macrocycleM1 signiﬁcantly absorbs light at 364 nm, which
is also the excitation wavelength that was employed. Part of the excitation energy is
then not transmitted to CAB but absorbed byM1. Surprisingly, when Li+ was present,
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a pronounced quenching was also observed during the reaction, although the signal
was still well distinguishable from the one recorded in the absence of Li+ (Figure 3.13).
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Figure 3.13 – Relative ﬂuorescence intensity at 443 nm for the reaction between
macrocycle M1 (33.3 μM) and CAB (75 μM), after the stock solution of M1 (2.0
mM solution) was equilibrated with various quantities of LiCl (solid line, 0.0 mM;
dashed line, 1.0 mM; dotted line, 2.0 mM; dash dotted line, 4.0 mM). The data
were obtained at 25C in H2O (pH 7.0, 20mMphosphate buﬀer), and the excitation
wavelength was 364 nm.
Two factors can explain this unexpected quenching phenomenon, which seems
quite contradictory to what was observed by 1H NMR: a) It is likely that one Ru center
can bind to more than one CAB molecule. This would result in a more pronounced
quenching even if a relatively small amount of Ru centers are made available by the
reaction; b) The absorbance at 364 nm mentioned above was found to be increasing
during the course of the reaction, which points to the formation of compounds which
deprive the ﬂuorophore of exciting light (timewise increase of the inner ﬁlter eﬀect). In
spite of these unavoidable side-eﬀects, it was still possible to diﬀerentiate the curves
corresponding to diﬀerent concentrations of Li+. Furthermore, it was observed that
the ratio of these curves relative to the curve corresponding to the solution containing
no lithiumwas constant (within the experimental error) in the range 310 – 370minutes.
This allows to measure the relative ﬂuorescence intensity in this time-windowwithout
taking the absolute variations of ﬂuorescence into account (Figure 3.14).
A series of experiments involving various Li+ concentrationswasperformed in order
to obtain a more accurate view of the performance of our sensing ensemble. The
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Figure 3.14 – Relative ﬂuorescence intensity ratios between the curves displayed in
Figure 3.13: the dashed line indicates the ratio between the curves corresponding
to 1.0 and 0.0 mM LiCl, the dotted line to the ratio between the curves
corresponding to 2.0 and0.0mMLiCl, and thedashdotted line to the ratio between
the curves corresponding to 4.0 and 0.0 mM LiCl.
procedure described above was used, and the ﬁnal mixtures containing CAB, M1 and
Li+ were stirred for 5.5 hours before their ﬂuorescence was measured (λex = 364 nm).
The obtained binding isotherm (Figure 3.15) was ﬁtted to a 1:1 binding model to obtain
an apparent binding constant of Ka (Li+) = 2.5 (0.3)  104 M-1, which indicates that our
system is well suited for the detection of Li+ in the low millimolar range.
Biological samples usually contain many potentially interacting cations such as Na+
(up to 150mM in blood), K+ (up to 5mM),Mg 2+ or Ca 2+ (both up to 1mM). It is therefore
of prime importance to assess the selectivity of our sensor towards these compounds.
The buﬀer used in the frame of this study (pH 7.0, 20 mM phosphate) contains more
than 30 mM K+ and no signal corresponding to a [M1+K+] adduct was observed by 1H
NMR. Inﬂuence of K+ on the behaviour of the sensor can therefore be neglected. Fur-
thermore, ﬂuorescence experiments were conducted in the samemanner as indicated
abovewith NaCl (up to 150mM), CaCl2 andMgCl2 (up to 5.0mM). None of these assays
showed any signiﬁcant ﬂuorescence increase, thus indicating a very high selectivity
for the detection of Li+, even in the presence of high concentrations of potentially
competing cations.
In summary, we have developed a simple assay, made of macrocycleM1 and ﬂuo-
rophore Calcein Blue, which can detect the presence of Li+ ions in aqueous solutions.
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a) b)
Figure 3.15 – a) Binding isotherms of the system made of M1 and CAB in the
presence of various cations in water. The curve was obtained by ﬁtting the data to
a 1:1 bindingmodel. b) Emission intensities of the sensing ensemble in the presence
of Li+, Ca 2+, Mg 2+ (5.0 mM), and Na+ (125 mM).
The sensing principle relies on the additional stabilization conferred by Li+ to the
macrocyclic receptorM1. As observed by 1H NMR spectroscopy, degradation ofM1 by
CAB, which occurs relatively quickly, is nearly inhibited when the receptor is saturated
with Li+. This phenomenon was partially translated into a ﬂuorescence signal: the
degradation reaction in absence of Li+ resulted in a pronounced quenching of the
ﬂuorescence of CAB, whereas in the presence of Li+, this quenching was reduced, as a
result of the degradation reaction being prevented. It is, however, unfortunate that a
complete suppression of the quenching of the ﬂuorescencewas not achieved, contrary
to what could be expected based on 1H NMR experiments.
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3.4 Conclusions
Salts containing lithium ions are frequently used drugs for patients suﬀering from
bipolar disorder. Furthermore, Li+-based drugs are investigated for neurodegenerative
diseases such as Alzheimer's or amyotrophic lateral sclerosis (ALS). In this context
it is desirable to have a spectroscopic tool, which allows the selective detection
of lithium ions in an aqueous environment. There have been numerous attempts
to prepare colorimetric or ﬂuorescence sensors for Li+ in homogeneous solution.
However, the reported sensors typically show limitations such as low solubility in
purely aqueous solution, diﬃcult synthesis, or a lack of selectivity and/or sensitivity.
We have developed two assays, which overcome the above-mentioned limitations.
The assays utilize a known Li+ receptor, but they are based on conceptually novel
signal transduction mechanisms with non-covalently bound ﬂuorescent dyes (CAB or
HPTS). In terms of sensitivity, the HPTS-based assay is particularly appealing. It allows
sensing sub-millimolar concentrations of Li+ in buﬀered aqueous solution with high
selectivity. It should also be pointed out that minimal synthetic eﬀorts are required.
Apart from dihydroxypyridine ligand L2, all reagents for the assay are commercially
available. Ligand L2, on the other hand, can be obtained in one step by a simple
Mannich reaction. One drawback of these assays is their response time: due to the
slow binding kinetics of receptorM1, 2-3 hours at room temperature are required until
equilibration, and the second assay needs additional time for the degradation reaction
to proceed. Furthermore, large amounts of proteins should be avoided because they
can decompose themacrocyclic receptor. Despite these restrictions, the assays should
be of interest as a simple but powerful analytical tool for sensing lithium ions in an
aqueous environment.
4 Cross-Reactive Sensor Arrays forthe Detection of Peptides inAqueous Solution by Fluorescence
Spectroscopy
Synopsis
A simple but powerful method for the sensing of peptides in aqueous solution was
developed. The transition-metal complexes [Cp*RhCl2]2, [(p-cymene)RuCl2]2, and
[(en)PdCl2] were combined with six diﬀerent ﬂuorescent dyes to build a cross-reactive
sensor array. The ﬂuorescence response of the individual sensor units was based on
competitive complexation reactions between the peptide analytes and the ﬂuorescent
dyes. The collective response of the sensor array in a time-resolved fashion was used
as an input for multivariate analyses. A sensor array composed of only six metal–dye
combinations was able to diﬀerentiate ten diﬀerent dipeptides in buﬀered aqueous
solution at a concentration of 50 µM. Furthermore, the cross-reactive sensor could be
used toobtain informationabout the identity and thequantity of thepharmacologically
interesting dipeptides carnosine and homocarnosine in a complex biological matrix,
such as protein depleted human blood serum. The sensor array was also able to sense
longer peptides, which was demonstrated by diﬀerentiating mixtures of nonapeptide
bradykinin and decapeptide kallidin.
Jie Gao is gratefully acknowledged for having performed the ﬂuorescence mea-
surements involving palladium complexes. The work presented in this chapter was
published in: S. Rochat, J. Gao, X. Qian, F. Zaubitzer, K. Severin, Chem. Eur. J. 2010,
16, 104-113, and in: S. Rochat, K. Severin, Chimia 2010, 64, 150-152.
65

4.1 Introduction
SčĔėę ĕĊĕęĎĉĊĘ Ćēĉ ĕėĔęĊĎēĘ are elusive targets for chemosensors. The design ofselective receptors for analytes of this kind, which possess multiple binding sites,
requires preorganization of multiple complementary moieties. The synthetic task
is therefore rendered prohibitively complicated. Additional diﬃculties come from
the intrinsic ﬂexibility of peptides, as well as from the fact that peptides are usually
present in complex ﬂuids, containing numerous, sometimes very similar, compounds.
It is therefore not surprising that many successful sensors for peptides are based on
pattern recognition protocols.[184]
Eﬀorts towards the selective detection of peptides were essentially limited to
analytes possessing histidine side chains,[297] which could be targeted owing to their
aﬃnity for metal cations, although methionine[65] and tryptophan[298] were also found
to be relevant targets. Peptides possessing no interacting side-chain are therefore
challenging analytes, since they must be diﬀerenciated based on minute diﬀerences
in reactivity or structure.
For the pattern-based analysis of short peptides, two conceptually diﬀerent ap-
proaches have been described. Anslyn and McDevitt et al. have generated libraries
of synthetic receptors containing Cu(II) and Cd(II) ions. The receptors were either
immobilized on a silicon microchip array[187] or used in homogeneous solution.[185] The
UV/Vis responseof the sensor collectionwas used todiﬀerentiate tri- and tetrapeptides
as well as the neurotransmitter peptides α-neurokinin (a decapeptide) and substance
P (an undecapeptide). Good discrimination was achieved in buﬀered aqueous solution
at peptide concentrations of 13[187] and 267 μM,[185] respectively. A drawback of these
systems, however, is the fact that considerable synthetic eﬀorts were required to
prepare the receptors. Indeed, the synthesis of a library of compounds (displayed in
Scheme 4.1) was necessary to perform discrimination of short peptides in solution. The
members of the library have ametal-binding ligandwith two appended peptide chains.
The metal center imparts selectivity toward peptides terminating in His. One peptide
arm was consistently Lys-Gly-Asp, while the second was variable in order to provide
the diﬀerential recognition character. Although the library made of 20a - 20f achieved
successful peptide discrimination, it is desirable to reduce the synthetic eﬀorts while
maintaining the analytical power.
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Scheme 4.1 – Library developed by Wright et al. for the discrimination of short
peptides in solution.[185]
Our group reported colorimetric sensors that were obtained by mixing CuCl2 and
NiCl2 with three dyes in buﬀered water.[183, 186, 188] The resulting solutions were com-
posed of complicatedmixtures ofmetal–dye complexes. Upon addition of the peptide
analyte, a characteristic change in theUV/Vis spectrumwas observed. The peptidewas
then identiﬁed with the help of multivariate analyses. The advantage of this method is
its simplicity. Zaubitzer et al. showed how mixtures of two related peptide hormones
(angiotensin I and angiotensin II, ten- and eight-amino acid peptides, respectively)
can be distinguished at concentrations of 20 μM with a sensing ensemble made of
commercially available metal salts and dyes (Figure 4.1). However, only a single UV/Vis
spectrum is used as the data input (the composite spectrum of all metal–dye–peptide
complexes), which potentially compromises the resolution that can be achieved.ƅ
Here we describe an alternative approach to sense peptides with metal–dye com-
plexes. Sensor arrayswith up to 14 individual sensor unitswere created by combination
of metal complexes with dyes. The dyes showed strong luminescence, and ﬂuores-
cence spectroscopy could be used for the analysis. Instead of 3d transition-metal ions,
we used 4d transition-metal complexes of rhodium, ruthenium, or palladium. These
compounds showed high binding constants andmoderately fast exchange kinetics. As
a result, it was possible to perform measurements at very low analyte concentrations
and in a time-resolved fashion. The sensor arrays were found to display a remarkable
ƅSee Chapter 5 for further discussion on the capacities of such sensing systems.
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Arsenazo I
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Xylenol Orange
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NiCl2 + CuCl2
UV/Vis measurement
a) b)
Figure 4.1 – a) Experimental setup for the sensing of the peptide hormones
angiotensin I and angiotensin II. The data from UV/Vis measurements were
evaluated by multivariate analysis. b) Score plots of LDA showing discrimination
between diﬀerent mixtures of angiotensin I and angiotensin II. [angiotensin I]tot =
(20 - x) μM, [angiotensin II]tot = x μM; x = 20 (maroon, u), 18 (blue, l), 16 (grey,
I), 14 (orange, +), 12 (green, s), 10 (yellow, t), 8 (light blue, ), 6 (light green,
I), 4 (light blue, n), 2 (green, u), 0 (dark blue, +). Adapted from ref. [183] with
permission of The Royal Society of Chemistry.
discriminatory power. An excellent diﬀerentiation of dipeptides was achieved at
concentrations as low as 20 – 50 μM. This includes peptides composed of amino
acids without coordinating side chains, a challenging class of analytes for metal-based
receptors. Furthermore, it was shown that mixtures of the nonapeptide bradykinin
and the decapeptide kallidin can be distinguished, and that the dipeptides carnosine
and homocarnosine can be analyzed in a complex matrix, such as human serum.
4.2 Building an Array of Fluorescence Sensors
The basic design principle of our cross-reactive sensor array is shown in Figure 4.2.
The peptide analytes compete with ﬂuorescent dyes for the coordination to metal
complexes. When coordinated to the metal complexes, the ﬂuorescence of the dyes
is signiﬁcantly reduced. The ﬂuorescence intensity is therefore an indication of the
proportion of metal–dye complex being formed for a given metal–dye–peptide com-
bination. For the minimal sensor array shown in Figure 4.2, two diﬀerent ﬂuorescent
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dyes were combinedwith twometal complexes to give a 2 2 array. Larger arrays can
be obtained by increasing the number of dyes and/or the number of metal complexes.
The identiﬁcation and/or quantiﬁcation of the peptide analytes can be achieved by
analyzing the ﬂuorescence response of the sensor array with pattern-recognition
protocols.
Figure 4.2 – Basic principle of a sensor array based on competition reactions of
peptide analytes and metal–dye complexes.
To implement such a sensor scheme, we had to identify metal complexes with the
following characteristics: 1) they should be water soluble and inert towards oxidation;
2) they should bind to peptides with high aﬃnity; 3) they should show reasonably
fast ligand exchange kinetics; and 4) they should quench the ﬂuorescence of metal-
binding dyes. For practical purposes, we were furthermore interested in having metal
complexes that are either commercially available or easy to synthesize. Simple 3d
transition-metal halides (e.g., CuCl2) might fulﬁll the above-mentioned criteria. How-
ever, we decided to focus on 4d transition-metal complexes, because they potentially
show higher binding constants to peptide analytes.
Previous experiments from our laboratory showed that the organometallic com-
plex [Cp*RhCl2]2 (C1) waswell suited for competitive assayswith dyes and peptides.[65]
The commercially available rhodium chloro dimer is soluble in water (aqua complexes
are formed) and the solutions are not air sensitive. Importantly, this complex showed
a good binding aﬃnity to peptides, albeit with a strong preference for those con-
taining histidine or methionine.[65] The coordination chemistry of the arene complex
[(p-cymene)RuCl2]2 (C2) is known to be similar to that of [Cp*RhCl2]2,[263] and studies
by Beck and Sheldrick showed that the (p-cymene)Ru fragment is able to bind to
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peptides.[299--304] The complex [(p-cymene)RuCl2]2 was therefore used as the second
metal constituent for our sensor array. The third and ﬁnal metal component that we
chose was [(en)PdCl2] (C4, en = ethylenediamine). Again, there was strong evidence
that this metal complex is able to bind to peptides, in particular due to the detailed
studies of Kostić and others on Pd(II)-induced peptide hydrolysis.[305--319] To the best of
our knowledge, therewas no precedence for the utilization of (en)Pd or (p-cymene)Ru
complexes in the context of indicator displacement assays.
The structures of the ﬂuorescent dyes that we used for the sensor are depicted
in Scheme 4.2. They are all commercially available and possess donor groups that are
suited for the complexation to transition metals.
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Scheme 4.2 – Metal complexes and ﬂuorescent dyes used in this study.
To obtain quantitative information about the binding aﬃnities of the dyes to the
three metal complexes, we performed ﬂuorescence titration experiments in buﬀered
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aqueous solution (100 mM phosphate buﬀer, pH 7.0) with a ﬁxed amount of dye and a
variable amount of metal complex. The binding constants were obtained by ﬁtting of
the binding isotherms. The case of Nuclear Fast Red (NFR) titrated by Ru is illustrated
in Figure 4.3 (for the other metal/dye combinations, see Appendix A.1). In most cases,
a 1:1 binding model provided a reasonably good ﬁt. For Calcein (CAL), it is likely that
[M2(CAL)] complexes are formed as well, but it was diﬃcult to obtain an accurate
binding constant for the coordination of the second metal, because the ﬂuorescence
was nearly fully quenched by the ﬁrst metal.
Figure 4.3 – Fluorescence emission spectra of a solution of Nuclear Fast Red
(50 μM) upon addition of complex [(p-cymene)RuCl2]2 ([Ru] = 0 − 100 μM). The
excitation wavelength was 540 nm. The spectra were recorded in H2O (100 mM
phosphate buﬀer, pH 7.0) after equilibration for two days in the dark. Inset:
emission intensity at 590 nm of a solution of Nuclear Fast Red (50 μM) upon
addition of complex [(p-cymene)RuCl2]2 ([Ru] = 0 − 100 μM). The curve was
obtained by ﬁtting the data to a 1:2 binding model.
When comparing the binding constants for the three diﬀerent metal complexes,
it is apparent that the values for a given dye generally increase in the order K1(Pd) <
K1(Ru) < K1(Rh), except in the case of Nuclear Fast Red (Table 4.1). Overall, the binding
constants span more than four orders of magnitude, which is advantageous for the
analysis of peptides possessing very diﬀerent binding aﬃnities to metal complexes.
No pronounced quenching was observed when solutions of Rh or Ru were added to
Lumazine (LUM) and N-Methylanthranilic Acid (MAA). Therefore, these combinations
were not taken into account for our sensor array.
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Table 4.1 – Binding constants for the complexation of the ﬂuorescent dyes to the
metal complexes.
Fluorescent Dye Metal Complex K1 [M-1]ƅ
CAL Rh 7.6 (0.8)  106
CAL Ru 1.9 (0.2)  106
CAL Pd 6.2 (0.6)  105
CAB Rh > 107
CAB Ru 1.6 (0.2)  106
CAB Pd 1.2 (0.1)  105
MCB Rh > 107
MCB Ru 1.8 (0.2)  107
MCB Pd 2.2 (0.2)  105
NFR Rh 1.6 (0.2)  106
NFR Ru > 107
NFR Pd > 107
LUM Pd 7.8 (0.8)  104
MAA Pd 8.6 (0.9)  103
ƅThe binding constants were calculated by numerical ﬁtting of the binding isotherms obtained from
ﬂuorescence titration experiments. The titrations were performed in buﬀered aqueous solution (100
mM phosphate buﬀer, pH 7.0)
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4.3.1 Dipeptides in Water
Next, we studied the sensor response to dipeptides for some selected metal–dye
combinations. For this purpose, an aqueous solution of the dye was mixed with the
respective peptide. The competition reaction was then initiated by adding a stock
solution of the metal complex and the ﬂuorescence response was recorded as a
function of time. The data for a mixture of [(en)PdCl2] (Pd) and Lumazine (LUM)
and the analytes Met-Leu, His-Ala, and Ser-Gly are shown in Figure 4.4. The ﬁnal
concentrations for these reactions were: [Pd] = [LUM] = 25 μM, [peptide] = 50 μM. In
all cases, an initial decrease in ﬂuorescence intensity was observed. However, within a
fewminutes the ﬂuorescence signal started to increase. After one hour, a steady state
was nearly reachedwith a ﬂuorescence signal thatwas only slightlyweaker than that of
the free dye. These data suggest that the Pd complex reacts faster with Lumazine than
with peptides (initial decrease of the signal), but peptides bind stronger to the metal
than Lumazine and ultimately displace the dye (subsequent increase of the signal).
A diﬀerent situation was encountered for reactions with [(en)PdCl2], Calcein Blue
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Figure 4.4 – Relative ﬂuorescence emission intensity at 460 nm for the reaction
of [(en)PdCl2] (25 μM) and Lumazine (25 μM) in the presence of Met-Leu (50 μM,
dotted line), His-Ala (50 μM, dashed line), and Ser-Gly (50 μM, solid line). The data
were obtained at 25C in H2O (100 mM phosphate buﬀer, pH 7.0). The excitation
wavelength was 328 nm.
(CAB), and the peptides Trp-Gly, Val-Phe and Phe-Pro (Figure 4.5). A steady decrease
of the ﬂuorescence signal was observed for all three peptides for the ﬁrst 20 min. A
minor increase in signal intensity occurred for Trp-Gly and Val-Phe over the last 30 min,
but for Phe-Pro the signal continued to decrease. The data show that the reaction
rate for the complexation of Calcein Blue to Pd is slower than that of Lumazine, and
that the peptides are less-eﬃcient competitors for the binding to the metal. Kinetic
proﬁles similar to that shown in Figure 4.5 were found for the Rh and Ru sensors (the
competition reactionswere slower for Ru than for Rh). Some representative examples
are shown in Appendix A.4.
From the results of these competition experiments, it is evident that for some
metal–dye–peptide combinations, larger diﬀerences in ﬂuorescence intensity are ob-
served at the beginning of the reaction, whereas other combinations show more
pronounced diﬀerences at the end. Consequently, the sensing of peptides was best
achieved by time-resolved measurements.
To test the scope of our sensor array, ten diﬀerent dipeptides were used. The
binding kinetics of the fourteen metal–dye combinations shown in Table 4.1 were
measured in the presence of each dipeptide. The assays were performed as follows:
Metal complexes ([M]ﬁnal = 25 μM) were added to solutions containing the respective
dye ([dye]ﬁnal = 25 μM) and peptide ([peptide]ﬁnal = 20 or 50 μM) to initiate the
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Figure 4.5 – Relative ﬂuorescence emission intensity at 440 nm for the reaction of
[(en)PdCl2] (25 μM) and Calcein Blue (25 μM) in the presence of Trp-Gly (50 μM,
dotted line), Val-Phe (50 μM, dashed line) and Phe-Pro (50 μM, solid line). The data
were obtained at 25C in H2O (100 mM phosphate buﬀer, pH 7.0). The excitation
wavelength was 336 nm.
competition reactions. The ﬂuorescence signal at the emission maximum (Table 4.2)
was measured at regular time intervals, and each reaction was repeated four or six
times. An inspection of the ﬂuorescence response revealed that 1) the ﬂuorescence
signal before the addition of themetal complex was stable over time and independent
of the peptide, thus indicating that no dye-peptide interactions occur, and 2) a pseudo-
equilibrium state was reached one hour after metal complex addition in most of the
cases.
Table 4.2 – Excitation and emission wavelengths of the ﬂuorescent dyes.
Fluorescent Dye Excitation [nm] Emission [nm]
CAL 493 520
CAB 336 440
MCB 363 445
NFR 540 590
LUM 328 460
MAA 325 439
For the statistical analyses, we chose to take the ﬂuorescence intensities of each
metal–dye–analyte combination at 5, 20, and 60 min as input values. This choice
allowed us to take into account kinetic diﬀerences (5 and 20 min values) as well as
variations of the pseudo-steady-states (60 min value). Figure 4.6 shows a qualitative
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view of the sensor response at 60 min. It is apparent that peptides containing
amino acids with coordinating side chains, in particular His-Ala and Met-Leu, are able
to displace a larger fraction of the dyes and thus give stronger signals. The least-
coordinating peptide was found to be Phe-Pro: it does not compete eﬃciently with
the ﬂuorescent dyes for the complexation to themetals, resulting in almost completely
quenched ﬂuorescence signals.
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Figure 4.6 – Graphic representation of the relative ﬂuorescence intensities after
60 min of solutions containing the indicated dyes, peptides and metal complexes
([M] = 25 μM, [dye] = 25 μM, [peptide] = 50 μM, 100mMphosphate buﬀer, pH 7.0).
The colors approximatelymatch thewavelengths atmaximumemission intensities,
and the brightness corresponds to the ﬂuorescence intensities of the samples. The
brightness was calculated by assuming that the signal of the free dyewas 100% and
that of a ‘‘blank’’ sample without peptide was 0%.
To evaluate the discriminatory power of our sensor array, a principal component
analysis (PCA)[110] was performed. PCA allows to reduce the multidimensional sensor
array data to only two or three dimensions with minimal loss of variance. The resulting
score plots are shown in Figure 4.7. The ﬁrst three principal components are displayed,
accounting for 94% of the total variance. All analytes are grouped in well-separated
clusters. The analytes that appear close to each other are the ones that possess the
weakest interaction with the metal complexes: Ala-Ala, Val-Phe, Phe-Pro, and Ala-Phe.
Despite their weak displacement abilities, these analytes are still well separated from
theblank sample. Interestingly, themainprincipal component (factor 1) correlateswith
4.3 Discrimination of Small Peptides 77
the aﬃnity of the peptide to the metal complexes: the blank sample shows the lowest
values (factor 1 = –6.27 ( 0.06)), close to those of the dipeptides possessing aliphatic
side chains. As qualitatively observed in Figure 4.6, the peptide appearing closest to
the blank on the factor 1 axis is Phe-Pro (at a concentration of 50 μM, factor 1 = –3.83
( 0.05)), whereas the peptides containing strongly coordinating His or Met residues
appear with the highest values (His-Ala: factor 1 = 11.53 ( 0.05); Met-Leu: factor 1 =
11.43 ( 0.12)). The dipeptides with other, weakly interacting side chains are found in
between. Also of importance is the fact that the 20 and the 50 μM samples of Val-Phe
and Ala-Ala appear well separated on the score plots, which underlines the possibility
of obtaining information about the nature and the concentration of the analytes.
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Figure 4.7 – PCA score plots for the discrimination of ten dipeptides. The peptide
concentrations were 50 μM (ﬁlled symbols) or 20 μM (open symbols). The input
data for the PCAwere obtained from a sensor array comprised of the 14metal–dye
combinations listed in Table 4.1.
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In addition to the PCA, the same data set was used to perform a linear discriminant
analysis (LDA),[110] which also resulted in a good separation of each analyte. Themodel
was built by using a stepwise variable selection algorithm. A ‘‘jack-knifed matrix’’
validation procedurewas performed, where onemeasurement at a timewas randomly
omitted. The remaining datawere used as the training set for the LDA, and the omitted
observation could be evaluated. In our case, all data were classiﬁed correctly (see
Appendix A.2 for detailed results).
The PCA of our data set allowed to establish which of the fourteen metal–dye
combinations brought the most information for the discrimination of the peptides.
For our analysis, we focused on principal component 1 (factor 1), which contains more
than 80% of the total variance. The component loadings to factor 1 of the three
measurements at 5, 20 and 60 min of each metal–dye mixtures were combined, thus
aﬀording fourteen contributions (see the Appendix A.2 for details). A comparison
of the resulting values allowed us to identify the six metal–dye combinations that
contribute most signiﬁcantly to the discriminating power: Pd/NFR, Pd/CAB, Rh/NFR,
Rh/CAL, Pd/MCB and Rh/CAB (MCB = Methylcalcein Blue).Ɔ Sensors involving Ru were
found to contribute less, plausibly because of the slower exchange kinetics.
To verify that the reduced sensor array was still able to give good separation,
multivariate analyses were performed with the ﬂuorescence data obtained from the
selected six metal–dye combinations. Both PCA and LDA resulted in complete dis-
criminations of all peptides. It is clear from the PCA score plots, as well as from the
contributionof the variables to theprincipal components, that the variancewas further
concentrated in factor 1. However, this eﬀect was expected (the sensors accounting
most for factor 1 were selected), the discrimination still works satisfyingly, and the loss
of resolution is minimal. A ‘‘jack-knifedmatrix’’ validation procedure was performed in
the same manner as in the case of the entire sensor array, and the classiﬁcations were
correct in all cases. Furthermore, if only 60% of the datawere used to build discriminant
functions, the remaining 40%were subsequently classiﬁedwith complete accuracy (see
Appendix A.2). Successful cross-validation procedures ensure the predictability and
quality of our sensing system.
ƆThis number of six metal–dye combinations was arbitrarily chosen. According to the vast amount
of experimental data available, it is likely that several sensor subsets exist that would also aﬀord a good
discrimination.
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4.3.2 Bradykinin and Kallidin
Encouraged by the results obtained for the discrimination of dipeptides, we investi-
gated whether the sensor array was able to discriminate mixtures of longer peptides.
We chose the closely related plasma peptides bradykinin (Arg-Pro-Pro-Gly-Phe-Ser-Pro-
Phe-Arg, BK) and kallidin (Lys-bradykinin, KD). Both peptides are hormones belonging
to the kinin group. Kinins are important inﬂammatory mediators that induce pain and
oedema.[320] Kallidin can be converted into bradykinin by aminopeptidases. The pep-
tides also show vasodilatatory eﬀects, and at the cellular level they inﬂuence glucose
and chloride release as well as neurotransmitter transport.[321] Kinins are degraded by
angiotensin I-converting enzymes (ACE), and it was suggested that ensuring a high
micromolar level of BK in plasma by inhibition of cleavage enzymes could provide
cardioprotective eﬀects.[322]Our goalwas to discriminate aqueous solutions containing
various kallidin/bradykinin ratios, where the total amount of peptidewas kept constant
at 50 μM. It should be pointed out that this was a challenging task because both
peptides lack His or Met amino acids with strongly coordinating side chains. Conse-
quently, relativelyweak signalswereobtained in competition reactionswithmetal–dye
combinations. A short pre-screening of the fourteen metal–dye combinations listed in
Table 4.1 revealed that the following six mixtures were best at discriminating BK from
KD:Rh/MCB, Rh/CAB, Rh/CAL, Pd/CAB, Pd/NFRandPd/LUM. This selectionwasmadeby
comparing the ﬂuorescence signals obtained when the diﬀerent metal–dye mixtures
were reacted with BK or KD: only the combinations aﬀording signiﬁcant diﬀerences
between the two analytes were chosen (see Appendix A.2). Thesemixtures were then
used for time-resolved sensor array analyses. The assay was performed as follows: an
aqueous solution of the respective ﬂuorescent dye was added to a solution containing
either the pure kinin or a mixture of KD and BK in the ratios 20:80, 40:60, 60:40, or
80:20. The competition reaction was then initiated by adding a stock solution of the
metal complex, and the ﬂuorescence response was recorded as a function of time.
The solutions contained 50 μM of peptide (100 mM phosphate buﬀer, pH 7.0). For
the Rh-based assays, the ﬁnal concentrations were [dye] = [Rh] = 10 μM, whereas
concentrations of [dye] = [Pd] = 20 μM were used for the Pd-based experiments (the
amount of dye and metal was semi-optimized in the prescreening). Each reaction
was repeated four times, and the ﬂuorescence signals measured after diﬀerent time
intervals were used as input for the multivariate analysis. The score plot of a PCA is
shown in Figure 4.8. The diﬀerent peptide mixtures appear in distinct clusters. The
factor 1 axis is clearly correlated with the presence or absence of any analyte, whereas
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the various peptide mixtures are separated along the factor 2 axis. Furthermore, the
analytes are classiﬁed along the factor 2 axis according to their composition: the higher
the mole ratio of bradykinin, the higher the position of the corresponding cluster
along this axis. This type of correlation could be used to create calibration curves,
which would allow the KD/BK ratios of samples with unknown composition to be
determined. By analyzing the contribution of each sensor to the principal components,
one observes that Rh-based sensors contribute mostly to factor 1, whereas Pd-based
sensors are more correlated to factor 2 (see Appendix A.2).
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Figure 4.8 – Two-dimensional PCA score plot for the discrimination of aqueous
solutions containing diﬀerent concentrations of kallidin (KD) and bradykinin (BK).
The input data for PCA were obtained from a sensor array composed of the
following six metal–dye combinations: Rh/MCB, Rh/CAB, Rh/CAL, Pd/CAB, Pd/NFR
and Pd/LUM.
In order to assess the predictability of our sensor in this case, a LDA-based ‘‘jack-
knifed’’ validation procedure was applied, and resulted in a correct classiﬁcation in all
cases.
4.3.3 Carnosine and Homocarnosine Solutions in Serum
Finally, we investigated whether the sensor array could be used in a more complex
environment such as human serum. As analytes, we chose the dipeptides carnosine
(β-alanyl–histidine) and homocarnosine (γ-aminobutyryl–histidine). Carnosine (C) is
a naturally occurring dipeptide that was initially isolated from meat extracts. Sev-
eral metabolic functions are known, including antioxidant[323, 324] and hydroxyl-radical
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scavenging eﬀects,[325] metal-ion chelation[326] and pH regulation.[327] Carnosine can
be found in high concentrations in the brains and muscles of mammals, whereas the
related homocarnosine (HC) can be found in cerebrospinal ﬂuid and brain.[323] The two
dipeptides are usually very short-lived in human plasma, due to the presence of restric-
tion enzymes (carnosinases) which degrade them to their constituent amino acids.[328]
Carnosinase deﬁciency, resulting from a rare genetic disorder,[329] was identiﬁed as
the cause of abnormal carnosine and homocarnosine levels in body ﬂuids (micromolar
instead of nanomolar concentrations in blood).[328, 330--334] People suﬀering from this
metabolic disorder show severe symptoms such as developmental delay and mental
retardation. In addition, reduced carnosinase activity was also detected in patients
suﬀering from Parkinson's disease, multiple sclerosis and cerebrovascular disease.[335]
O
H
N O
OH
H2N
HN
N
O
H
N O
OH
HN
N
H2N
C HC
Scheme 4.3 – Carnosine (C) and homocarnosine (HC).
Our goal was to selectively detect carnosine and homocarnosine in the micro-
molar concentration range. Blood serum contains large amounts of salts, sugars,
hormones and proteins. The latter were expected to interfere with our metal re-
ceptors, so a simple precipitation technique with acetonitrile was used to remove
them. The deproteinized serum would still contain non-negligible quantities of other
potentially interfering substances, including micromolar concentrations of histidine
and methionine.[336] To counterbalance the eﬀect of these strong chelators, we de-
cided to perform the competition reactions with slightly higher metal concentrations
(200 – 500 μM, determined by preliminary tests). The ﬁnal assays were carried out
as follows: deproteinized serum samples were spiked with diﬀerent quantities of
carnosine or homocarnosine, an aqueous solution of the respective ﬂuorescent dye
was added, and the competition reaction was initiated by adding a stock solution of
the metal complex. The reduced sensor array, which we had already used for the
dipeptide analysis was employed (sensors: Pd/NFR, Pd/CAB, Rh/NFR, Rh/CAL, Pd/MCB,
and Rh/CAB). As before, the ﬂuorescence response was recorded as a function of
time. The ﬁnal solutions contained 25% (v/v) serum, 25% (v/v) buﬀered water (100 mM
phosphate buﬀer, pH 7.0), and 50% (v/v) acetonitrile. Each reaction was repeated four
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times, and the ﬂuorescence signals after 5, 20, and 60 min were used as input for the
multivariate analysis. The score plot of a PCA is shown in Figure 4.9. The data for the
two peptides at four diﬀerent concentrations (25, 50, 75, and 100 μM) appear in well-
separatedgroupswithnoapparent overlap. Ananalysis of the respective contributions
of the sensors to the principal components indicates that all the sensors contribute
signiﬁcantly to both factor 1 and factor 2. The peptides themselves are separated
along the factor 1 axis (49.1% of the total variance), whereas most of the concentration
information is described by factor 2 (36.9% of the total variance). A LDA with a cross-
validation routine resulted in a correct assignment of all data when one measurement
was omitted at a time and then reclassiﬁed. When only 80% of the data were used as
the training set, the remaining data were also classiﬁed correctly (see Appendix A.2).
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Figure 4.9 – Two-dimensional PCA score plot for the discrimination of various
concentrations of carnosine (C) and homocarnosine (HC). The input data for the
PCA were obtained from a sensor array composed of the following six metal–dye
combinations: Pd/NFR, Pd/CAB, Rh/NFR, Rh/CAL, Pd/MCB and Rh/CAB.
These results demonstrate that a sensor array composed of metal–dye complexes
is able to analyze structurally very similar molecules in a complex matrix. One should
note, however, that the matrix in our experiments was always the same. For a real
application, one would have to consider that the matrix could change (e.g., the blood
composition varies from one person to another). These changes could aﬀect the
response of the sensors independently of the concentration of analytes of interest.
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4.4 Conclusions
Cross-reactive sensor arrays can be constructed from ﬂuorescent dyes and simple 4d
transition metal complexes. Sensor arrays comprising only six metal–dye combina-
tions displayed a remarkable analytical power: samples containing low-micromolar
concentrations of dipeptides were identiﬁed with high accuracy, and mixtures of the
nonapeptide bradykinin and the decapeptide kallidin could be distinguished. Further-
more, it was possible to obtain information about the identity and quantity of the
pharmacologically interesting dipeptides carnosine and homocarnosine in a complex
biological matrix. A key advantage of our approach is its simplicity: all components
of the sensor array are commercially available (if necessary, the metal complexes can
be easily synthesized), and the individual sensors are rapidly obtained by mixing stock
solutions of the respective reagents. The modular nature of our array makes it easy to
optimize a sensor for a particular sensing problem, by varying the nature and/or the
amount of the dyes and metal complexes. Furthermore, the approach should be well
suited for parallelization and automatization.

5 Pattern-Based Sensing withMetal-Dye Complexes: SensorArrays versus Dynamic
Combinatorial Libraries
Synopsis
In this chapter, we describe colorimetric sensors for peptides which are based on the
dyes Methyl Calcein Blue, Arsenazo I, and Xylenol Orange, and the metal salts CuCl2
and NiCl2. Two diﬀerent approaches were followed: (1) Sensors based on dynamic
combinatorial libraries ofmetal-dye complexeswere createdbymixing dyeswithmetal
salts in one pot. The optical response of these libraries was analyzed by measuring
the spectral changes of the mixtures upon addition of the peptide analytes at six
selected wavelengths. (2) A sensor array was created from the six possible metal-dye
combinations. The six individual sensors were analyzed at one wavelength, and the
resulting data was used as the input for a multivariate analysis. Both types of sensors
were evaluated for their ability to diﬀerentiate 13 diﬀerent di- and tripeptides. The
sensors basedondynamic combinatorial libraries gave inmost cases better results than
the sensor array. Furthermore, it was found that libraries of intermediate complexity
perform best as sensors.
Thework presented in this chapter was published in: S. Rochat, K. Severin, J. Comb.
Chem. 2010, 12, 595-599.
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5.1 Introduction
5.1.1 Sensor Arrays and Dynamic Combinatorial Libraries
A ĈĔĒĕđĊĝ between a synthetic receptor and a dye can be used as a chemosensingensemble, given that the displacement of the dye by an analyte leads to a
change in color or ﬂuorescence. Sensors of this type are commonly referred to as
indicator displacement assays (IDAs).[3] Transition metal complexes have been used
very successfully as receptor units in IDAs.[59, 65, 66, 68, 73, 76, 82, 83, 86, 88, 89, 337--339] In the
presence of a dye and an analyte, a dynamic mixture of metal-dye and metal-analyte
complexes is established (Figure 5.1a). Fluorescence or UV/Vis spectroscopy can then
beused to obtain information about the equilibrium, and thus about the identity and/or
quantity of the analyte.
Figure 5.1 – (a) Basic principle of a metal-based indicator displacement assay.
(b) A sensor array based on the combination of diﬀerent metal complexes with
diﬀerent dyes. (c) A sensor based on a dynamic combinatorial library of metal-dye
complexes. M = metal complex.
The analytical power of IDAs can be increased if they are performed in an array
format.[1] In such an array, several IDAs are performed in parallel, and the recognition
of the analyte is then achieved by a pattern-based analysis of the response of the
entire array. Sensor arrays of metal-based IDAs have been created by mixing diﬀerent
dyes with diﬀerent metal complexes (Figure 5.1b),[143, 145, 155, 163, 179, 181, 182, 185, 187, 260] or by
utilization of one metal-dye combination at diﬀerent pH values.[176, 180]
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Another way to increase the analytical power of displacement assays is to per-
form several IDAs simultaneously in one pot (Figure 5.1c).[157, 158, 166, 183, 186, 188, 212] This
approach results in the formationof a dynamic combinatorial library (DCL)[205, 206, 208--210]
of metal-dye complexes. The optical response of a DCL is likewise analyzed with
pattern-recognition protocols.
The sensors described above have fundamental diﬀerences. In a sensor array, each
metal-dye combination is analyzed separately by UV/Vis or ﬂuorescence spectroscopy.
This measurement is typically done at the wavelength, where the largest changes are
observed. For a DCL sensor, on the other hand, the information about the analyte
is distributed over the entire spectrum, and the absorption (or emission) at multiple
wavelengths is used as the data input for a pattern-based analysis. Consequently, it is
suﬃcient to record a single UV/Vis or ﬂuorescence spectrum for a DCL sensor (once the
sensor is calibrated). Sensor arrays and DCL sensors based on metal-dye complexes
may also diﬀer on the molecular level. Each sensing unit of an array will contain ho-
moleptic complexes of type [(M)n(Dye)m]. A DCL sensor, on the other hand, may also
contain heteroleptic complexes such as [(M1)(Dye)(M2)] or [(M)(Dye1)(Dye2)]. These
heteroleptic complexes can participate in displacement reactions with analytes and
can help to diﬀerentiate them. DCL sensors therefore have two distinct advantages:
only oneopticalmeasurement is needed, andheteroleptic complexes can contribute to
the analysis. However, there is also one drawback: since multiple IDAs are performed
simultaneously in one pot, it is likely that the spectra of the diﬀerent dyes and of the
metal-dye complexes show signiﬁcant overlap. This spectral overlap is expected to
result in some loss of resolution.
From the arguments outlined above it is clear that both types ofmetal-dye sensors,
arrays and DCLs, have advantages and disadvantages. It thus appears interesting to
perform a direct comparison of the two approaches for a particular sensing problem.
The results of such an investigation are reported below. As a case study, we chose
to compare the discriminating abilities of a sensor array and of DCL sensors toward a
series of di- and tripeptides combining only four diﬀerent amino acids. Interestingly,
DCL sensors were found to perform signiﬁcantly better than sensor arrays for most
cases studied.[213]
5.1.2 Linear Discriminant Analysis
Asmentioned in section 1.4.4, linear discriminant analysis (LDA) canbeused to separate
classes of objects, or assignnewobjects to appropriate classes.[110]Oneway to evaluate
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the goodness of ﬁt of the discriminant function is to assess the hit rate, i.e. the
proportion of observations classiﬁed correctly. However, if the samedata set is used to
assess the hit rate, that was used to determine the discriminant function, the estimate
of prediction accuracywill be biased upwards. This problem is usually solved by parting
the data set into a holdout and a training sample: the holdout sample can be used to
validate the predictive performance of the discriminant function established by using
the training sample.
When a more accurate estimation of the quality of a LDA is necessary (i.e., when
one needs to compare diﬀerent models), Wilks' lambda can be used.[215, 340, 341] Wilks'
lambda () represents the ratio of intraclass versus interclass variances, and canalsobe
expressed as a function of the eigenvalues of the model. Its value is always comprised
between 0 and 1. The smaller the value, the better the model. On the other hand, a
value of  = 1 indicates that all clusters are overlapping.
 =
jWj
jVj =
Y
i
1
1 + i
(5.1)
W is the within-group variancematrix, V is the total variancematrix, and i is the ith
eigenvalue.
There is no threshold value for , which indicates when a discrimination can be
considered as satisfactory. Assessing the quality of a discrimination also depends on
the number of classes, samples, and variables. Wilks' lambda is related to a F-statistic
test, which can be represented as the ratio of two variances: the total variance of the
sample, and the residual variance (the amount left unexplained by the model):
F =
explained variance
unexplained variance =
between-group variability
within-group variability (5.2)
When this ratio is large, it suggests that a large proportion of the variance can be
explained by the regression model; when the ratio is close to 1, the conclusion is that
the model is probably not signiﬁcant. More formally, the F-ratio can be expressed as a
function of Wilks' lambda:
F =
1  1=t
1=t
 df2
df1
(5.3)
with
df1 = pH (5.4)
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df2 = wt  0:5(pH   2) (5.5)
and
w = E + H   0:5(p+ H + 1) (5.6)
t =
s
p22H   4
p2 + 2H   5
(5.7)
where p, H and E are deﬁned as:
p = number of variables (dimension) (5.8)
H = degrees of freedom for hypothesis (i.e., number of classes - 1) (5.9)
E = degrees of freedom for error (i.e., (class  replicates in the class)) (5.10)
Critical values for F have been calculated[340] and can be used to determinewhether
a statistical model is signiﬁcant (i.e., if the null hypothesis implying that there is no
diﬀerence across the classes can be rejected). It must be noted, however, that the
F-ratio can be misleading in some cases: for example, it can be very high if only one
analyte is very diﬀerent, and the others are grouped and not well separated. On the
other hand, the F-ratio can be low if all the analytes behave slightly diﬀerently, but are
nonetheless very well separated. The F-ratio must therefore be employed while being
aware of these limitations.
5.2 Discrimination of Peptides with a Sensor Array and
with a DCL
For our study we decided to use a colorimetric DCL sensor, which was recently devel-
oped by our group.[183] It is composed of the dyesMethylcalcein Blue (MCB), Arsenazo I
(AI), and Xylenol Orange (XO), and themetal salts CuCl2 (Cu) and NiCl2 (Ni, Scheme 5.1).
When the ﬁve components are mixed in buﬀered aqueous solution, a dynamic mixture
of homo- and heteroleptic metal-dye complexes is formed. The sensor can be used
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for the colorimetric detection of peptides, as evidenced by an analysis of the peptide
hormones angiotensin I and angiotensin II.[183]
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Scheme 5.1 – The metal complexes, the dyes, and the peptide analytes used in this
study.
For the creation of a sensor array, we used the same ﬁve components tomake a to-
tal of six sensors composed of all possible metal-dye combinations. The readout of the
six sensors was performed at the wavelength, where the largest spectral change was
observed upon complexation of the dye to the respective metal (spectrophotometric
titrations of the dyes and the metal salts are described in ref. [183]). The following
values were used: MCB/Cu: 372 nm, AI/Cu: 492 nm, XO/Cu: 584 nm, MCB/Ni: 376 nm,
AI/Ni: 532 nm, and XO/Ni: 592 nm.
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The DCL sensor and the sensor arrays were then employed for the sensing of di-
and tripeptides. The analytical task was the diﬀerentiation of the 13 peptides listed in
Scheme 5.1 at a concentration of 1.0 mM.
For the analysis with the DCL sensor, the UV/Vis spectrum of the library was
recorded for each of the 13 analytes after equilibration (10 replicates each). The initial
data contained 93 values for each measurement (absorbance values in the region
λ = 332 − 700 nm, with intervals of 4 nm). To determine the wavelengths which
contribute most to the diﬀerentiation of the peptides, an internal variable selection
algorithm of the software package Systat[342] (version 11) was applied. This allowed
reducing the data set to 6 values for each measurement. The reduced data set was
then used as the input for a linear discriminant analysis (LDA).[110] LDA was chosen as
a method because it allows to obtain quantitative information about the quality of the
classiﬁcation. This information is very useful for comparing diﬀerent sensors. One
should note, however, that LDA tends to give ‘‘overoptimistic’’ resultswhen compared
to unsupervised methods such as principal component analysis (PCA).
For the analysis of the sensor array, the optical response of the six diﬀerent sensors
was recorded for each of the 13 peptides. As in the case of the sensor array, 10
independent measurements were performed for each peptide. The resulting data was
also classiﬁed by an LDA.
A graphic representation of the two analyses in form of two-dimensional score
plots is shown in Figure 5.2. It is evident that the resolution of the DCL sensor is
superior to that of the sensor array. The qualitative assessment is conﬁrmed by a cross-
validation analysis, in which 33% of the cases are removed from the data set and then
reclassiﬁed using the remaining data as a training set. For the sensor array, the cross-
validation procedure results in a correct classiﬁcation in 96% of the cases, whereas 98%
is obtained for the DCL sensor (averaged results of 10 independent executions of the
cross-validation routine).
One can note that the ﬁrst two scores of the sensor array contain 89% of the total
variance. In the case of the DCL sensor, 97% of the total variance is found for the ﬁrst
two scores. The higher dispersion of the sensor array data is not unexpected, since
the displacement assays are performed independently from each other and not in one
pot. Still, the dimensionality of the sensor array data is low compared towhat has been
observed for some other systems.[127, 142, 152, 171, 198]
The complexity of a DCL sensor, that is, the number of its constituent components,
is expected to inﬂuence the analytical power of the system. Reducing the complexity
substantially should lead to a loss in resolution. However, it is not clear whether
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Figure 5.2 – LDA score plots generated from the data of the sensor array composed
of six individual metal-dye sensors (top), or the data of the DCL sensor made
by mixing the dyes MCB, AI, and XO with the metal complexes CuCl2 and NiCl2
(bottom). Both sensors were used for the diﬀerentiation of 13 di- and tripeptides
in buﬀered aqueous solution at a concentration of 1.0 mM.
DCL sensors of high complexity (more dyes and metals) are necessarily better. To
address this point, we have examined the performance of DCL sensors containing
fewer components than our original 3-dye-2-metal sensor. Systematically, we have
omitted one, two, or three components, and the resulting DCLs were then evaluated
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for their ability to diﬀerentiate the 13 peptides used before. To characterize the quality
of the sensor, we have performed cross-validation procedures in all cases. As a second
criterion for comparison, we have examined the F-ratios associated to Wilks’ lambda
values for the diﬀerent analyses. As mentioned in section 5.1.2 (p. 88), F-values can be
used to determinewhether a statisticalmodel is signiﬁcant, and larger F-values indicate
a better model and analysis.[215, 340] A summary of the results is given in Table 5.1.
Table 5.1 – Analysis of 13 di- and tripeptides with DCL sensors of diﬀerent
composition and with the sensor array described in the main text. The percentage
of correct cross-validation and the F-value associated to each discriminant model
are indicated.
Entry Dye(s) Metal Salt(s) % cross-validation F-value
1 AI + XO CuCl2 + NiCl2 100 510
2 MCB + AI + XO NiCl2 100 423
3 MCB + XO CuCl2 + NiCl2 100 325
4 XO NiCl2 100 238
5 MCB + XO CuCl2 100 220
6 AI CuCl2 + NiCl2 100 209
7 MCB + AI NiCl2 100 154
8 AI + XO NiCl2 100 154
9 AI NiCl2 100 141
10 MCB + XO NiCl2 100 133
11 MCB + AI CuCl2 + NiCl2 99 661
12 MCB + AI + XO CuCl2 99 230
13 MCB + AI CuCl2 99 190
14 MCB CuCl2 99 121
15 MCB + AI + XO CuCl2 + NiCl2 98 254
16 AI CuCl2 98 209
17 XO CuCl2 + NiCl2 98 194
18 AI + XO CuCl2 98 105
19 MCB CuCl2 + NiCl2 96 161
20 Sensor Array 96 92
21 XO CuCl2 87 63
22 MCB NiCl2 81 60
Interestingly, the quality of the analysis was found to increase in most cases when
one component was removed from the original 5-component DCL sensor. All sensors
made from two dyes and two metal salts, for example, gave a better discrimination
than the full library (Table 5.1, entries 1, 3 and 11 vs. entry 15). Further reduction
in complexity to 3 or 2 components typically resulted in a loss of quality as shown
by comparison of the F-values (Figure 5.3). The score plots associated with the
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combinations listed in Table 5.1 which are not discussed in detail here, are given in
Appendix B.1.
Quite surprisingwas the performance of some of the sensors composed of just one
metal and one dye. The combination ofNiCl2with XO, for example, resulted in a sensor,
which gave 100% correct classiﬁcation in the cross-validation procedure and an F-value
of 238 (Table 5.1, entry 4 and Figure 5.4). Consequently, it performs signiﬁcantly better
than the sensor arraywith only 96% correct classiﬁcation and an F-value of 92 (Table 5.1,
entry 20).ƅ
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Figure 5.3 – Comparison of the F-values for multivariate analyses of DCL sensors
composed of a diﬀerent number of dyes (D) andmetal salts (M). The F-value of the
sensor array is given for comparison.
At ﬁrst hand, it may appear paradoxical that a mini-DCL sensor composed of just
NiCl2 and XO is superior to an array of six individual sensors, one of which is based on
a mixture of the very same components: NiCl2 and XO. However, only one wavelength
is taken into account for each of the six sensors of the array (592 nm for XO/Ni),
whereas six wavelengths are used for the analysis of the mini-DCL sensor. A buﬀered
aqueous solution ofNiCl2, XO, and the peptide analyte is expected to containmetal-dye
complexes of the stoichiometry [Ni(XO)] and [Ni2(XO)]Ɔ,metal-peptide complexes, and
possibly heteroleptic metal-dye-peptide complexes. The system is thus more complex
than the idealized displacement assay shown in Figure 5.1a, which assumes that the
dye and a 1:1 metal-dye complex are the only colored species. An analysis of the
ƅA comparison of the F-factors is legitimate because the format of the data input is the same for the
DCL sensors and for the sensor array (13 analytes, 10 replicates, 6 wavelengths).
ƆSpectrophotometric titrations had shown that the dominant species in mixtures of XO and NiCl2 are
complexes with the stoichiometry [Ni(XO)] and [Ni2(XO)] (see ref. [183]).
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Figure 5.4 – LDA score plot generated from the data of a sensor made from XO
and NiCl2. The sensor was used for the diﬀerentiation of 13 di- and tripeptides in
buﬀered aqueous solution at a concentration of 1.0 mM.
XO/Ni sensor at only one wavelength neglects the information that is provided by
the inherent complexity of the system (multiple colored species, the concentration of
whichdependson thenatureof the analyte).Ƈ In this regard it is easy to understand that
a pattern-based analysis of the XO/Ni sensor is better than a single-wavelength analysis.
It is surprising, however, that the information provided by the ﬁve other sensors of the
array (MCB/Cu, AI/Cu, XO/Cu, MCB/Ni, and AI/Ni) is not suﬃcient to outperform the
simple DCL sensor composed of NiCl2 and XO.
5.3 Conclusions
DCL sensors containing one, two, or three dyes (XO, AI, MCB) as well as one or two
metal salts (CuCl2, NiCl2) were used to diﬀerentiate short peptides. The analytical
power of the DCL sensorswas comparedwith that of a sensor arraymade from six sep-
aratemetal-dyemixtures (MCB/Cu, AI/Cu, XO/Cu, MCB/Ni, AI/Ni, XO/Ni). DCL sensors of
intermediate complexity (e.g., 4-component sensors) were found to give better results
than the full library made from all ﬁve components. This ﬁnding will be of interest
for future studies in this area because it shows that more is not necessarily better.
Interestingly,mostDCL sensors including very simple 2-component systemsperformed
better than the sensor array. However, the fact that these results cannot be easily
ƇFor a discussion about the advantages of higher order complexes in IDAs see ref. [155].
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generalized must be acknowledged. For example, chemically rather homogeneous
analytes were used, and diﬀerent results may be obtained with a more diverse set of
analytes. However, the results clearly show that the one-pot-one-spectrum approach
ofDCL sensors represents a potentially very attractive alternative to themore common
sensor array approach.

6 General Conclusions
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TčėĊĊ ĉĎċċĊėĊēę ĘęėĆęĊČĎĊĘ havebeenpresented for thedetectionof thebiologicallyrelevant Li+ ion in aqueous solution (Figure 6.1). All these approaches are based
on 12-metallacrown-3 complexes, which act as selective receptors for Li+.
PET sensorswere developed, where ruthenium-basedmetallacrownswere labelled
with ﬂuorescent dyes (Figure 6.1a). The main issue turned out to be solubility: several
amino groups were required to obtain a water-soluble macrocycle (at neutral pH, the
amines are protonated, which confers their solubility to the macrocycles), and the
ﬂuorophores needed to be of limited hydrophobicity. On the other hand, ﬂuorophores
containing functional groups that may interfere with the self-assembly of macrocycles
(i.e., that possess strong aﬃnity for ruthenium centers) had to be avoided. The
most successful system was found to be ruthenium-based macrocycleM10, featuring
methoxycoumarin as ﬂuorophore and an amino substituted π-ligand. This compound
is water-soluble, and it can be obtained in situ by combination of its building blocks in
buﬀered aqueous solution. CompoundM10 possesses a strong aﬃnity for Li+ (with an
aﬃnity constant of ca. 103 M-1) as well as a good selectivity over potentially interfering
ions such as Na+ or K+. Its ﬂuorescence intensity depends on the concentration of Li+,
which allows detection of lithium ions in the pharmacologically relevant range (0.5 - 1.5
mM). Themacrocycle is stable in blood serum (after removal of proteins), and can thus
be employed as a lithium sensor in complex biological samples.
The development of sensorM10 came at the price of tedious and time-consuming
syntheses. An alternative approach involving non-covalent interactions between the
binding and signalling units was devised. Simple macrocycleM1 was employed, which
is made by self-assembly of [(p-cymene)RuCl2]2 and ligand L2. Depending on the
ﬂuorophore that was employed, the sensing of Li+ was achieved by two diﬀerent
mechanisms: a) when HPTS was used, it interacted with macrocycle M1 without
disrupting it. The ﬂuorescence was modulated as a function of the presence of Li+ at
the binding site (Figure 6.1b). This simple assay was found to have a detection limit
of less than 100 μM. b) when Calcein Blue was used, its strong aﬃnity for ruthenium
led to the destruction of the macrocyclic receptors, and to a strong quenching of
the ﬂuorescence. In the presence of lithium at the binding site, the macrocycle was
eﬃciently stabilized and its destruction by Calcein Blue considerably slowed down
(Figure 6.1c). This resulted in an attenuated quenching of the ﬂuorescence, which
allowed to detect Li+ down to low millimolar concentrations.
A diﬀerent approach to chemical sensing is described in the second part of this
work: instead of designing selective sensors, we developed arrays of cross-reactive dif-
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a)
b)
c)
Figure 6.1 – Three diﬀerent methods for the detection of Li+ ions. a) a conjugated
PET sensor; b) a ditopic sensor for Li+ and a ﬂuorophore (HPTS); c) detection
through the stabilizing eﬀect of Li+ on the receptor. All systems result in a
ﬂuorescence turn-on in the presence of Li+.
ferential sensors for the detection and discrimination of small peptides. By combining
ﬂuorescent dyes such as Methylcalcein Blue, Calcein Blue, Calcein, Nuclear Fast Red,
Lumazine and N-methylanthranilic acid with metal fragments ([(p-cymene)RuCl2]2,
[Cp*RhCl2]2 and [(en)PdCl2]), sensor arrays were generated (Figure 6.2). Their use for
the discrimination of dipeptides in deproteinized serum, as well as for the discrimina-
tion of mixtures of longer peptides was demonstrated. The diﬀerential responses of
the sensor arrays were interpreted with the help of pattern-recognition software, and
resulted in the detection of peptides in the low micromolar range.
Finally, the performance of a sensor array was compared with the performance of
a dynamic combinatorial library (DCL) for the discrimination of a series of related small
peptides. The array was composed of combinations of the three dyes Methylcalcein
Blue, Arsenazo I and Xylenol Orange, and the metal salts CuCl2 and NiCl2. The DCL was
prepared bymixing the ﬁve constituents, and sub-libraries were prepared by removing
one or several constituents. The diﬀerent systems were tested for the discrimination
of 13 di- and tripeptides. Two important conclusions could be drawn: a) Generally, the
DCL outperforms the sensor array; b) Increasing the complexity of the DCL generally
increases the quality of its performances, but only until a certain threshold. When
numerous species are present in the mixture, the resulting UV/Vis spectrum is the sum
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Figure 6.2 – Representation of a sensor array for peptides. Each row corresponds
to the ﬁngerprint of a given dipeptide.
of many diﬀerent contributions, that can potentially cancel each other. In such a case,
the advantage of amulticomponent system is annihilated by the averaging of its UV/Vis
spectrum.
In summary, we have shown that simple systems can achieve complex sensing
tasks: self-assembledmacrocycles made of easily accessible building blocks can detect
the elusive lithium ion, whereasmixture of commercially available dyes andmetal com-
pounds can form sensor arrays or dynamic combinatorial libraries with a high potential
to detect small peptides down to lowmicromolar concentrations. These systemswere
found to work well in water at neutral pH and in deproteinized human serum, paving
the way to applications involving real biological or environmental samples.
a) b)
Figure 6.3 – Representation of two diﬀerent systems that were compared in the
last part of this work: a) a sensor array; b) a dynamic combinatorial library made of
the same constituents.
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7.1 General and Instrumentation
7.1.1 General
UēđĊĘĘ ĔęčĊėĜĎĘĊ ĘęĆęĊĉ, non-aqueous reactions were performed in oven-driedglassware under an atmosphere of dry dinitrogen with standard Schlenk-line
techniques. Reactions performed in aqueous environment were carried out in air,
except the syntheses ofmacrocyclesM4,M5,M9, andM10, thatwereperformedunder
N2. Solvents were of analytical grade quality, and were stored under an atmosphere
of dinitrogen. When required, benzene, hexane, dichloromethane, chloroform or
diethyl etherweredehydratedbyﬁltration through activated aluminiumoxide columns
under dinitrogen (Innovative Technology solvent puriﬁcation system). Anhydrous
methanol and ethanol were obtained by distillation over magnesium. The weights of
the commercial compounds given in the detailed procedures are impurity corrected,
and indicated yields refer to puriﬁed and dried compounds. The indications in square
brackets correspond to reactions codes in laboratory books: [SR-B100(3)] refers to the
book B, reaction number 100, 3rd repetition.
7.1.2 Instrumentation
NMR spectroscopy. 1HNMR and 13C NMR spectra were recorded at room temperature
on a Bruker Avance DPX 400 spectrometer or on a Bruker Avance 200 spectrometer,
using the residual protonated solvents as internal standards. 13C NMR spectra in D2O
were recorded using dioxane as internal standard. Chemical shifts δ are reported in
ppm, and the multiplicity is reported as follows: s = singlet, d = doublet, t = triplet, dd
= doublet of doublets, quint = quintet, sept = septuplet, m = multiplet or unresolved.
Coupling constants J are given in Hz.
Elemental analysis. Measurement were performed by the elemental analysis service
at EPFL on a EA 1110 CHN Carlo Erba, or on a Flash 2000 Organic Elemental Analyser
Thermo Fisher Scientiﬁc instrument.
Mass spectrometry. High resolution mass spectra were recorded by the mass spec-
trometry service at EPFL on a Waters CapLC-coupled Micromass Q-ToF Ultima ESI-
instrument equipped with a Z-spray type ESI source.
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UV-Visible spectroscopy. UV-Visible spectra were recorded at room temperature on a
Perkin-Elmer Lambda 40 spectrometer.
Fluorescence spectroscopy. Fluorescence measurements were performed with a
Varian Cary Eclipse spectrophotometer equipped with a thermostatted cell holder and
a stirring mechanism.
HPLC. Puriﬁcations by reversed phase HPLC were carried out using a Waters system
consisting of aWaters 600 controller unit, aWaters Delta 600 pump and aWaters 2487
dual wavelength absorbance detector. A Sunﬁre semi-preparative C18 column (5 mm,
10 250mm)was used as stationary phase, andMilliporewater and acetonitrile (HPLC
grade) as mobile phase.
Cyclic Voltammetry. Measurements were performed at the Laboratory of Inorganic
Synthesis and Catalysis at EPFLwith a computer controlled IVIUMSTAT Electrochemical
Interface at a sweep rate of 50 mV/s. An aqueous Ag/AgCl electrode was used as
reference electrode. The solution was purged with nitrogen prior to recording the
electrochemical data, and all measurements were recorded at room temperature
under a dinitrogen atmosphere.
Others. Concentrations under reduced pressure were performed at 40C with a Büchi
Rotavapor R200 rotary evaporator (unless otherwise indicated); Thin layer chromatog-
raphy was performed on Merck silica gel 60 F254 plates and ﬂash chromatography was
eﬀectuated using silica gel 60 from Fluka; pH measurements were recorded with a
Metrohm Titrino 716 DMS instrument equipped with a combined LL pH glass electrode
(Metrohm Ecotrode).
7.1.3 Purchase of Compounds
The following compounds were used as received: PdCl2 (ca. 60% Pd), RhCl3  3H2O
(37 - 42% Rh), RuCl3  xH2O (40 - 43% Ru) (Precious Metals Online), 4-aminobutyric acid
(99%), ammonium hydroxyde (25% solution in H2O), Asp-Phe (95%), carnosine (β-Ala-
His, 98%), dibenzylamine (98%), N,N-dimethylbenzylamine (99%), formaldehyde (37wt%
solution in H2O, stabilized with 10-15% MeOH), HCl (25% in H2O), N-methylpiperazine
(99%), NaBH4 (99%), NaCl (extrapure), NaOH (97%), palladium (10% Pd on activated car-
bon), α-terpinene (90%), Xylenol Orange (sodium salt, pure) (Acros), Ala-Ala, Ala-Phe,
benzyl chloroformate (95%), Calcein Blue, Celite, coumarin (99%), Cs2CO3 (>99.999%),
CsOH H2O (99.5%), dimethyl sulfate (99%), 2,3-dihydroxypyridine (98%), ethylenedi-
amine (99%), Gly-Leu, Gly-Met, HEPES (>99%), HPTS trisodium salt (97%), human serum,
KOH (extra pure), Leu-Gly, Leu-Met, Lumazine (97%), Met-Gly, N-methylanthranilic
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acid (95%), Methyl Calcein Blue, methyl chloroformate (99%), Met-Leu, Nuclear Fast
Red, Phe-Pro, Ser-Gly, sodium (purum), Trp-Gly (Sigma-Aldrich), Calcein, CuCl2  2H2O
(99%), DCl (38% in D2O), N,N-dimethylformamide (absolute, over molecular sieve, H2O <
0.01%), Gly-Gly, hexamethylenetetramine (99%), K2CO3 (99%), KH2PO4 (>99.5%), K2HPO4
(>99.5%), LiCl (99%), MgSO4  6H2O (>99%), MgSO4 (98%), NaHCO3 (99%), Na2SO4(99%),
NH4Cl (99%) (Fluka), dansyl chloride, ethyl chloroformate, human serum, 7-hydroxycou-
marin (99%), 1,2,3,4,5-pentamethylcyclopentadiene, triethylamine (VWR), Arsenazo I, 1-
pyrenecarboxaldehyde, triﬂuoroacetic acid (HPLC grade) (Alfa Aesar), Histidinemethyl
ester dihydrochloride (Senn Chemicals), bradykinin, Gly-Gly-Met, Gly-Met-Gly, Gly-Phe,
His-Ala, kallidin, Lys-Tyr, Met-Leu-Gly, Met-Phe, Met-Phe-Gly, Val-Phe (Bachem), CHES
(AppliChem), and NiCl2  6H2O (Strem Chemicals).
7.1.4 Software
WinEQNMR[293] was used to calculate equilibrium constants fromNMRor ﬂuorescence
data.
UV-Vis andﬂuorescencebinding isothermswereﬁttedusinga routinebuilt inMATLAB R
which implements the Newton-Gauss non-linear least squares ﬁtting algorithm.[343--345]
Systat (version 11)[342] was used to perform statistical analyses (principal component
and linear discriminant analyses).
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7.2 Syntheses
7.2.1 Organometallic Complexes
Organometallic complexes [Cp*RhCl2]2 (C1),[280] [(p-cymene)RuCl2]2 (C2),[346, 347] [η6-
(C6H5CH2NMe2H)RuCl2]2Cl2 (C3),[291] and [PdCl2(en)] (C4)[348] were synthesized accord-
ing to published methods. Typical procedures are given below:
[Cp*RhCl2]2 (C1).[280]
Rh
Cl
Cl
Cl
Rh
Cl
C1
RhCl3  3H2O (3.45 g, 13.1 mmol) was dissolved
in MeOH (100 mL). 1,2,3,4,5-Pentamethyl-1,3-cyclo-
pentadienewas added (2.25mL, 14.4mmol, 1.1 equiv.)
and the mixture was heated to reﬂux for 48 hours.
The solution was left overnight at -20C to aﬀord red
microcrystals, which were ﬁltered oﬀ and washed
with coldMeOH. Compound C1was obtained as a red
solid (3.29 g, 5.33 mmol, 81%) with spectral data in good agreement with literature.[349]
[SR-C224(1)].
1H NMR (CDCl3, 400 MHz): δ (ppm) = 1.62 (s, 30 H, CH3).
13C{1H} NMR (CDCl3, 101 MHz): δ (ppm) = 10.1 C5(CH3)5), 94.3 (C5(CH3)5).
[(p-cymene)RuCl2]2 (C2).[346, 347]
Ru
Cl
Cl
Cl
Ru
Cl
C2
RuCl3  xH2O (ca. 41% Ru, 5.0 g, 20.3 mmol) was
dissolved in a mixture of EtOH (250 mL) and water
(25 mL). α-Terpinene was added (28 mL, 155 mmol,
7.6 equiv.) and the mixture was heated to reﬂux
for 6 hours. The solution was left to cool to room
temperature, and ﬁltered through a fritte in order to
remove any unreacted RuCl3. The solution was then
evaporated under reduced pressure to ca. 1/3 of its initial volume, and placed in a fridge
for 24 hours. A red precipitate was collected by ﬁltration, washed with Et2O and dried
under vacuum. The mother liqueur could be further evaporated in order to collect a
second fraction of the product. Puriﬁcation of the product was performed as follows:
the solid was dissolved in degassed CH2Cl2, the solution was ﬁltered through a pad of
Celite and evaporated to dryness. The obtained solid was then washed with Et2O and
dried under vacuum to aﬀord C2 as an orange powder (4.75 g, 7.76 mmol, 76%) with
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spectral data in good agreement with literature.[347] [SR-A6(3)].
1H NMR (CDCl3, 200 MHz): δ (ppm) = 1.27 (d, 3J = 7.0 Hz, 12 H, CH(CH3)2), 2.15 (s, 6 H,
CH), 2.92 (sept, 3J = 6.9 Hz, 2 H, CH(CH3)2), 5.34 (d, 3J = 5.8 Hz, 4 H, MeC6H4iPr), 5.47 (d,
3J = 5.8 Hz, 4 H, MeC6H4iPr).
13C{1H} NMR (CDCl3, 101 MHz): δ (ppm) = 19.1 (CH3), 22.3 (CH(CH3)2), 30.7 (CH(CH3)2),
80.7, 81.4, 96.9, 101.3 (arene).
[η6-(C6H5CH2NMe2H)RuCl2]2Cl2 (C3).[291]
Ru
Cl
Cl
Cl
Ru
Cl
NHCl
NHCl
C3
RuCl3 · xH2O
N 21
22 = 21·HCl
(Cyclohexa-1,4-dienyl)-N, N-dimethylmethanamine
(21) was obtained from N,N-dimethylbenzylamine
byaBirch reduction:[350, 351] Amixtureof freshlydis-
tilled EtOH (40 mL) and N,N-dimethylbenzylamine
(11.1 mL, 10.0 g, 73.1 mmol) was added to 300 mL
of condensed ammonia at -70C. Freshly cut pieces
of sodium (10.0 g, 435 mmol) were slowly added,
and the mixture was stirred at -70C for 4 hours.
EtOH (30mL)was slowly added, followedbyNH4Cl
(30 g). Ammonia was evaporated and H2O (120
mL) was added. The solution was extracted with
Et2O (2 150 mL), the organic phase was dried on
MgSO4 and evaporated under reduced pressure to
aﬀord 21 as a colorless oil that was usedwithout further puriﬁcation (7.18 g, 52.3 mmol,
72 %). [SR-A58(1)].
1HNMR (CDCl3, 400MHz): δ (ppm) = 2.11 (s, 6 H, CH3), 2.62 (m, 4 H, CH2 (cycle)), 2.71 (s,
2 H, NCH2), 5.53 (s, 1 H, cycle), 5.61 (d, 3J = 12.0 Hz, 1 H, cycle), 5.68 (d, 3J = 12.0 Hz, 1 H,
cycle).
The diene 21was converted to the corresponding ammonium salt 22 prior to coordina-
tion to ruthenium: A solution of 21 (3.57 g, 26.0 mmol) in CH2Cl2 was treated with HCl
(3.9mL of a 25% solution in H2O, 30.0mmol). The solventswere removed and thewhite
solid was dried under vacuum (3.62 g, 20.8 mmol, 80%). [SR-A59(1)].
1H NMR (D2O, 400 MHz): δ (ppm) = 2.72 (s, 6 H, CH3), 3.56 (s, 2 H, NCH2), 4.69 (s, 4 H,
CH2 (cycle)), 5.66 (s, 2 H, CH (cycle)), 5.92 (s, 1 H, CH (cycle)).
13C{1H} NMR (D2O, 101 MHz): δ (ppm) = 26.18, 26.82 (CH2 (cycle)), 42.14 (NH(CH3)2),
63.62 (NCH2), 123.2, 123.9 (–CH=), 131.6 (quaternary).
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A solution of RuCl3  xH2O (1.42 g, ca. 41% Ru, 5.75mmol) in EtOH (50mL)was prepared.
Diene 22was added (3.00g, 17.3mmol, 3.0 equiv.) and themixturewasheated to reﬂux
for 5 hours. Thegreen solidwasﬁlteredoﬀ,washedwith EtOH (15mL) followedbyEt2O
(15 mL) and dried under vacuum to aﬀord C3 (1.61 g, 2.34 mmol, 81%) with spectral data
in good agreement with literature.[291] [SR-A60(1)].
1H NMR (d6-DMSO, 400 MHz): δ (ppm) = 2.79 (s, 12 H, NH(CH3)2), 4.04 (s, 4 H, NCH2),
6.09 - 6.15 (m, 6 H, aromatic p- and m-protons), 6.32 (d, 3J = 5.6 Hz, 4 H, aromatic o-
protons), 11.57 (s, 2 H, NH).
13C{1H} NMR (d6-DMSO, 101 MHz): δ (ppm) = 41.8 (NH(CH3)2), 57.5 (CH2), 86.2, 88.2,
88.8, 92.1 (arene).
Elemental analysis (%) calcd (found) for C18H28Cl6N2Ru2  H2O : C 30.65 (30.36), H 4.40
(4.07), N 3.97 (3.93).
[PdCl2(en)] (C4).[348]
Pd
H2
N
Cl
Cl
N
H2
C4
PdCl2 (500 mg, 2.85 mmol) was dissolved in water under acidic
conditions (10mLH2O+ 3mLHCl (37%)). The solutionwas heated
to reﬂux and ﬁltered. The pH of the solution was increased
to 2 - 3 by addition of NaOH (ca. 20 mL of a 1.5 M solution).
Ethylenediamine (0.19 mL, 2.85 mmol, 1.0 equiv.) was added
dropwise, while ensuring the pH was kept under 3 (addition of
HCl if necessary). The brown solution turned yellow, and was stirred at 70C for one
hour. It was then left to cool to room temperature overnight. A yellow solid was
ﬁltered oﬀ, washed with small portions of H2O and acetone, and dried under vacuum
to aﬀord C4 (455 mg, 1.92 mmol, 67%) with spectral data in good agreement with
literature.[352]
1H NMR (d6-DMSO, 400 MHz): δ (ppm) = 2.33 (s, 4 H, CH2), 4.88 (s, 4 H, NH2).
13C{1H} NMR (d6-DMSO, 101 MHz): δ (ppm) = 47.2 (CH2).
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7.2.2 Dihydroxypyridine-based Bridging Ligands
Commercially available 2,3-dihydroxypyridine (L1) was used as the starting material for
the synthesis of ligands L2 and L3.[289, 290, 353] L4 was obtained from L3 by Pd-catalyzed
hydrogenolysis, and the ﬂuorescent ligands L5-L10 were prepared by coupling a ﬂuo-
rophore to L4.[22]
4-((4-Methylpiperazine)-1-yl)methyl)-2,3-dihydroxypyridine (L2).[289, 290]
N
N
N
OH
OH
L2
2,3-Dihydroxypyridine (L1, 2.0 g, 17.1 mmol), formaldehyde (1.3 mL,
37 wt% in H2O, 17.1 mmol, 1 equiv.) and N-methylpiperazine (1.9
mL, 17.1 mmol, 1 equiv.) were heated under reﬂux in EtOH (75 mL)
for 7 hours. The mixture was stirred for an additional 12 hours at
room temperature. The solution was concentrated to ca. 25 mL
and acetone was added to aﬀord a precipitate which was ﬁltered
oﬀ and washed with acetone. The crude product was solubilized in
hot CHCl3. The obtained solution was ﬁltered through a pad of Celite and cooled down
to -20C. The precipitatewas ﬁltered oﬀ, washedwith acetone and dried under vacuum
to aﬀord ligand L2 as a white solid (1.34 g, 6.00 mmol, 35%). [SR-C232(1)].
1H NMR (CDCl3, 400 MHz): δ (ppm) = 2.29 (s, 3 H, CH3), 2.58 (m, br, 8 H, NCH2,
piperazine), 3.59 (s, 2 H, NCH2), 5.98 (d, 3J = 6.4 Hz, 1 H, pyridine), 6.92 (d, 3J = 6.4
Hz, 1 H, pyridine).
13C{1H} NMR (CDCl3, 101 MHz): δ (ppm) = 46.0, 52.8, 54.9, 59.5 (NCH3, NCH2), 107.7,
123.9, 125.5, 146.7, 159.8 (pyridine).
Elemental analysis (%) calcd (found) for C11H17N3O2  1/25 CHCl3 : C 58.15 (58.36), H 7.53
(7.63), N 18.43 (18.24).
2,3-Dihydroxy-4-(N,N-dibenzylaminomethyl)pyridine (L3).[353]
N
N
OH
OH
L3
2,3-Dihydroxypyridine (L1, 10.0 g, 87.3 mmol), formaldehyde
(7.1mL, 37wt % inH2O, 87.3mmol, 1 equiv.) and dibenzylamine
(33.5 mL, 175 mmol, 2 equiv.) were heated under reﬂux in
EtOH (700mL) for 6 days. After themixturewas cooled down
to room temperature, a solid residue was ﬁltered oﬀ and
discarded. The solution was concentrated to ca. 50 mL and a
solid was ﬁltered oﬀ, which was solubilized in hot CHCl3 (400
mL). The hot solution was ﬁltered through a pad of Celite and
concentrated to 100 mL under reduced pressure. Addition of
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acetone (100 mL) and storage of the mixture in the fridge aﬀorded a white precipitate
which was ﬁltered oﬀ, washed with acetone and dried under vacuum. Ligand L3 was
obtained in 46% yield (12.8 g, 40.0 mmol) with spectral data in good agreement with
literature.[353] [SR-A30(1)].
1H NMR (CDCl3, 400 MHz): δ (ppm) = 3.62 (s, 2 H, NCH2), 3.65 (s, 4 H, NCH2Ph), 6.17 (d,
3J = 6.8 Hz, 1 H, pyridine), 6.95 (d, 3J = 6.8 Hz, 1 H, pyridine), 7.26 - 7.39 (m, 10 H, Ph),
10.04 (s, 1 H, OH), 12.95 (s, 1 H, OH).
13C{1H} NMR (CDCl3, 101 MHz): δ (ppm) = 54.0, 58.4 (NCH2), 108.1, 123.7, 127.0, 127.8,
128.8, 129.5, 137.2, 146.0, 159.5 (pyridine, Ph).
4-Aminomethyl-DHP (L4).[22]
N
NH2
OH
OH
L4
4-(Dibenzylamino)methyl-2,3-dihydroxypyridine (L3, 1.00 g, 3.12mmol)
was dissolved in degassed methanol (200 mL). Pd/C (0.332 g, 0.312
mmol, 10 mol%) was added and the mixture was stirred under an
atmosphere of dihydrogen for 8 h. After ﬁltration through a pad
of Celite, the solvent was evaporated under reduced pressure. The
residue was suspended in MeOH (10 mL), and the resulting solid was
ﬁltered oﬀ, and dried in vacuum. Yield: 305 mg (2.18 mmol, 70%). [SR-A95(2)].
1H NMR (DCl 0.1 M in D2O, 400 MHz): δ (ppm) = 4.11 (s, 2 H, CH2), 6.41 (d, 3J = 6.6 Hz, 1
H, pyridine), 7.08 (d, 3J = 6.9 Hz, 1 H, pyridine).
13C{1H}NMR (DCl 0.1M inD2O, 101MHz): δ (ppm) = 38.3 (CH2), 109.6 (C-H), 124.8 (C-CH2),
125.3 (C-H), 145.4 (C-OH), 159.0 (C-OH).
m/z (ESI) 141.0665 (M + H+. [C6H9N2O2]+ requires 141.0659).
Pyrene-DHP imine (L5a).[22]
N
N
OH
OH
L5a
4-Aminomethyl-2,3-dihydroxypyridine (L4, 200mg, 1.43mmol)
and 1-pyrenecarboxaldehyde (329 mg, 1.43 mmol, 1 equiv.)
were stirred in anhydrous methanol (75 mL) for 2 h. The
resulting imine L5a was ﬁltered oﬀ, washed with MeOH, and
dried under vacuum. Yield: 372 mg (1.06 mmol, 74%). [SR-
A52(3)].
1H NMR (d6-DMSO, 400 MHz): δ (ppm) = 4.87 (s, 2 H, NCH2),
6.30 (d, 3J = 6.8 Hz, 1 H, pyridine), 6.90 (d, 3J = 6.8 Hz, 1 H,
pyridine), 8.12 (t, 3J = 7.6 Hz, 1 H, pyrene), 8.22 (d, 3J = 9.1 Hz,
1 H, pyrene), 8.28 (d, 3J = 8.8 Hz, 1 H, pyrene), 8.32 – 8.38 (m,
4 H, pyrene), 8.59 (d, 3J = 8.0 Hz, 1 H, pyrene), 9.12 (d, 3J = 9.6
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Hz, 1 H, pyrene), 9.55 (s, 1 H, CH=N).
13C{1H}NMR (d6-DMSO, 101MHz): δ (ppm) = 58.2 (NCH2), 106.5, 122.9, 123.2, 123.7, 124.0,
125.0, 125.8, 126.1, 126.4, 126.6, 127.2, 127.4, 128.4, 128.7, 128.8, 129.3, 130.1, 130.8, 132.4,
143.7 (pyrene, pyridine, CH=N), 158.1, 161.9 (pyridine).
m/z (ESI) 353.1287 (M + H+. [C23H17N2O2]+ requires 353.1290).
Pyrene-DHP amine (L5).[22]
N
NH
OH
OH
L5
A suspension of the imine L5a (250mg, 0.71 mmol) and NaBH4
(96mg, 2.48mmol, 3.5 equiv.) in anhydrousmethanol (50mL)
was stirred for 2 h. The oﬀ-white precipitate was ﬁltered oﬀ,
washed with MeOH, and dried in vacuum to aﬀord the ligand
L5. Yield: 181 mg (0.51 mmol, 72%). [SR-A2(1)].
1H NMR (d6-DMSO, 400 MHz): δ (ppm) = 3.76 (s, 2 H, NCH2),
4.40 (s, 2 H, NCH2), 6.30 (d, 3J = 7.0 Hz, 1 H, pyridine), 6.86 (d,
3J = 7.0 Hz, 1 H, pyridine), 8.07 (t, 3J = 8.0 Hz, 1 H, pyrene), 8.10
(d, 3J = 8.0 Hz, 1 H, pyrene), 8.15 (m, 2 H, pyrene), 8.21 (d, 3J =
9.0 Hz, 1 H, pyrene), 8.26 (d, 3J = 8.0 Hz, 1H, pyrene), 8.29 (d,
3J = 8.0 Hz, 1 H, pyrene), 8.44 (d, 3J = 9.0 Hz, 1 H, pyrene), 11.57
(s, br, 1 H, OH).
13C{1H}NMR (d6-DMSO, 101MHz): δ (ppm) = 46.5, 50.2 (NCH2), 106.4, 122.9, 123.7, 124.0,
124.1, 124.6, 125.0, 125.1, 126.2, 126.8, 127.2, 127.4, 127.9, 128.6, 129.9, 130.4, 130.8, 134.3,
144.2, 157.9 (pyrene, pyridine).
m/z (ESI) 355.1444 (M + H+. [C23H19N2O2]+ requires 355.1447).
N-Methylanthranilic acid-DHP (L6).
N
NH
OH
OH
O
H
N
L6
L4
NO
O
O
24
HO
O
HN
Cl
O
O
23
As a consequenceof thepoor purity of commercially available samples,N-methylisatoic
anhydride (24)was synthesized fromN-methylanthranilic acid (23):[354] N-Methylanthra-
nilic acid (5.0 g, 31.4 mmol) was reﬂuxed in methyl chloroformate (50 mL) for 7 h.
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The solvent was then removed under vacuum, and the obtained solid was washed
with anhydrous MeOH (4  10 mL) and dried under vacuum to aﬀord N-methylisatoic
anhydride (24) as a white solid (1.98 g, 11.2 mmol, 36%) with spectral data in good
agreement with literature.[355] [SR-B115(2)].
1H NMR (d6-DMSO, 400 MHz): δ (ppm) = 3.46 (s, 3 H, NCH3), 7.34 (t, 3J = 7.6 Hz, 1 H,
aromatic), 7.44 (d, 3J = 8.6 Hz, 1 H, aromatic), 7.86 (t, 3J = 7.8 Hz, 1 H, aromatic), 8.00 (d,
3J = 7.8 Hz, 1 H, aromatic).
13C{1H} NMR (d6-DMSO, 101 MHz): δ (ppm) = 31.7 (NCH3), 111.5, 114.8, 123.6, 129.3, 137.2,
142.2 (arene), 147.7 (O=CO), 159.0 (O=CON).
N-methylisatoic anhydride (24) (253 mg, 1.43 mmol) and 4-aminomethyl-2,3-dihydroxy-
pyridine (L4) (1.43mmol, 1 equiv.) were reﬂuxed in anhydrous EtOH (8mL) for 3 hours.
The obtained precipitate was ﬁltered oﬀ, washed with EtOH (3  3 mL) followed by
Et2O (3  3 mL), and dried under vacuum to aﬀord the ligand L6 as an oﬀ-white solid
(352 mg, 1.29 mmol, 90%). [SR-A104(7)].
1H NMR (d6-DMSO, 400MHz): δ (ppm) = 2.76 (d, 3J = 5.2, 3 H, CH3), 4.28 (d, 3J = 5.6 Hz,
2 H, NCH2), 6.03 (d, 3J = 6.8 Hz, 1 H, pyridine), 6.56 (t, 3J = 7.4 Hz, 1 H, Ph), 6.63 (d, 3J =
8.4 Hz, 1 H, Ph), 6.82 (d, 3J = 6.8 Hz, 1 H, pyridine), 7.29 (t, 3J = 7.8 Hz, 1 H, Ph), 7.61 (d, 3J
= 8.0 Hz, 1 H, Ph), 7.69 (d, 3J = 4.8 Hz, 1 H, PhNHCH3), 8.71 (t, 3J = 5.8 Hz, 1 H, CH2NHCO),
8.86 (s, 1 H, OH), 11.59 (s, 1 H, OH).
13C{1H} NMR (d6-DMSO, 101 MHz): δ (ppm) = 29.3 (CH3), 36.2 (CH2), 105.1, 110.6, 113.9,
114.4, 123.1, 127.4, 128.3, 132.6, 143.2, 150.3, 157.8, 169.3 (pyridine, arene, CO).
Elemental analysis (%) calcd (found) for C14H15N3O3  1/3 H2O : C 60.21 (60.57), H 5.65
(5.26), N 15.05 (14.78).
Dansyl-DHP (L7).[22]
N
NH
OH
OH
SO O
N
L7
Dansyl chloride (400 mg, 1.47 mmol) was added to a suspension
of 4-aminomethyl-2,3-dihydroxypyridine (L4, 1150mg, 7.40mmol,
5.0 equiv.) in anhydrous DMF (20 mL). The mixture was stirred
overnight at room temperature. The excess of 4-aminomethyl-
2,3-dihydroxypyridine was ﬁltered oﬀ and washed with CH2Cl2.
The organic solutions were poured into 30 mL of H2O, and
evaporated under vacuum. The residual solid was puriﬁed by
ﬂash chromatography on silica gel (MeOH/CH2Cl2 2:98 to 10:90)
to aﬀord L7. Yield: 356 mg (953 mmol, 65%). [SR-B113(5)].
1HNMR (d6-DMSO, 400MHz): δ (ppm) = 2.82 (s, 6 H, N(CH3)2), 3.87 (s, 2 H, NCH2), 5.97
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(d, 3J = 6.8 Hz, 1 H, pyridine), 6.58 (br, 1 H, pyridine), 7.24 (d, 3J = 7.6 Hz, 1 H, dansyl),
7.54 – 7.60 (m, 2 H, dansyl), 8.09 (d, 3J = 7.4 Hz, 1 H, dansyl), 8.29 (d, 3J = 8.6 Hz, 1 H,
dansyl), 8.41 (d, 3J = 8.6 Hz, 1 H, dansyl).
13C{1H} NMR (d6-DMSO, 101 MHz): δ (ppm) = 39.4 (CH2), 45.1 (N(CH3)2), 105.5, 115.1,
119.1, 122.3, 123.4, 125.0, 127.8, 128.3, 128.9, 129.0, 129.4, 135.9, 143.7 (pyridine, dansyl),
151.3, 157.8 (pyridine).
m/z (ESI) 374.1156 (M + H+. [C18H20N3O4S]+ requires 374.1175).
Coumarin-DHP imine (L8a).
N
N
OH
OH
L8a
L4
26
O O
O O
O
H
O O NaOH
CHCl3
25
Formylation of coumarin:[292] Coumarin (25, 16.0 g, 109.5 mmol) and NaOH (27.0 g, 675
mmol) were dissolved in H2O (40 mL), and the mixture was heated to 80C. CHCl3 (20
mL, 250mmol) was added over 1.5 hour and themixture was then reﬂuxed for 6 hours.
The temperature was then decreased to 80C, and the excess CHCl3 was evaporated.
The solution was then cooled down to room temperature, and a solid residue was
ﬁltered oﬀ and discarded. The residual mixture was acidiﬁed with HCl (37% solution
in H2O) until a red liquid started to separate. The solution was left to stand overnight,
and the red solid was ﬁltered oﬀ. Washing it with H2O followed by extractions with
hot EtOH / Et2O 8:1 mixture (ca. 50C, 5 40 mL) aﬀorded 6-formylcoumarin (26) as a
white solid with spectral data in good agreement with literature.[356] Yield: 1.49 g (8.56
mmol, 8.0%). [SR-B116(1)].
1H NMR (CDCl3, 400 MHz): δ (ppm) = 6.52 (d, 3J = 9.8 Hz, 1 H, aromatic), 7.47 (d, 3J =
8.3 Hz, 1 H, aromatic), 7.80 (d, 3J = 9.8 Hz, 1 H, aromatic), 8.04 - 8.07 (m, 2 H, aromatic),
10.04 (s, 1 H, CHO).
13C{1H} NMR (CDCl3, 101 MHz): δ (ppm) = 118.1 (CH), 119.3 (CH), 128.1 (C10), 130.2 (CH),
132.6 (CH), 133.0 (C-CHO), 143.0 (CH), 157.9, 159.8 (C=O, C9), 190.2 (CHO)
Formation of imine L8a: A suspension of 6-formylcoumarin (26, 1181 mg, 6.78 mmol)
and 4-aminomethyl-2,3-dihydroxypyridine (L4, 950 mg, 6.78 mmol, 1 equiv.) in anhy-
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drousMeOH (100mL) was stirred at room temperature for 3 hours. The obtained solid
was ﬁltered oﬀ, washed with methanol and dried under vacuum to aﬀord the imine
L8a as a pale yellow solid. Yield: 1.50 g (5.06 mmol, 75%). [SR-B119(5)].
1H NMR (d6-DMSO, 400 MHz): δ (ppm) = 4.64 (s, 2 H, NCH2), 6.14 (d, 3J = 6.6 Hz, 1 H,
pyridine), 6.52 (d, 3J = 11.7 Hz, 1 H, coumarin), 6.84 (d, 3J = 6.6 Hz, 1 H, pyridine), 7.47
(d, 3J = 8.6 Hz, 1 H, coumarin), 8.0 (d, 3J = 8.8 Hz, 1 H, coumarin), 8.13 - 8.16 (m, 2 H,
coumarin), 8.52 (s, 1 H, CH=N), 8.85 (s, br, 1 H, OH), 11.63 (s, br, 1 H, OH).
13C{1H}NMR (d6-DMSO, 101MHz): δ (ppm) = 57.3 (NCH2), 106.6, 116.8, 116.9, 119.0, 123.1,
126.7, 128.1, 131.2, 132.4, 143.7, 144.3, 154.9, 158.1, 159.8, 161.1.
Elemental analysis (%) calcd (found) for C16H12N2O4  1/2 H2O : C 62.95 (62.73), H 4.29
(4.21), N 9.18 (9.47).
Coumarin-DHP amine (L8).
N
NH
OH
OH
O O
L8
A suspension of the imine L8a (500 mg, 1.69 mmol) and
NaBH4 (224 mg, 5.92 mmol, 3.5 equiv.) in anhydrous
methanol (100 mL) was stirred for 3 h. The solvent
was then evaporated under reduced pressure, and the
crude product was puriﬁed by reversed phase HPLC
(H2O/CH3CN, gradient 90:10 to 80:20 in 25 minutes, λmax
= 254 nm, sample: 1 mL, 7.5 mg crude material, Rf = 15.5
min). Yield: 125 mg (0.42 mmol, 25%). [SR-B120].
1H NMR (d6-DMSO, 400 MHz): δ (ppm) = 3.56 (s, 2 H,
NCH2), 3.70 (s, 2 H, NCH2), 6.22 (d, 3J = 6.8 Hz, 1 H, pyridine), 6.46 (d, 3J = 9.6 Hz, 1 H,
coumarin), 6.79 (d, 3J = 6.8 Hz, 1 H, pyridine), 7.34 (d, 3J = 8.4 Hz, 1 H, coumarin), 7.57 (d,
3J = 9.2 Hz, 1 H, coumarin), 7.66 (s, 1 H, coumarin), 8.04 (d, 3J = 9.6 Hz, 1H, coumarin).
13C{1H} NMR (d6-DMSO, 51 MHz): δ (ppm) = 46.0, 51.4 (NCH2), 106.6, 116.1, 116.2, 118.4,
122.3, 127.5, 127.7, 131.8, 137.1, 144.4, 145.0, 152.4, 158.3, 160.2 (coumarin, pyridine).
m/z (ESI) 321.1123 (M + Na+. [C16H14N2O4Na]+ requires 321.0851).
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Hydroxycoumarin-DHP imine (L9a).
N
N
OH
OH
L9a
L4
28
O OO O HO
O H
HO
OH
O
O
CH3COOH
N
N
N
N
27
Preparation of 8-formyl-7-hydroxycoumarin (28):[357] 7-Hydroxycoumarin (27, 20.0 g,
123 mmol) and hexamethylenetetramine (40.0 g, 285 mmol, 2.3 equiv.) were added
to glacial acetic acid (150 mL). The solution was heated to 95C for 5.5 hours. Dilute
hydrochloric acid (HCl-H2O = 84:100 (v/v), 300 mL) was added, and the solution was
heated to reﬂux for 30 minutes. The mixture was poured into H2O (1500 mL) and
extractedwith Et2O(4 500mL). Theorganic fractionsweredriedoverMgSO4 and the
solvent was removed under reduced pressure to aﬀord 8-formyl-7-hydroxycoumarin
(28) as apale yellowsolid (3.80g, 20.0mmol, 16%)with spectral data in goodagreement
with literature.[357] [SR-B183(1)].
1H NMR (d6-DMSO, 400 MHz): δ (ppm) = 6.37 (d, 3J = 9.6 Hz, 1 H, coumarin), 6.96 (d,
3J = 8.8 Hz, 1 H, coumarin), 7.87 (d, 3J = 8.8 Hz, 1 H, coumarin), 8.03 (d, 3J = 9.6 Hz, 1 H,
coumarin), 10.43 (s, 1 H, CHO).
13C{1H} NMR (d6-DMSO, 101 MHz): δ (ppm) = 109.2, 111.2, 112.6, 114.0, 136.3, 144.6, 155.7,
159.1, 163.9 (coumarin), 190.9 (CHO).
Formation of the imine L9a: A suspension of 8-formyl-7-hydroxycoumarin (28, 570
mg, 3.0 mmol) and 4-aminomethyl-2,3-dihydroxypyridine (L4, 420 mg, 3.0 mmol, 1.0
equiv.) in anhydrous MeOH (50 mL) was stirred at room temperature for 2 hours. The
precipitate was ﬁltered oﬀ, washed with MeOH, and dried under vacuum. The imine
L9awas obtained as a pale orange powder (514 mg, 1.65 mmol, 55%). [SR-B176(2)].
1HNMR (d6-DMSO, 400MHz): δ (ppm) = 4.77 (s, 2 H, NCH2), 6.11 - 6.18 (m, 2 H, pyridine,
coumarin), 6.55 (d, 3J = 9.2 Hz, 1 H, coumarin), 6.90 (d, 3J = 6.8 Hz, 1 H, pyridine), 7.54
(d, 3J = 9.2 Hz, 1 H, coumarin), 7.88 (d, 3J = 9.2 Hz, 1 H, coumarin), 9.02 (s, 1 H, CH=N).
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13C{1H} NMR (d6-DMSO, 101 MHz): δ (ppm) = 57.9 (NCH2), 103.9, 106.1, 106.4, 108.7,
118.6, 123.7, 123.8, 134.0, 144.8, 145.2, 156.2, 157.9, 159.8, 160.5, 174.4 (coumarin, pyridine,
CHN).
Elemental analysis (%) calcd (found) for C16H12N2O5  0.75 H2O : C 58.99 (58.67), H 4.18
(4.35), N 8.60 (8.34).
Hydroxycoumarin-DHP amine (L9).
N
NH
OH
OH
OH
O
O
L9
A suspension of the imine L9a (744 mg, 2.38 mmol) and NaBH4
(315 mg, 8.33 mmol, 3.5 equiv.) in anhydrous methanol (120
mL) was stirred for 3 h. An orange powder was ﬁltered oﬀ
and discarded, and the solvent was removed under reduced
pressure. The obtained solid was dissolved inMeOH (15mL), and
Et2Owas added to precipitate the product. The ﬁnal puriﬁcation
was performed by reversed phase HPLC (H2O/CH3CN + 0.1% TFA,
gradient 92:8 to 82:18 in 10 minutes, λmax = 254 nm, sample: 1 mL
H2O/CH3CN 92:8, 10.0 mg crude material, Rf = 8.1 min). Yield (L9
 TFA: 172 mg (0.400 mmol, 17%). [SR-B181(3)].
1H NMR (D2O, 400 MHz): δ (ppm) = 4.23 (s, 2 H, NCH2), 4.49 (s, 2 H, NCH2), 6.23 (d, 3J =
7.2 Hz, 1 H, pyridine), 6.30 (d, 3J = 9.2 Hz, 1 H, coumarin), 6.89 - 6.92 (m, 2 H, coumarin,
pyridine), 7.53 (d, 3J = 8.8 Hz, 1 H, coumarin), 7.91 (d, 3J = 9.6 Hz, 1 H, coumarin).
13C{1H} NMR (d6-DMSO, 101 MHz): δ (ppm) = 38.6, 44.2 (NCH2), 105.3, 106.4, 111.3, 111.6,
112.4, 119.1, 123.6, 130.6, 144.8, 146.2, 154.1, 157.8, 159.7, 160.3 (coumarin, pyridine).
m/z (ESI) 315.0995 (M + H+. [C16H15N2O5]+ requires 315.0981).
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Methoxycoumarin-DHP imine (L10a).
N
N
OH
OH
L10a
L4
28
O OHO
O H
O
O
O
O OO
O H
Me2SO4
K2CO3
29
Preparation of 8-formyl-7-methoxycoumarin (29):[357, 358] 8-Formyl-7-hydroxycoumarin
(28, 2.77 g, 14.6 mmol), K2CO3 (11.1 g, 80.3 mmol, 5.5 equiv.), and dimethyl sulfate
(22.2 mL, 235 mmol, 16 equiv.) were heated to reﬂux in anhydrous acetone (300
mL). After 8 hours, the solution was cooled down to room temperature, and poured
into 500 mL H2O. The solid residue was ﬁltered oﬀ, washed with 25 mL of a NH4OH
aqueous solution (3%), followedbywater (50mL), anddried under vacuum. 8-Formyl-7-
methoxycoumarin (29) was obtainedwithout further puriﬁcation as a pale yellow solid
(1.31 g, 6.42 mmol, 44%) with spectral data in good agreement with literature.[359] [SR-
C194(4)].
1H NMR (CDCl3, 400 MHz): δ (ppm) = 4.02 (s, 3 H, OCH3), 6.33 (d, 3J = 9.6 Hz, 1 H,
coumarin), 6.95 (d, 3J = 8.8 Hz, 1 H, coumarin), 7.62 - 7.66 (m, 2 H, coumarin), 10.67
(s, 1 H, CHO).
13C{1H} NMR (CDCl3, 101 MHz): δ (ppm) = 56.9 (OCH3), 108.3 (CH), 112.8 (C-CHO and C10),
114.1 (CH), 134.3 (CH), 143.2 (CH), 156.2 (C9), 159.6, 163.3 (C=O, C-OCH3), 187.0 (CHO).
Formation of the imine L10a: 8-Formyl-7-methoxycoumarin (29, 408 mg, 2.00 mmol)
and 4-aminomethyl-2,3-dihydroxypyridine (L4, 280 mg, 2.00 mmol) were stirred for 3 h
in anhydrous methanol (20 mL). The resulting imine L10awas ﬁltered oﬀ, washed with
methanol, and dried under vacuum. Yield: 490 mg (1.50 mmol, 75%). [SR-C206(4)].
1H NMR (d6-DMSO, 400 MHz): δ (ppm) = 3.94 (s, 3 H, OCH3), 4.69 (s, 2 H, NCH2), 6.29
(d, 3J = 6.8 Hz, 1 H, pyridine), 6.33 (d, 3J = 9.5 Hz, 1 H, coumarin), 6.83 (d, 3J = 6.8 Hz, 1 H,
pyridine), 7.17 (d, 3J = 8.8 Hz, 1 H, coumarin), 7.78 (d, 3J = 8.8 Hz, 1 H, coumarin), 8.02 (d,
3J = 9.5 Hz, 1 H, coumarin), 8.67 (s, 1 H, CHN), 8.83 (s, br, 1 H, OH), 11.55 (s, br, 1 H, OH).
13C{1H} NMR (d6-DMSO, 101 MHz): δ (ppm) = 56.6 (CH2), 58.9 (CH3), 106.2, 108.5, 112.2,
112.8, 112.9, 122.9, 127.13, 131.1, 143.3, 144.5, 152.6, 155.6, 157.9, 159.9, 160.9 (pyridine,
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coumarin, CHN).
m/z (ESI) 327.0979 (M + H+. [C17H15N2O5]+ requires 327.0975).
Methoxycoumarin-DHP amine (L10).[22]
N
NH
OH
OH
O
O
O
L10
Excess NaBH4 (166 mg, 4.39 mmol, 3.5 equiv.) was added to a
suspension of the imine L10a (409 mg, 1.25 mmol, 1 equiv.) in
anhydrous methanol (50 mL). After stirring the mixture for 3 h,
the solvent was evaporated. The crude product was puriﬁed by
reversed phase HPLC (H2O/CH3CN, gradient 88:12 to 76:24 in 16
minutes, λmax = 254 nm, sample: 1 mL, 20 mg crude material, Rf =
14.5 min). Yield: 197 mg (0.60 mmol, 48%). [SR-208(2)]
1H NMR (DCl 0.1 M in D2O, 400 MHz): δ (ppm) = 3.88 (s, 3 H,
OCH3), 4.11 (s, 2 H, NCH2), 4.43 (s, 2 H, NCH2), 6.11 (d, 3J = 6.8 Hz,
1 H, pyridine), 6.26 (d, 3J = 9.5 Hz, 1 H, coumarin), 6.83 (d, 3J = 6.9
Hz, 1 H, pyridine), 6.99 (d, 3J = 9.1 Hz, 1 H, coumarin), 7.60 (d, 3J = 8.8 Hz, 1 H, coumarin),
7.87 (d, 3J = 9.5 Hz, 1H, coumarin).
13C{1H} NMR (DCl 0.1 M in D2O, 101 MHz): δ (ppm) = 39.6 (NCH2), 45.6 (NCH2), 57.1
(OCH3), 106.2, 109.1, 109.6, 112.8, 113.6, 122.4, 124.9, 132.4, 145.7, 146.6, 153.4, 158.5, 161.8,
163.9 (pyridine, coumarin).
m/z (ESI) 329.1121 (M + H+. [C17H17N2O5]+ requires 329.1132).
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7.2.3 Syntheses of Trimeric Complexes
The general procedure for the preparation of neutral 12-metallacrown-3 trimeric com-
plexes was described in the literature.[267, 274] Appropriate amounts ofmetal fragments
and bridging ligands were mixed in methanol in the presence of a base (cesium
carbonate or hydroxyde). After 2 hours, the solvent was removed under reduced
pressure, andCH2Cl2wasused toextract theproduct fromthe salts. Additionof hexane
generally resulted in the precipitation of the product.
Syntheses of macrocycles based on (p-cymene)Ru fragments with dansyl or cou-
marin derivatives L7, L8, L9 and L10 were not attempted, owing to the poor solubility
observed for macrocycles M2 and M3. The fragment (η6-C6H5CH2NMe2)Ru was used
for the synthesis of macrocycles M4 - M10. The hydroxycoumarin-based ligand L9
was not suitable for the self-assembly process, and no macrocycle was isolated, which
contained L9. Furthermore, the macrocycles M1, M4, M5, M9, and M10 could be
obtainedby self-assembly directly inH2O, in thepresenceof a buﬀer (phosphate buﬀer,
pH 7.0 - 8.0).
Neutral 12-Metallacrown-3 Complexes based on the (p-cymene)Ru Fragment
[(p-cymene)Ru(L2-2H+)]3 (M1).[267]
N
O
O
N
N
Ru
N
O O
N
N
Ru
N
O
O
N NRu
M1
A suspension of [(p-cymene)RuCl2]2 (C2, 612 mg, 1.00
mmol), ligand L2 (447 mg, 2.00 mmol, 2 equiv.) and
Cs2CO3 (1.60 g, 5.00 mmol, 5 equiv.) in degassed
MeOH (40 mL) was stirred for 2 h at room tempera-
ture. After evaporation of the solvent under reduced
pressure, the product was extractedwith hot hexane
(1  300 mL and 3  125 mL). The solution was
concentrated (15 mL) and cooled down to − 18C for
1 h. The precipitate was ﬁltered and dried under
vacuum. The productM1 was obtained as an orange
powder in 58% yield (539 mg, 0.39 mmol) with spectral data in good agreement with
literature.[267]
1H NMR (CDCl3, 400 MHz): δ (ppm) = 1.25 (d, 3J = 7.2 Hz, 9 H, CH(CH3)2), 1.33 (d, 3J = 6.8
Hz, 9 H, CH(CH3)2), 2.00 (s, 9 H, C6H4CH3), 2.23 (s, 9 H, NCH3), 2.25 - 2.55 (m, br, 24 H,
NCH2, piperazine), 2.75 (sept, 3J = 6.9 Hz, 3 H, CH(CH3)2), 3.25 (d, 2J = 13.2 Hz, 3 H, NCH2),
3.33 (d, 2J = 13.6 Hz, 3 H, NCH2), 5.07 (d, 3J = 5.6 Hz, 3 H, MeC6H4iPr), 5.25 (d, 3J = 6.0 Hz,
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3 H, MeC6H4 iPr), 5.38 (d, 3J = 5.6 Hz, 3 H, MeC6H4 iPr), 5.66 (d, 3J = 5.6 Hz, 3 H, MeC6H4
iPr), 5.69 (d, 3J = 6.4 Hz, 3 H, pyridine), 6.50 (d, 3J = 6.4 Hz, 3 H, pyridine).
13C{1H}NMR (CDCl3, 101MHz): δ (ppm) = 18.4, 22.6, 23.4 (CH3, CH(CH3)2) 31.2 (CH(CH3)2),
46.2 (NCH3), 53.4, 55.4, 55.5 (NCH2), 77.4, 79.7, 81.9, 82.3, 96.5, 97.9 (C, CH, p-cymene),
110.8, 123.9, 131.2, 154.9, 170.5 (C, CH, C-O, pyridine).
[(p-cymene)Ru(L5-2H+)]3 (M2).[22]
N
O
O
HN
Ru
N
O O
NH
Ru
N
O
O
NHRu
M2
Amixture of [(p-cymene)RuCl2]2 (C2, 86.3
mg, 141 mmol), ligand L5 (100 mg, 282
mmol, 2 equiv.), and CsOH (94.7 mg, 564
mmol, 4 equiv.) in 10 mL of degassed
methanol was stirred for 2 h. The precip-
itate was ﬁltered oﬀ, washed with cold
methanol and dried under vacuum. Yield:
132 mg (74.9 mmol, 80%). [SR-A11(1)].
1H NMR (C6D6, 400 MHz): δ (ppm) = 1.07
(d, 3J = 6.8 Hz, 9 H, CH(CH3)2), 1.10 (d, 3J
= 7.1 Hz, 9 H, CH(CH3)2), 1.76 (s, 9 H, CH3),
2.63 (sept, 3J = 6.8 Hz, 3 H, CH(CH3)2), 3.88
(d, 2J = 13.2 Hz, 3 H, NCH2), 3.94 (d, 2J = 13.2
Hz, 3 H, NCH2), 4.15 (d, 2J = 13.4 Hz, 3 H, NCH2), 4.19 (d, 2J = 13.4 Hz, 3 H, NCH2), 4.58 (d,
3J = 5.6 Hz, 3 H, MeC6H4iPr), 5.13 (d, 3J = 5.6 Hz, 3 H, MeC6H4iPr), 5.25 (d, 3J = 5.6 Hz, 3 H,
MeC6H4iPr), 5.61 (d, 3J = 5.6 Hz, 3 H, MeC6H4iPr), 5.90 (d, 3J = 6.1 Hz, 3 H, pyridine), 6.96
(d, 3J = 6.1 Hz, 3 H, pyridine), 7.70 – 7.75 (m, 9 H, pyrene), 7.83 – 7.90 (m, 12 H, pyrene),
8.00 (d, 3J = 7.8 Hz, 3 H, pyrene), 8.28 (d, 3J = 9.3 Hz, 3 H, pyrene).
m/z (ESI) 882.7197 (M + 2H+. [C99H92N6O6Ru3] 2+ requires 882.7131).
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[(p-cymene)Ru(L6-2H+)]3 (M3).
N
O
O
HN
Ru
N
O O
NH
Ru
N
O
O
NHRu
M3
O
O
O
NH
HN
NH
A mixture of [(p-cymene)RuCl2]2 (C2, 224
mg, 0.366mmol), ligand L6 (200mg, 0.732
mmol, 2 equiv.), and CsOH (3.0 mL of a
1.0 M stock solution in MeOH, 3.00 mmol,
8 equiv.) in 15 mL of degassed methanol
was stirred for 2 h. The solvent was
removedunder reducedpressure, and the
obtained solid was extracted with CHCl3
(30 mL). Hexane (60 mL) was added, and
the volume reduced to ca. 10 mL. The
precipitate was ﬁltered oﬀ, washed with
hexane, and dried under vacuum. The
macrocycle M3 was obtained as a red
powder. Yield: 231 mg (0.152 mmol, 62%).
[SR-A109(5)].
1HNMR (CDCl3, 400MHz): δ (ppm) = 1.28 (d, 3J = 6.8 Hz, 9 H, CH(CH3)2), 1.33 (d, 3J = 6.9
Hz, 9 H, CH(CH3)2), 1.96 (s, 9 H, CH3), 2.78 (sept, 3J = 7.0 Hz, 3 H, CH(CH3)2), 2.83 (s, 9
H, NHCH3), 4.14 (d, 2J = 15.4 Hz, 3 H, NCH2), 4.34 (d, 2J = 15.4 Hz, 3 H, NCH2), 4.95 (d, 3J
= 5.9 Hz, 3 H, MeC6H4iPr), 5.25 (d, 3J = 5.6 Hz, 3 H, MeC6H4iPr), 5.38 (d, 3J = 5.6 Hz, 3 H,
MeC6H4iPr), 5.51 (d, 3J = 6.1 Hz, 3 H, pyridine), 5.67 (d, 3J = 5.6 Hz, 3 H, MeC6H4iPr), 6.50
(d, 3J = 6.4 Hz, 3 H, pyridine), 6.59 (br, 3 H, arene), 6.65 (d, 3J = 8.3 Hz, 3 H, arene), 7.30
(t, 3J = 7.8 Hz, 3 H, arene), 7.47 (d, 3J = 7.8 Hz, 3 H, arene).
13C{1H} NMR (CDCl3, 101 MHz): δ (ppm) = 18.4, 22.4, 23.6 (CH3, CH(CH3)2), 29.7 (NCH3),
31.4 (CH(CH3)2), 40.7 (NCH2), 76.1, 79.0, 82.8, 82.9, 97.7, 97.8 (C, CH, cymene), 111.1, 111.4,
114.2, 116.3, 123.3, 127.6, 131.6, 132.5, 150.5, 154.7, 169.4, 170.3 (pyridine, arene, C=O).
Elemental analysis (%) calcd (found) for C72H81N9O9Ru3  H2O  4CHCl3 : C 45.30
(44.98), H 4.35 (4.33), N 6.26 (6.32).
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Neutral 12-Metallacrown-3 Complexes based on the (η6-C6H5CH2NMe2)Ru Fragment
[(η6-C6H5CH2NMe2)Ru(L1-2H+)]3 (M4).
N
O
O
Ru N
OO
Ru
N
O
ORu
N
N
N
M4
A mixture of [(η6-C6H5CH2NMe2H)RuCl2]2Cl2 (C3, 344
mg, 0.50 mmol), ligand L1 (117 mg, 1.00 mmol, 2
equiv.) and CsOH (504 mg, 3.00 mmol, 6 equiv.) was
stirred in degassed methanol (40 mL) for 2 hours.
The solvent was then removed under vacuum and
the solid was extracted with degassed CH2Cl2 (2 
20 mL). Hexane was added (80 mL) and the volume
was reduced to ca. 20mL. Theprecipitatewas ﬁltered
oﬀ, washed with hexane, and dried under vacuum to
aﬀord the macrocycle M4 as a red powder (255 mg,
0.246 mmol, 74 %). [SR-A74(1)].
1H NMR (CDCl3, 400 MHz): δ (ppm) = 2.37 (s, 18 H, N(CH3)2), 3.35 (d, 2J = 13.2 Hz, 3 H,
NCH2), 3.46 (d, 2J = 12.8 Hz, 3 H, NCH2), 5.37 - 5.41 (m, 6 H, arene), 5.48 (d, 3J = 5.4 Hz, 3
H, arene), 5.53 - 5.59 (m, 6 H, arene), 5.69 (t, 3J = 6.7 Hz, 3 H, pyridine), 6.16 (dd, 4J = 1.4
Hz, 3J = 7.1 Hz, 3 H, pyridine), 6.61 (dd, 4J = 1.5 Hz, 3J = 6.1 Hz, 3 H, pyridine).
13C{1H} NMR (MeOD, 101 MHz): δ (ppm) = 45.5 (N(CH3)2), 62.8 (NCH2), 76.8, 80.5, 81.8,
83.2, 84.7, 94.6 (arene), 110.9, 116.2, 134.1, 156.3, 172.0 (pyridine).
Elemental analysis (%) calcd (found) for C42H48N6O6Ru3  2 H2O  2 CH2Cl2 : C 42.55
(42.37), H 4.54 (4.17), N 6.77 (6.96).
[(η6-C6H5CH2NMe2)Ru(L2-2H+)]3 (M5).
N
O
O
Ru N
OO
Ru
N
O
ORu
N
N
N
N
N
N
N
N
N
M5
A mixture of [(η6-C6H5CH2NMe2H)RuCl2]2Cl2
(C3, 154 mg, 0.224 mmol), ligand L2 (100 mg,
0.448 mmol, 2 equiv.) and Cs2CO3 (538 mg,
1.65 mmol, 7.5 equiv.) was stirred in degassed
methanol (20 mL) for 2 hours. The solvent was
then removed under vacuum and the solid was
extracted with degassed CH2Cl2 (2  20 mL).
Hexane was added (50 mL) and the volume
was reduced to ca. 15 mL. The precipitate was
ﬁltered oﬀ, washed with hexane, and dried
under vacuum to aﬀord the macrocycle M5 as
a red powder (136 mg, 0.099 mmol, 66%). [SR-C235(1)].
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1H NMR (CDCl3, 400 MHz): δ (ppm) = 2.23 (s, 9 H, NCH3), 2.35 (s, 18 H, N(CH3)2), 2.27 -
2.80 (m, br, 24 H, piperazine), 3.22 (d, 2J = 13.3 Hz, 3 H, NCH2), 3.30 (d, 2J = 13.3 Hz, 3 H,
NCH2), 3.33 (d, 2J = 13.7 Hz, 3 H, NCH2), 3.43 (d, 2J = 13.3 Hz, 3 H, NCH2), 5.28 (d, 3J = 5.4
Hz, 3 H, arene), 5.40 - 5.42 (m, 6 H, arene), 5.56 - 5.60 (m, 6 H, arene), 5.69 (d, 3J = 6.3
Hz, 3 H, pyridine), 6.51 (d, 3J = 6.2 Hz, 3 H, pyridine).
13C{1H} NMR (CDCl3, 101 MHz): δ (ppm) = 45.7 (N(CH3)2), 46.2 (NCH3), 50.9, 53.5, 55.5
(NCH2 (piperazine)), 61.8 (NCH2 (π-ligand)), 78.7, 79.9, 80.8, 83.9, 84.4, 94.9 (π-ligand),
111.2, 124.5, 131.8, 154.6, 170.5 (pyridine).
m/z (ESI) 1375.3773 (M + H+. [C60H85N12O6Ru3]+ requires 1375.3790).
[(η6-C6H5CH2NMe2)Ru(L5-2H+)]3 (M6).
N
O
O
Ru N
OO
Ru
N
O
ORu
N
N
N
M6
HN
HN
NH
Ligand L5 (90.0mg, 0.254mmol, 2 equiv.),
[(η6-C6H5CH2NMe2H)RuCl2]2Cl2 (C3, 87.3
mg, 0.127 mmol) and CsOH (0.76 mL of
a 1.0 M solution in MeOH, 0.76 mmol,
6 equiv.) were stirred in degassed
methanol (20 mL) for 2 hours. The
precipitate was ﬁlered oﬀ, washed with
cold MeOH, and dried under vacuum.
The macrocycle M6 was obtained as an
orange powder (91 mg, 0.052 mmol, 61%).
The compound was found to be insoluble
in many solvents, except in hot benzene.
[SR-C266(1)].
1H NMR (C6D6, 400 MHz): δ (ppm) = 2.01
(s, 18 H, N(CH3)2), 3.18 (d, 2J = 14.1 Hz, 3 H, NCH2), 3.36 (d, 2J = 13.3 Hz, 3 H, NCH2), 3.92
(s, 6 H, NCH2), 4.16 (d, 2J = 13.7 Hz, 3 H, NCH2), 4.23 (d, 2J = 13.3 Hz, 3 H, NCH2), 4.98 (d,
3J = 5.5 Hz, 3 H, arene), 5.08 - 5.15 (m, 6 H, arene), 5.27 (d, 3J = 5.5 Hz, 3 H, arene), 5.47
(t, 3J = 5.1 Hz, 3 H, arene), 5.92 (d, 3J = 5.8 Hz, 3 H, pyridine), 7.00 (d, 3J = 6.3 Hz, 3 H,
pyridine), 7.70 - 7.74 (m, 9 H, pyrene), 7.83 - 7.89 (m, 12 H, pyrene), 8.00 (d, 3J = 7.8 Hz,
3 H, pyrene), 8.26 (d, 3J = 9.4 Hz, 3 H, pyrene).
Elemental analysis (%) calcd (found) for C96H87N9O6Ru3  MeOH: C 64.80 (64.82), H
5.10 (5.04), N 7.01 (6.93).
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[(η6-C6H5CH2NMe2)Ru(L6-2H+)]3 (M7).
N
O
O Ru
N
N
O O
Ru
N N
O
O
Ru
N
HN
NHNH
O
O
O
NH
HN
NH
M7
Ligand L6 (200.0 mg, 0.732 mmol, 2 equiv.),
[(η6-C6H5CH2NMe2H)RuCl2]2Cl2 (C3, 252mg,
0.366 mmol) and CsOH (3.7 mL of a 1.0
M solution in MeOH, 3.7 mmol, 10 equiv.)
were stirred in degassed methanol (15 mL)
for 4 hours. The solvent was evaporated
under reduced pressure and the obtained
solid was extracted with CH2Cl2 (2  15
mL). Hexane (60 mL) was added, and the
volume of the solution was reduced to
ca. 10 mL. The precipitate was ﬁltered
oﬀ, washed with hexane, and dried under
vacuum. The macrocycleM7 was obtained
as a red powder (190 mg, 0.125 mmol, 51%). [SR-B114(4)].
1H NMR (CDCl3, 400 MHz): δ (ppm) = 2.34 (s, 18 H, N(CH3)2), 2.84 (s, 9 H, NCH3), 3.36
(d, 2J = 13.2 Hz, 3 H, NCH2), 3.47 (d, 2J = 13.2 Hz, 3 H, NCH2), 4.14 (d, 2J = 15.2 Hz, 3 H,
NCH2), 4.35 (d, 2J = 15.2 Hz, 3 H, NCH2), 5.27 - 5.30 (m, 3 H, η6-arene), 5.41 - 5.53 (m, 15 H,
η6-arene, pyridine), 6.49 (d, 3J = 6.1 Hz, 3 H, pyridine), 6.61 - 6.66 (m, 6 H, Ph), 7.31 (d, 3J
= 6.6 Hz, 3 H, Ph), 7.47 (d, 3J = 7.6 Hz, 3 H, Ph), 7.59 (s, br, 3 H, PhNHCH3), 8.14 (s, br, 3
H, CH2NHCO).
13C{1H} NMR (CDCl3, 101 MHz): δ (ppm) = 29.7 (NCH3), 45.7, 45.8 (N(CH3)2), 61.5, 64.5
(NCH2), 79.2, 80.6, 81.0, 83.5, 84.0, 94.8 (η6-arene), 111.2, 114.5, 124.0, 127.6, 128.4, 129.3,
132.0, 132.6, 150.6, 154.4, 169.5, 170.4 (pyridine, Ph, C=O).
m/z (ESI) 509.0765 (M + 3H+. [C69H81N12O9Ru3] 3+ requires 509.1108).
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[(η6-C6H5CH2NMe2)Ru(L7-2H+)]3 (M8).
N
O
O Ru
N
N
O O
Ru
N N
O
O
Ru
N
HN
NHNH
S
S
S
O
O
O
O
O
O
N
N
N
M8
A mixture of ligand L7 (100 mg, 0.268
mmol), [(η6-C6H5CH2NMe2H)RuCl2]2Cl2 (92
mg, 0.134 mmol), and Cs2CO3 (329 mg, 1.01
mmol) in degassed methanol (15 mL) was
stirred for 3 h. The solvent was removed
under vacuum, and the solid residue was
extracted with CH2Cl2 (2  15 mL). Hexane
(60 mL) was added to the orange solution,
and the volume was reduced to 30 mL
under reduced pressure. The precipitate
was ﬁltered oﬀ, washed with hexane, and
dried under vacuum. Yield: 129 mg (0.071
mmol, 79%). [SR-B125(4)].
1H NMR (MeOD, 400 MHz): δ (ppm) = 2.36 (s, 18 H, N(CH3)2), 2.89 (s, 18 H, N(CH3)2
(dansyl)), 3.35 (m, 6 H, NCH2), 3.68 (s, 6 H, NCH2), 5.40 – 5.53 (m, 15 H, arene and
pyridine), 5.62 (t, 3J = 5.5 Hz, 3 H, arene), 6.20 (d, 3J = 6.4 Hz, 3 H, pyridine), 7.28 (d,
3J = 7.3 Hz, 3 H, dansyl), 7.52 (t, 3J = 7.9 Hz, 3 H, dansyl), 7.60 (t, 3J = 8.1 Hz, 3 H, dansyl),
8.13 (d, 3J = 7.2 Hz, 3 H, dansyl), 8.36 (d, 3J = 8.8 Hz, 3 H, dansyl), 8.55 (d, 3J = 8.6 Hz, 3
H, dansyl).
m/z (ESI) 912.6633 (M + 2 H+. [C81H92N12O12S3Ru3] 2+ requires 912.6647).
[(η6-C6H5CH2NMe2)Ru(L8-2H+)]3 (M9) - Attempted synthesis.
N
O
O Ru
N
N
O O
Ru
N N
O
O
Ru
N
HN
NHNH
O
O
O
O
O
O M9
No pure product could be isolated, nei-
ther when the reaction was performed
in MeOH in the presence of a base, nor
in H2O in the presence of a phosphate
buﬀer. In the next section, the 1H NMR
spectrum corresponding to a solution of
M9 in buﬀered D2O is given.
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[(η6-C6H5CH2NMe2)Ru(L10-2H+)]3 (M10).
N
O
O Ru
N
N
O O
Ru
N N
O
O
Ru
N
HN
NHNH
O
O
O
O
O
O
O
O
O
M10
A mixture of ligand L10 (4.9 mg, 15 μmol,
2 equiv.), [(η6-C6H5CH2NMe2H)RuCl2]2Cl2
(5.2 mg, 7.5 μmol) and Cs2CO3 (0.19 mL
of a 0.3 M solution in MeOH, 57 μmol,
7.6 equiv.) in degassed MeOH (1 mL)
was stirred for 3 h. The solvent was
removed in vacuum, and the solid residue
was extracted with CH2Cl2 (2  1 mL).
Hexane (4 mL) was added to the orange
solution, and the volume was reduced to
ca. 0.5 mL. The precipitate was ﬁltered
oﬀ, washed with hexane, and dried under
vacuum. Yield: 5.5 mg (3.3 μmol, 65%).
[SR-C222(1)].
1H NMR (CDCl3, 400 MHz): δ (ppm) = 2.25 (s, 18 H, N(CH3)2), 3.18 (d, 2J = 13.2 Hz, 3 H,
NCH2), 3.25 (d, 2J = 13.2 Hz, 3 H, NCH2), 3.35 (d, 2J = 12.8 Hz, 3 H, NCH2), 3.51 (d, 2J = 12.8
Hz, 3 H, NCH2), 3.81 (s, 9 H, OCH3), 3.95 (d, 2J = 12.4 Hz, 3 H, NCH2), 3.99 (d, 2J = 12.4 Hz,
3 H, NCH2), 5.33 (d, 3J = 4.8 Hz, 3 H, arene), 5.40 (d, 3J = 5.2 Hz, 3 H, arene), 5.52 (d, 3J
= 6.0 Hz, 3 H, pyridine), 5.63 (t, 3J = 5.2 Hz, 3 H, arene), 5.75 (t, 3J = 5.0 Hz, 3 H, arene),
6.16 (t, 3J = 5.2 Hz, 3 H, arene), 6.23 (d, 3J = 9.6 Hz, 3 H, pyridine), 6.46 (d, 3J = 6.0 Hz,
3 H, coumarin), 6.83 (d, 3J = 8.4 Hz, 3 H, coumarin), 7.35 (d, 3J = 8.4 Hz, 3 H, coumarin),
7.64 (d, 3J = 9.6 Hz, 3 H, coumarin).
13C{1H} NMR (D2O pD 8.0, 101 MHz): δ (ppm) = 37.9 (NCH2), 43.2, 43.4 (N(CH3)2), 45.5
(NCH2), 56.9 (OCH3), 60.1 (NCH2), 80.0, 82.8, 84.1, 87.8, 106.5, 109.1 (arene), 111.3, 112.4,
113.4, 118.8, 129.9, 131.4, 132.2, 133.8, 146.3, 153.0, 154.4, 161.3, 163.0, 170.8 (coumarin,
pyridine).
m/z (ESI) 845.1574 (M + 2H+. [C78H83N9O15Ru3] 2+ requires 845.1588).
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Self-Assembly and LiCl Adducts of 12-Metallacrown-3 Complexes in Water
The macrocyclesM1,M4,M5,M9, andM10 are water soluble, and can be synthesized
in water in the presence of a buﬀer, following this general procedure: appropriate
amounts of [(p-cymene)RuCl2]2 (C2, 4.6 mg, 7.5 μmol) or [(C6H5CH2NHMe2)RuCl2]2Cl2
(C3, 5.2mg, 7.5 μmol) and respective bridging ligand (15 μmol, 2 equiv.) weremixed for
2 hours in D2O (100mMphosphate buﬀer, pD 7.0 or 8.0), to aﬀord solutions containing
5.0 mM of macrocycles (for experiments with lower receptor concentration (2.0 mM),
the amounts of building blocks were varied accordingly). 1H NMR spectra were
recorded directly thereafter. LiCl adducts were obtained by adding an excess of LiCl (2
equiv.) to the solution during self-assembly of themacrocycle. They could be identiﬁed
on 1H NMR spectra, appearing slightly shifted relative to signals corresponding to
empty macrocycles, and displaying broader peaks.
[(p-cymene)Ru(L2-2H+)]3 (M1).
N
O
O
N
N
Ru
N
O O
N
N
Ru
N
O
O
N NRu
M1
1H NMR (D2O, pD 7.0, phosphate buﬀer (100 mM),
400 MHz): δ (ppm) = 1.25 (d, 3J = 6.8 Hz, 9 H,
CH(CH3)2), 1.28 (d, 3J = 6.4 Hz, 9 H, CH(CH3)2), 1.80 (s,
9 H, C6H4CH3), 2.53 (s, 9 H, NCH3), 2.55 - 3.00 (m, 27
H, NCH2 (piperazine), CH(CH3)2), 3.33 (d, 2J = 13.2 Hz,
3 H, NCH2), 3.66 (d, 2J = 12.8 Hz, 3 H, NCH2), 5.23 (d,
3J = 5.6 Hz, 3 H, MeC6H4iPr), 5.48 (d, 3J = 5.6 Hz, 3 H,
MeC6H4iPr), 5.76 - 5.79 (m, 6 H, MeC6H4iPr, pyridine),
6.03 (d, 3J = 5.6 Hz, 3 H, MeC6H4iPr), 6.65 (d, 3J = 6.4
Hz, 3 H, pyridine).
[(p-cymene)Ru(L2-2H+)]3LiCl (M1 LiCl).
1H NMR (D2O, pD 7.0, phosphate buﬀer (100 mM), 400MHz): δ (ppm) = 1.23 (d, 3J = 7.2
Hz, 9 H, CH(CH3)2), 1.27 (d, 3J = 7.2 Hz, 9 H, CH(CH3)2), 1.74 (s, 9 H, C6H4CH3), 2.40 - 2.80
(m, 36 H, NCH3, NCH2 (piperazine), CH(CH3)2), 3.33 (d, 2J = 13.2 Hz, 3 H, NCH2), 3.58 (d,
2J = 13.2 Hz, 3 H, NCH2), 5.23 (br, 3 H, MeC6H4iPr), 5.67 (d, 3J = 5.6 Hz, 3 H, MeC6H4iPr),
5.99 (d, 3J = 6.0 Hz, 3 H, MeC6H4iPr), 6.03 (d, 3J = 6.8 Hz, 3 H, pyridine), 6.15 (br, 3 H,
MeC6H4iPr), 6.77 (d, 3J = 6.0 Hz, 3 H, pyridine).
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[(η6-C6H5CH2NMe2)Ru(L1-2H+)]3 (M4).
N
O
O
Ru N
OO
Ru
N
O
ORu
N
N
N
M4
1H NMR (D2O, phosphate buﬀer (100 mM) pD 8.0,
400 MHz): δ (ppm) = 2.29 (s, 18 H, N(CH3)2), 3.05
(d, 2J = 12.7 Hz, 3 H, NCH2), 3.18 (d, 2J = 12.7 Hz,
3 H, NCH2), 5.42 (d, 3J = 5.8 Hz, 3 H, arene), 5.63
(t, 3J = 5.5 Hz, 3 H, arene), 5.70 (d, 3J = 5.6 Hz, 3
H, arene), 5.77 - 5.83 (m, 6 H, arene), 6.06 (t, 3J
= 5.6 Hz, 3 H, pyridine), 6.23 (d, 3J = 6.8 Hz, 3 H,
pyridine), 6.63 (d, 3J = 5.9 Hz, 3 H, pyridine). [SR-
A74(1)].
[(η6-C6H5CH2NMe2)Ru(L1-2H+)]3LiCl (M4 LiCl).
1H NMR (D2O, phosphate buﬀer (100 mM) pD 8.0, 400 MHz): δ (ppm) = 2.27 (s, 18 H,
N(CH3)2), 2.91 (d, 2J = 11.5 Hz, 3 H, NCH2), 3.06 (d, 2J = 11.5 Hz, 3 H, NCH2), 5.53 (s, br, 3
H, arene), 5.77 (t, 3J = 5.7 Hz, 3 H, arene), 5.83 (s, 3 H, arene), 6.00 (t, 3J = 6.7 Hz, 3 H,
arene), 6.05 (t, 3J = 5.7 Hz, 3 H, arene), 6.20 (s, br, 3 H, pyridine), 6.46 (d, 3J = 7.1 Hz, 3
H, pyridine), 6.73 (d, 3J = 6.1 Hz, 3 H, pyridine). [SR-A86(1)].
[(η6-C6H5CH2NMe2)Ru(L2-2H+)]3 (M5).
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M5
1H NMR (D2O, phosphate buﬀer (100 mM) pD
8.0, 400MHz): δ (ppm) = 2.60 (s, 18 H, N(CH3)2),
2.67 (s, 9 H, NCH3), 2.50 - 3.10 (m, br, 24 H,
NCH2 (piperazine)), 3.36 (d, 2J = 13.2 Hz, 3 H,
NCH2), 3.51 (s, 6 H, NCH2), 3.60 (d, 2J = 13.2 Hz,
3 H, NCH2), 5.67 (d, 3J = 5.9 Hz, 3 H, arene),
5.81 - 5.86 (m, 9 H, arene, pyridine), 5.92 (t, 3J
= 5.6 Hz, 3 H, arene), 6.12 (t, 3J = 5.7 Hz, 3 H,
arene), 6.62 (d, 3J = 6.4 Hz, 3 H, pyridine). [SR-
A63(1)].
[(η6-C6H5CH2NMe2)Ru(L2-2H+)]3LiCl (M5  LiCl). In the presence of LiCl, the spec-
trumbroadens considerably, leavingonly a fewpeaks clearly identiﬁable. 1HNMR(D2O,
phosphate buﬀer (100 mM) pD 8.0, 400 MHz): δ (ppm) = 2.25 - 3.30 (m, br, 39 H, CH2
(piperazine), NCH3, NCH2), 2.70 (s, 18 H, N(CH3)2), 3.39 (d, 2J = 12.9 Hz, 3 H, NCH2), 3.61
(d, 2J = 13.2 Hz, 3 H, NCH2), 5.55 - 6.20 (m, br, 12 H, arene), 6.07 (d, 3J = 5.6 Hz, 3 H,
pyridine), 6.25 (t, 3J = 5.4 Hz, 3 H, arene), 6.76 (d, 3J = 6.1 Hz, 3 H, pyridine). [SR-A63(2)].
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[(η6-C6H5CH2NMe2)Ru(L8-2H+)]3 (M9).
N
O
O Ru
N
N
O O
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N N
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O
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O
O M9
The spectrum contains characteristic sig-
nals indicating the formation of a macro-
cycle (such as diastereotopic protons)
but contains many other signals, mak-
ing a clear assignment diﬃcult. The
situation worsens in the presence of
lithium.
1HNMR (D2O, phosphate buﬀer (100mM)
pD 8.0, 400 MHz): δ (ppm) = 2.59 (s, 18 H,
N(CH3)2), 3.32 (d, 2J = 13.6 Hz, 3 H, NCH2),
3.52 (d, 2J = 12.8 Hz, 3 H, NCH2), 3.58 (d, 2J
= 12.8 Hz, 3 H, NCH2), 3.74 - 3.80 (m, 9 H, NCH2), 5.61 - 5.95 (m, 15 H, arene, pyridine), 6.12
(m, 3 H, arene), 6.29 (d, 3J = 9.2 Hz, 3 H, coumarin), 6.72 (d, 3J = 6.0 Hz, 3 H, pyridine),
6.78 (s, br, 6 H, coumarin), 7.20 (s, 3 H, coumarin), 7.67 (d, 3J = 9.6 Hz, 3 H, coumarin).
[SR-B168(3)].
[(η6-C6H5CH2NMe2)Ru(L8-2H+)]3LiCl (M9  LiCl). 1H NMR (D2O, phosphate buﬀer
(100 mM) pD 8.0, 400 MHz): δ (ppm) = 2.57 (s, 18 H, N(CH3)2), 3.20 (d, 2J = 13.6 Hz,
3 H, NCH2), 3.66 - 3.77 (m, 12 H, NCH2), 3.87 (d, 2J = 13.3 Hz, 3 H, NCH2), 5.65-6.27 (m, br,
21 H, arene, pyridine, coumarin), 6.70 (s, br, 6 H, coumarin), 6.86 (d, 3J = 5.6 Hz, 3 H,
pyridine), 7.15 (s, 3 H, coumarin), 7.64 (d, 3J = 9.6 Hz, 3 H, coumarin). [SR-B168(3)].
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[(η6-C6H5CH2NMe2)Ru(L10-2H+)]3 (M10).
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In absence of LiCl, the 1H NMR spectrum
contains well-deﬁned signals with very
few impurities. Upon addition of lithium,
the peaks broaden and the spectrum
becomes more diﬃcult to interpret.
1HNMR (D2O, phosphate buﬀer (100mM)
pD 8.0, 400MHz): δ (ppm) = 2.60 (s, 18 H,
N(CH3)2), 3.59 - 3.64 (m, 6 H, NCH2), 3.68
(s, 9 H, OCH3), 3.77 – 4.02 (m, 12 H, NCH2),
5.72 (d, 3J = 5.6 Hz, 3 H, arene), 5.83 – 5.90
(m, 9 H, arene), 5.94 (t, 3J = 5.6 Hz, 3 H,
arene), 6.06 – 6.11 (m, 6 H, arene, coumarin), 6.78 (d, 3J = 6.4 Hz, 3 H, pyridine), 6.89 (d,
3J = 9.2 Hz, 3 H, coumarin), 7.52 (d, 3J = 8.8 Hz, 3 H, coumarin), 7.76 (d, 3J = 9.2 Hz, 3 H,
coumarin). [SR-C213(5)].
[(η6-C6H5CH2NMe2)Ru(L10-2H+)]3LiCl (M10  LiCl). 1H NMR (D2O, phosphate buﬀer
(100 mM) pD 8.0, 400MHz): δ (ppm) = 2.50 - 2.80 (m, br, 18 H, N(CH3)2), 3.50 - 4.05 (m,
18 H, NCH2), 3.63 (s, 9 H, OCH3), 5.60 - 6.20 (m, 21 H, arene, pyridine, coumarin), 6.87
(d, 3J = 8.8 Hz, 3 H, coumarin), 6.92 (d, 3J = 6.4 Hz, 3 H, pyridine), 7.50 (d, 3J = 8.8 Hz, 3
H, coumarin), 7.74 (d, 3J = 9.6 Hz, 3 H, coumarin). [SR-C213(5)].
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7.2.4 Other Syntheses
Homocarnosine (HC)[360]
HN
N
H
N O
OH
O
H2N
HC
H2N
O
OH
O
O
Cl
NaOH
CbzNH
O
OH
31
1. TEA, ClCO2Et
2. His methyl ester
3. NaOH
4. H2 / Pd30
Synthesis of N-carboxybenzyl-γ-aminobutyric acid (31):[361, 362] 4-Aminobutyric acid (30,
5.20 g, 50 mmol) was dissolved in aqueous NaOH (25 mL, 2 M), and the mixture was
cooled in an ice bath. A solution of benzyl chloroformate (7.5 mL, 50 mmol, 1 equiv.) in
toluene (5.0 mL), and a solution of NaOH (4.0 M, 12.5 mL) were simultaneously added
dropwise. After the addition was complete, the solution was stirred for further 10
minutes. The toluene layer was separated, and the aqueous phase was extracted with
Et2O (100 mL). The aqueous solution was cooled in an ice bath, and HCl (37% in H2O)
was slowly added to precipitate the product. The obtained solid was dissolved in hot
ethyl acetate, ﬁltered, and hexane was added. The solution was left overnight in a
freezer, which resulted in the precipitation of the product. It was ﬁltered oﬀ, washed
with hexane, and dried under vacuum. Yield: 8.39 g (35.4 mmol, 71%). [SR-D382(1)].
1H NMR (CDCl3, 400 MHz): δ (ppm) = 1.75 (quint, 3J = 6.9 Hz, 2 H, CH2CH2CH2), 2.31 (t, 3J
= 7.2 Hz, 2 H, CH2COOH), 3.17 (m, br, 2 H, CH2NH), 4.85 (s, br, 1 H, NH), 5.01 (s, br, 2 H,
OCH2Ph), 7.21 - 7.27 (m, 5 H, Ph).
Synthesis of Homocarnosine sulfate: Cbz-4-aminobutyric acid (31, 5.93 g, 25 mmol)
was suspended in CH2Cl2 (125 mL). Triethylamine (TEA) was added (3.5 mL, 25 mmol,
1 equiv.) and the mixture was cooled to -5C in an CaCl2/ice bath. To this solution was
added ethyl chloroformate (2.4 mL, 25 mmol, 1 equiv.) followed, after 10 minutes, by
cold CH2Cl2 (125 mL, 0C) containing histidine methyl ester  2 HCl (6.08 g, 25 mmol,
1 equiv.) and TEA (10.5 mL). The mixture was stirred at room temperature for 24 h. It
was then washed with H2O (200 mL), followed by aqueous NaHCO3 (200 mL, 1 M) and
dried over Na2SO4. Solvents were removed under reduced pressure, and the residue
was solubilized in MeOH (50 mL), and aqueous NaOH (50 mL, 1 M) was added. The
solution was stirred at room temperature for 3 h, acidiﬁed to pH 5 by addition of dilute
H2SO4, and evaporated under reduced pressure. The residue was extracted with hot
EtOH (2  50 mL), and H2O (50 mL) was added to the extracts. Pd/C was added (0.5
g, 10% Pd), and the mixture was stirred under an atmosphere of dihydrogen for 9 h.
When the reaction was complete, the mixture was ﬁltered over Celite and evaporated
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under reduced pressure. The residue was dissolved in H2O, acidiﬁed to pH 3.0 (dilute
H2SO4) and EtOH (200 mL) was added. The solution was left in a freezer for 72 h. The
precipitate was ﬁltered oﬀ and recristallized from H2O/EtOH to aﬀord homocarnosine
sulfate as a white solid. Yield: 5.40 g (16.0 mmol, 64%). [SR-D391(1)].
1H NMR (D2O, 400 MHz): δ (ppm) = 1.89 (quint, 3J = 7.6 Hz, 2 H, CH2CH2CH2), 2.38 (t, 3J
= 7.6 Hz, 2 H, CH2CONH), 2.97 (t, 3J = 7.0 Hz, 2 H, CH2NH2), 3.16 (m, 1 H, CH2CH), 3.33 (m,
1 H, CH2CH), 4.71 (m, 1 H, CH2CH), 7.31 (s, 1 H, CH, imidazole), 8.62 (s, 1 H, CH, imidazole).
13C{1H} NMR (D2O, 101 MHz): δ (ppm) = 23.4, 26.9 (CH2, His- and γ-aminobutyryl side-
chains) 32.7, 39.4 (CH2, γ-aminobutyryl side-chain), 52.7 (CH, Cα), 117.8, 129.5, 134.7 (CH,
imidazole), 174.5, 175.4 (C=O).
Elemental analysis (%) calcd (found) for C10H18N4O7S  1/2 H2O: C 34.58 (34.85), H 5.51
(5.45), N 16.13 (15.67).
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7.3 Lithium Detection with Conjugate 12-Metallacrown-3
Complexes
7.3.1 NMR Studies for Ka Determination
General procedure for Ka determination by NMR measurements: 5.0 mM solutions of
the respectivemacrocycleswere prepared, either by dissolving the isolated compound
in theappropriatedeuterated solvent, or by in situ self-assembly inD2O(pD8.0, 100mM
phosphate). The solutions also contained 10.0mMLiCl (2 equiv.) andwere equilibrated
for 2 h (when necessary, lower concentrations were employed, but there was always a
twofold excess of Li+ ions). The binding constants Ka were determined by integration
of suited 1H NMR signals of the free and complexed receptor. When many baseline-
resolved signals were available, their integration values were averaged and used for
calculations.
In order to determine Ka, it is necessary to know the equilibrium concentrations of
macrocycle [M], [Li+], and adduct [MLi+]:
Ka =
[MLi+]
[M]  [Li+] (7.1)
The total concentrations ofmacrocycle and lithium are known from the experimen-
tal conditions:
[M]tot = [M]+ [MLi+] (7.2)
[Li+]tot = [Li+]+ [MLi+] (7.3)
The ratio R between the concentrations of adduct [MLi+] and macrocycle [M] can
be determined by analyzing the NMR integrations:
R = [MLi
+]
[M] (7.4)
Ka can thus be expressed as a function of R:
Ka =
R
[Li+] (7.5)
From Eq. 7.2, one can write:
[M]tot
[M] =
[M]
[M] +
[MLi+]
[M] (7.6)
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Therefore
[M] = [M]totR + 1 (7.7)
Combining this expression with Eq. 7.2 gives:
[Mtot] =
[M]tot
R + 1 + [MLi
+] (7.8)
Therefore,
[MLi+] = [M]tot   [M]totR + 1 (7.9)
Combining Eq. 7.9 and Eq. 7.3 gives:
[Li+] = [Li+]tot   [M]tot + [M]totR + 1 (7.10)
Ka can be expressed by combining the latter equation with Eq. 7.5:
Ka =
R
[Li+]tot   [M]tot + [M]totR + 1
(7.11)
7.3.2 Fluorescence Measurements
Measurements in Water/MeOH systems
For 1H NMR measurements, macrocycle M7 was dissolved in CD3OD, and an equal
volume of D2O (containing 100 mM phosphate buﬀer, pH 7.0) was added. The ﬁnal
concentrations were [M7] = 2.0 mM, [phosphate] = 50 mM. Another solution was
prepared similarly, which contained additional 2.0 equivalents (4.0 mM) of LiCl. Both
solutions were stirred at room temperature for 2 h before ﬂuorescence and NMR
measurements were performed. [SR-B122(3)].
Macrocycles M7 and M8 were dissolved in MeOH, and H2O (containing 100 mM
phosphate buﬀer, pH 7.0) was added in the following quantities: 1:1 ratio for com-
plex M7, ﬁnal phosphate concentration: 50 mM; 10% v/v H2O for complex M8, ﬁnal
phosphate concentration: 10 mM. Final volumes were 3.0 mL, and concentrations of
macrocycles were 2.0 mM. Fluorescence spectra were recorded (M7: λex = 350 nm,
[SR-B122(3)];M8: λex = 360 nm, [SR-B132(5)]) 5 minutes after each addition of LiCl (μL
amounts of a 1.0 M solution in MeOH).
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Measurements in Water
MacrocyclesM9 andM10were synthesized in H2O (pH 8.0, 100 mM phosphate buﬀer)
and their ﬂuorescence response was immediately studied. General procedure: A 2.0
mM solution of complex (M9 orM10) was prepared in H2O (pH 8.0, 100mMphosphate
buﬀer). The solution was ﬁltered and an aliquot of 3.0 mL was placed in a cuvette for
ﬂuorescencemeasurements. The solutionwas stirred and its temperature equilibrated
to 20C. The ﬂuorescencewasmeasured (M9: λex = 495 nm, λem = 523 nm, [SR-B170(6)];
M10: λex = 382 nm, λem = 480 nm, [SR-C213(12)-(15)]) in a kinetic fashion every 4 seconds
during one minute, or until the signal was stabilized. The solution was then titrated
with μL amounts of a 1.10 M solution of LiCl (respectively NaCl or MgCl2 for selectivity
tests) in H2O. After each addition, the solution was equilibrated as long as required
(usually, 1 minute was enough), and ﬂuorescence was recorded for one minute every
4 seconds (15 measurements that were averaged) before the next addition of analyte
took place. The data were ﬁtted with the non-linear least square curve-ﬁtting program
WinEQNMR[293] using a 1:1 binding model to calculate the association constant Ka(Li+).
Measurements with Complex M10 in Human Serum
Serumpreparation:[294] 5.0mLof HPLC-grade acetonitrilewere added to 2.5mL serum.
The suspensionwas vigorouslymixed for 5min at room temperature, then centrifuged
at 4000 rpm for 30 minutes. 6.0 mL of the supernatant were removed and lyophilized.
The residue was dissolved in 2.0 mL H2O (pH 8.0, 100 mM phosphate buﬀer) to obtain
reconstituted serum.
Lithium titration in reconstituted serum: the reconstituted serum solutionwas ﬁltered
and 1.5mLwas added to0.5mLof a solutionof the receptorM10 (8.0mM inH2OpH8.0,
100 mM phosphate buﬀer). The resulting mixture was equilibrated (as indicated by a
stable ﬂuorescence signal), and titrated with LiCl (μL doses of a 0.30 M stock solution)
while ﬂuorescence was recorded under the same conditions as in plain water. The
ﬁnal concentration of complexM10was 2.0 mM, whereas all serum constituents were
diluted to 75% of their initial value. [SR-C242(7)].
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7.4 Lithium Detection with Supramolecular Assays
7.4.1 Assay based on the HPTS Fluorophore
Buﬀers. Phosphate buﬀer (pH 7.0, 20mM)was prepared by dissolution of appropriate
amounts of KH2PO4 and K2HPO4 in bidistilled water. HEPES buﬀer (pH 7.0, 20mM)was
prepared by dissolving an appropriate amount of HEPES in bidistilled water, and the
pH was adjusted to 7.0 by adding KOH.
Interaction between complex M1 and HPTS: In order to determine the association
constant between complex M1 and HPTS, ﬂuorescence titration experiments were
performed. A solution of complex M1 (1.0 mM) was prepared in situ by mixing
appropriate amounts of [(p-cymene)RuCl2]2 (C2) and ligand L2 in HEPES buﬀer (20mM,
pH 7.0). Aliquots of this solutionweremixedwith a solution of HPTS to prepare a series
of solutions with a constant HPTS concentration of 50 μM and variable concentrations
of complexM1 (0 – 1000 μM). The ﬂuorescence spectra (λex = 462 nm) were measured
after equilibration for 16 h at room temperature. The titration data (λem = 520 nm)
were ﬁtted to a 1:1 binding algorithm to give an association constant of Ka = 3.4 (
0.3)  104 M-1. The data for the Job plot analysis were obtained by recording the
ﬂuorescence emission intensity at 520 nm (λex = 462 nm) of solutions (20 mM HEPES
buﬀer, pH 7.0) containing diﬀerent ratios of complex M1 and HPTS and a constant
total concentration of [complexM1 + HPTS]tot = 100 μM. The solutions for the 1H NMR
spectra were prepared with buﬀered D2O (20 mM phosphate buﬀer, pD = 7.0).
Assay in buﬀeredwater: Various amounts of a LiCl stock solution (100mM)were added
to a solution containing HPTS (ﬁnal concentration = 0.5 mM), [(p-cymene)RuCl2]2 (ﬁnal
concentration = 1.5 mM), and ligand L2 (ﬁnal concentration = 3.0 mM) in H2O (100 mM
HEPES buﬀer, pH 7.0). The ﬂuorescence spectrum was measured (λex = 462 nm) after
equilibration for 16 h at room temperature.
Assay in deproteinized serum: Preparation of reconstituted, deproteinized serum:
HPLC-grade acetonitrile (30 mL) was added to serum (15 mL). The suspension was
vigorously mixed for 5 min at room temperature, and then centrifuged at 4000 rpm
for 30 min. 36 mL of the supernatant were removed and lyophilized. The residue
was dissolved in 12 mL of HEPES buﬀer (100 mM, pH 7.0) and ﬁltered through a
0.45 μm Millipore ﬁlter. Fluorescence measurements: reconstituted serum (1.5 mL)
was added to 0.5 mL of a solution containing HPTS (ﬁnal concentration = 0.5 mM),
[(p-cymene)RuCl2]2 (ﬁnal concentration = 1.5 mM), ligand L2 (ﬁnal concentration = 3.0
mM), and LiCl (ﬁnal concentration = 0 – 20 mM) in H2O (100 mMHEPES buﬀer, pH 7.0).
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The ﬂuorescence spectrumwas measured (λex = 462 nm) after equilibration for 16 h at
room temperature.
7.4.2 Assay based on the Calcein Blue Fluorophore
General. The macrocycleM1was prepared as described in the section about synthesis
of trimeric complexes (p. 123). Phosphate buﬀer (20 mM, pH 7.0) was prepared in
bidistilledwater andused for all experiments. Stock solutions of Calcein Blue (CAB) and
metal salts were prepared in buﬀer and stored at 4C. Solutions ofmacrocycleM1were
freshly prepared in buﬀer prior to each experiment. Fluorescencemeasurementswere
recorded at 25C. All NMR and UV/Vis spectra were recorded at room temperature.
Fluorescence titration of CAB by the macrocycle M1. A ﬁxed amount of the dye and a
variable amount of the complex (M1) were dissolved in buﬀered water (pH 7.0, 20 mM
phosphate buﬀer). The ﬁnal concentrations were [CAB] = 30 μM, and [Ru] = 0 – 400
μM. The solutions were equilibrated at room temperature for 24 h in the dark before
measurement. The resulting ﬂuorescence spectra were recorded with an excitation
wavelength of 364 nm. The binding constant was obtained by ﬁtting of the binding
isotherm using a routine built in MATLAB which implements the Newton-Gauss non-
linear least squares ﬁtting algorithm.[343--345] Theminimumerror of the binding constant
was estimated to be 10%. [SR-E442(1)].
Detection of Li+. An aqueous solution (pH 7.0, 20 mM phosphate buﬀer) containing
macrocycle M1 (2.0 mM) in the presence of a deﬁnite amount of LiCl (0 – 20 mM)
was stirred at room temperature. After 2 h, a 50 μL portion was poured into 2950
μL of a Calcein Blue solution in water (pH 7.0, 20 mM phosphate buﬀer). The ﬁnal
concentrations were [M1] = 33.3 μM, [CAB] = 75 μM and the solution was stirred at
room temperature for 5.5 h before ﬂuorescence measurement was performed (λex
= 364 nm). The ﬂuorescence measurements need to be performed after a reaction
time comprised between 5.5 and 6.5 hours in order to keep maximal accuracy [SR-
E438(11)]. The apparent binding constant was obtained as indicated above. For
selectivity experiments, LiCl was replaced by the appropriate chloride salts.
NMR measurements. Macrocycle M1 was dissolved in D2O at neutral pH (20 mM
phosphate buﬀer, pH 7.0). The concentration was [M1] = 4.0 mM. A second solution
was prepared, which contained 2 equivalents of LiCl ([Li+] = 8.0 mM) in addition to
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complexM1. Both solutions were equilibrated for 2 hours at room temperature under
an atmosphere of dinitrogen. An equivalent volume of a Calcein Blue solution (12 mM
in 20 mM phosphate buﬀer, pH 7.0) was then added to the solutions of M1. 1H NMR
measurements were performed directly after the solutions were mixed, and pursued
at regular time intervals for 12 hours. The concentrations at t = 0 min were: [M1] (or
[M1 + Li+]) = 2.0 mM; [CAB] = 6.0 mM. [SR-E438].
UV/Vis measurements. UV/Vis measurements were performed in the same fashion as
the ﬂuorescencemeasurements described above: An aqueous solution (pH 7.0, 20mM
phosphate buﬀer) containing macrocycle M1 (2.0 mM) in the presence of a deﬁnite
amount of LiCl (0 or 20mM)was stirred at room temperature. After 2 h, a 50 μL portion
was poured into 2950 μL of a Calcein Blue solution in water (pH 7.0, 20 mM phosphate
buﬀer). The ﬁnal concentrations were [M1] or [M1 + Li+] = 33.3 μM, [CAB] = 75 μM.
UV/Vis measurements were started immediately, and performed at regular intervals
during 10 hours in the range 250 - 600 nm.
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7.5 Sensor Arrays for Small Peptides
7.5.1 General
Homocarnosine (HC) and the metal complexes [Cp*RhCl2]2 (C1), [(p-cymene)RuCl2]2
(C2) and [(en)PdCl2] (C4) were prepared as described in the Syntheses section (p. 110).
Phosphate buﬀer (100 mm, pH 7.0) was prepared with bidistilled H2O and used for all
experiments. Stock solutions of dyes, metal complexes, and peptides were prepared
in buﬀer and stored at 4C. Fluorescence measurements were recorded at 25C.
7.5.2 Metal/Dye Titrations
Fluorescence titration experiments were performed in buﬀered aqueous solution (100
mM phosphate buﬀer, pH 7.0) with a ﬁxed amount of the dye and a variable amount
of themetal complex (Table 7.1). The solutionswere equilibrated at room temperature
for 48 h in the dark before measurement. The binding constants were obtained by
ﬁtting of the binding isotherm using a routine built in MATLAB which implements the
Newton-Gauss non-linear least squares ﬁtting algorithm.[343--345] The minimum error of
thebinding constantswasestimated tobe 10%. [SR-C262, C269, C272, C276, D302, D303,
D304, E407].
Table 7.1 – Concentrations of dyes and organometallic complexes for titration
experiments.
Fluorescent Dye Metal Fluorescent Dye [μM] Metal [μM]
CAL Rh 25 0 - 40
CAB Rh 2.5 0-20
MCB Rh 25 0 - 200
NFR Rh 25 0 - 500
CAL Ru 25 0 - 40
CAB Ru 25 0 - 40
MCB Ru 25 0 - 200
NFR Ru 50 0 - 200
CAL Pd 25 0 - 400
CAB Pd 25 0 - 400
MCB Pd 25 0 - 400
NFR Pd 25 0 - 125
LUM Pd 25 0 - 600
MAA Pd 25 0 - 5000
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7.5.3 Fluorescence Assays with Dipeptides
Stock solutions of the respective dipeptide and the dye were diluted with buﬀered
water. The ﬂuorescence signal was measured in a time-resolved fashion at the max-
imum emission intensity until it stabilized; this ensured the homogeneity and thermal
stability of the solution. The reaction was then started by adding a stock solution of
the respective metal complex. The ﬁnal volume was 3.0 mL; the ﬁnal concentrations
were: [dipeptide] = 50 or 20 μM, [dye] = 25 μM, [metal] = 25 μM, [phosphate buﬀer]
= 100 mM. Each of the ten dipeptides was treated with each of the 14 metal–dye
combinations indicated in Table 7.1, and a blank (with no peptide) was also recorded.
The experimentswere repeated four times (when [dipeptide] = 50 μMor for the blank)
or six times (when [dipeptide] = 20 μM), totalling 784 experiments. Fluorescence
intensities that were recorded 5, 20, and 60 min after addition of the metal complex
were used for multivariate analyses. [SR-C282-C293, D309-D379].
Reduced sensor array: The component loading to factor 1 (PC1) of the three
measurements at 4, 20 and 60 min of each metal-dye mixture were combined, thus
aﬀording fourteen contributions. A comparison of the resulting values allowed us
to identify the six metal–dye combinations that contribute most signiﬁcantly to the
discriminating power: Pd/NFR, Pd/CAB, Rh/NFR, Rh/CAL, Pd/MCB and Rh/CAB. Fluores-
cence data obtained from these six combinations in the presence of various dipeptides
were used for multivariate analyses.
7.5.4 Fluorescence Assays with Bradykinin (BK) and Kallidin (KD)
Sensor subset determination: A selection was performed by comparing the ﬂuores-
cence signals obtained when a metal complex stock solution was added to a solution
containing the respective peptide (BK or KD) and dye. The ﬁnal concentrations were:
[metal] = 10 μM, [dye] = 10 μM (for the cases in which the metal was Rh or Ru), [metal]
= 20 μM, [dye] = 20 μM (for the cases where the metal was Pd) and [peptide] = 50 μM
in a phosphate buﬀer (100 mM).
These concentrationswereexperimentally determined, andare explainable accord-
ing to two conditions: a) the weak aﬃnity of the peptides to the metal receptors led
to the use of an excess of peptide; b) in order to obtain exploitable kinetic data, higher
concentrations were necessary for the Pd-based sensors than for the Rh- or Ru-based
ones (Pd binds dyes with lower equilibrium constants than Rh or Ru). Each experiment
was monitored by ﬂuorescence spectroscopy, and for every metal-dye combination,
the intensity diﬀerence between mixtures containing KD or BK was calculated after 5,
7.5 Sensor Arrays for Small Peptides 145
30 and 60 minutes of reaction time. The results were summed up for each metal-dye
combination, allowing an estimation of howgood anymetal-dye combination is for the
discrimination of KD from BK. The results are shown in Figure 7.1. The ﬁve metal-dye
combinations displaying the biggest diﬀerences were chosen for subsequent analyses,
whereas Rh/NFR was eliminated because it was displaying constant signals over time.
Rh/CAL was utilized instead as the sixth combination.
Figure 7.1 – Diﬀerences in the ﬂuorescence responses between reactions involving
bradykinin or kallidin together with the indicated metal-dye combinations: the
values (in percent) were obtained by addition of the ﬂuorescence diﬀerences
recorded after 5, 30 and 60 minutes of reaction time. The combinations, which
were selected for the diﬀerentiation experiments are shown in grey.
Diﬀerentiation of mixtures of KD and BK: Stock solutions of the peptides and the
dyes were diluted with buﬀered H2O. The ﬂuorescence signal was measured in a time-
resolved fashion at its maximum emission intensity until it stabilized; this ensured the
homogeneity and thermal stability of the solution. The reaction was then started by
adding a solution of the respective metal complex. The ﬁnal volume was 3.0 mL; the
ﬁnal concentrationswere: [total peptide] = 50 μM, [phosphate buﬀer] = 100mM;when
themetal complexwasRh: [dye] = [Rh] = 10μM;when themetal receptorwasPd: [dye]
= [Pd] = 20 μM. Six mixtures containing diﬀerent KD/BK ratios (100:0; 80:20; 60:40;
40:60; 20:80; 0:100) and a blank were measured with the six metal–dye combinations
indicated above. Each reaction was repeated four times, totalling to 168 experiments.
The ﬂuorescence intensities were recorded 2.5, 5, and 10 min after the reaction was
initiated when Rh was the receptor, and after 40, 50, and 60 min when Pd was the
receptor. These data were used as input values for multivariate analyses. [SR-E410-
E429].
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7.5.5 Fluorescence Assays with Carnosine and Homocarnosine
Serum preprocessing: Two volumes of HPLC-grade MeCN were added to one volume
of serum. The mixture was vigorously shaken for 5 min at room temperature, then
centrifuged for 30min at 4000 rpm. The supernatantwas removed, ﬁltered, and stored
at 4C.
Fluorescence measurements: The six metal–dye combinations, which were success-
fully used for the diﬀerentiation of the ten dipeptides, were employed again (i.e.,
Pd/NFR, Pd/CAB, Rh/NFR, Rh/CAL, Pd/MCB and Rh/CAB). Stock solutions of the respec-
tive peptide and the dye were added to a mixture of serum (prepared as described
above) and buﬀer. The ﬂuorescence signal was measured in a time-resolved fashion
at its maximum emission intensity until it was stabilized; this ensured the homogeneity
and thermal stability of the solution. The reactionwas then startedby adding a solution
of the respective metal complex. The ﬁnal volume was 3.0 mL and contained 25%
serum, 50% MeCN, and 25% buﬀered H2O. The ﬁnal concentrations were: [peptide]
= 25, 50, 75 or 100 μM, [dye] = 25 μM, [phosphate buﬀer] = 25 mM. The ﬁnal metal
concentration was 500 μM for Pd/NFR, Pd/CAB, Rh/NFR and Rh/CAL mixtures, 300 μM
for Pd/MCB mixtures, and 200 μM for Rh/CAB mixtures. Four diﬀerent concentrations
of each dipeptide were reacted with each of the six metal–dye combinations indicated
above, and a blank (with no peptide) was also recorded. The experiments were
repeated four times, totalling to 216 experiments. The ﬂuorescence intensities that
were recorded 5, 20, and 60 min after the reaction was initiated were used for
multivariate analyses. [SR-E398-E406].
7.5.6 Data Processing
The ﬂuorescence data, recorded after given reaction times (indicated above for each
system) at the emission maxima (Table 4.2, p. 75), were normalized relative to the
ﬂuorescence intensity measured before addition of the metal complex (i. e., before
quenching occurs). The multivariate analyses (LDA and PCA) were performed with the
help of the SYSTAT software package (version 11).[342]
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7.6 SensorArrays versusDynamic Combinatorial Libraries
7.6.1 General
Stock solution of CHES buﬀer (286 mM, pH 8.4) was prepared with bidistilled H2O and
used for all experiments (the pH was adjusted by addition of NaOH). Stock solutions
of dyes (MCB: 0.60 mM; AI: 0.30 mM; XO: 0.15 mM), metal salts (NiCl2: 1.0 mM; CuCl2:
1.0mM), and peptides (5.0mM)were prepared in plain water and stored at 4C. UV/Vis
measurements were performed at room temperature.
7.6.2 Sensing of Peptides with DCL Sensors
Aliquots of stock solutions ofMethylcalcein Blue (83.3 μL), Arsenazo I (83.3 μL), Xylenol
Orange (83.3μL), CuCl2 (100μL),NiCl2 (100μL), CHESbuﬀer (350μL), and the respective
peptide (200 μL) were mixed in a UV/Vis cuvette. The ﬁnal concentrations were [MCB]
= 50 μM, [AI] = 25 μM, [XO] = 12.5 μM, [NiCl2] = [CuCl2] = 100 μM, [peptide] = 1.0 mM,
and [CHES] = 100 mM, and the ﬁnal volume was 1.0 mL. The solution was equilibrated
for 30min at 60C, cooled to room temperature, and its UV/Vis spectrumwas recorded
between 332 and 700 nm. The experiment was repeated 10 times for each peptide. An
analogous procedure was employed for DCL sensors of reduced complexity (smaller
number of dyes and/ormetal complexes). In these cases, the library components to be
omitted were replaced by bidistilled water. [SR-E443-E582, F583-F736].
Data Analysis
The UV/Vis data obtained for each DCL sensor were analyzed as follows: For each
measurement, 93 data points (absorbance values in the region λ = 332 - 700 nm,
with intervals of 4.0 nm) were used as input. To determine the wavelengths, which
contribute most to the diﬀerentiation of the peptides, a variable selection algorithm
was applied. Six wavelengths were selected for each data set. The selected variables
were then utilized to calculate the LDA classiﬁcation functions and to generate the
score plots. The commercial software package Systat[342] (version 11) was employed
for the variable selections, the linear discriminant analyses, and the calculation of the
F-values.
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7.6.3 Sensing of Peptides with the Sensor Array
First, we have determined the wavelengths, at which the largest spectral changes
occurred for each metal-dye combination. For that purpose, the UV/Vis spectra of
buﬀered aqueous solutions containing the free dye were compared with the spectra
of solutions containing a mixture of MCl2 (100 μM) and the dye (50 μM for MCB, 25
μM for AI, or 12.5 μM for XO). The largest diﬀerences were observed at the following
wavelengths: MCB/Cu: 372 nm, AI/Cu: 492 nm, XO/Cu: 584 nm, MCB/Ni: 376 nm, AI/Ni:
532 nm, and XO/Ni: 592 nm. The assays were carried out in a similar manner as the
measurements with the DCL sensors: mixtures of the respective dye (50 μM for MCB,
25 μM for AI, or 12.5 μM for XO), metal chloride (100 μM), and peptide (1.0 mM) in
water (pH 8.4, CHES buﬀer) were heated at 60C for 30 min. After cooling to room
temperature, UV/Vis measurements were performed (10 independent measurements
for each peptide).
Data Analysis
The six individual sensors were analyzed at the wavelengths given above. The ab-
sorbances for the 2 3 13 metal-dye-peptide combinations (10 replicates per combi-
nation) were used as input to calculate the LDA classiﬁcation functions with Systat.[342]
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A.1 Fluorescence Titration Experiments
Fluorescence titration data for the Rh complex and Calcein
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Figure A.1 – Fluorescence emission spectra of a solution of Calcein (25 μM) upon
addition of complex [Cp*RhCl2]2 ([Rh] = 0 − 40 μM). The excitation wavelength
was 493 nm. The spectra were recorded in H2O (100mMphosphate buﬀer, pH 7.0)
after equilibration for two days in the dark.
Figure A.2 – Fluorescence emission intensity at 520 nm of a solution of Calcein
(25 μM) upon addition of complex [Cp*RhCl2]2 ([Rh] = 0 − 40 μM). The curve was
obtained by ﬁtting the data to a 1:1 binding model (K1 = 7.6 (0.8)  106 M−1).
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Fluorescence titration data for the Rh complex and Calcein Blue
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Figure A.3 – Fluorescence emission spectra of a solution of Calcein Blue (2.5
μM) upon addition of complex [Cp*RhCl2]2 ([Rh] = 0 − 20 μM). The excitation
wavelength was 336 nm. The spectra were recorded in H2O (100 mM phosphate
buﬀer, pH 7.0) after equilibration for two days in the dark.
Figure A.4 – Fluorescence emission intensity at 440 nmof a solution of Calcein Blue
(2.5 μM) upon addition of complex [Cp*RhCl2]2 ([Rh] = 0 − 20 μM). The curve was
obtained by ﬁtting the data to a 1:1 binding model (K1 = 1.3 (0.5)  109 M−1).
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Fluorescence titration data for the Rh complex and Methylcalcein Blue
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Figure A.5 – Fluorescence emission spectra of a solution of Methylcalcein Blue (25
μM) upon addition of complex [Cp*RhCl2]2 ([Rh] = 0 − 200 μM). The excitation
wavelength was 363 nm. The spectra were recorded in H2O (100 mM phosphate
buﬀer, pH 7.0) after equilibration for two days in the dark.
Figure A.6 – Fluorescence emission intensity at 445 nm of a solution of
Methylcalcein Blue (25 μM) upon addition of complex [Cp*RhCl2]2 ([Rh] = 0 − 200
μM). The curve was obtained by ﬁtting the data to a 1:1 binding model (K1 = 1.8
(0.8)  108 M−1).
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Fluorescence titration data for the Rh complex and Nuclear Fast Red
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Figure A.7 – Fluorescence emission spectra of a solution of Nuclear Fast Red (25
μM) upon addition of complex [Cp*RhCl2]2 ([Rh] = 0 − 500 μM). The excitation
wavelength was 540 nm. The spectra were recorded in H2O (100 mM phosphate
buﬀer, pH 7.0) after equilibration for two days in the dark.
FigureA.8 – Fluorescence emission intensity at 590 nmof a solution of Nuclear Fast
Red (25 μM) upon addition of complex [Cp*RhCl2]2 ([Rh] = 0 − 500 μM). The curve
was obtained by ﬁtting the data to a 1:1 binding model (K1 = 1.6( 0.2)  106 M−1).
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Fluorescence titration data for the Ru complex and Calcein
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Figure A.9 – Fluorescence emission spectra of a solution of Calcein (25 μM)
upon addition of complex [(p-cymene)RuCl2]2 ([Ru] = 0 − 40 μM). The excitation
wavelength was 493 nm. The spectra were recorded in H2O (100 mM phosphate
buﬀer, pH 7.0) after equilibration for two days in the dark.
Figure A.10 – Fluorescence emission intensity at 520 nm of a solution of Calcein (25
μM) upon addition of complex [(p-cymene)RuCl2]2 ([Ru] = 0 − 40 μM). The curve
was obtained by ﬁtting the data to a 1:1 binding model (K1 = 1.9 ( 0.2)  106 M−1).
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Fluorescence titration data for the Ru complex and Calcein Blue
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Figure A.11 – Fluorescence emission spectra of a solution of Calcein Blue (25 μM)
upon addition of complex [(p-cymene)RuCl2]2 ([Ru] = 0 − 40 μM). The excitation
wavelength was 336 nm. The spectra were recorded in H2O (100 mM phosphate
buﬀer, pH 7.0) after equilibration for two days in the dark.
Figure A.12 – Fluorescence emission intensity at 440 nm of a solution of Calcein
Blue (25 μM) upon addition of complex [(p-cymene)RuCl2]2 ([Ru] = 0 − 40 μM). The
curve was obtained by ﬁtting the data to a 1:1 binding model (K1 = 1.6 ( 0.2)  106
M−1).
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Fluorescence titration data for the Ru complex and Methylcalcein Blue
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Figure A.13 – Fluorescence emission spectra of a solution of Methylcalcein Blue
(25 μM) upon addition of complex [(p-cymene)RuCl2]2 ([Ru] = 0 − 200 μM). The
excitation wavelength was 363 nm. The spectra were recorded in H2O (100 mM
phosphate buﬀer, pH 7.0) after equilibration for two days in the dark.
Figure A.14 – Fluorescence emission intensity at 445 nm of a solution of
Methylcalcein Blue (25 μM) upon addition of complex [(p-cymene)RuCl2]2 ([Ru] =
0 − 200 μM). The curve was obtained by ﬁtting the data to a 1:1 binding model (K1 =
1.8 ( 0.2)  107 M−1).
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Fluorescence titration data for the Ru complex and Nuclear Fast Red
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Figure A.15 – Fluorescence emission spectra of a solution of Nuclear Fast Red
(50 μM) upon addition of complex [(p-cymene)RuCl2]2 ([Ru] = 0 − 200 μM). The
excitation wavelength was 540 nm. The spectra were recorded in H2O (100 mM
phosphate buﬀer, pH 7.0) after equilibration for two days in the dark.
Figure A.16 – Fluorescence emission intensity at 590 nm of a solution of Nuclear
Fast Red (50 μM) upon addition of complex [(p-cymene)RuCl2]2 ([Ru] = 0 − 200
μM). The curve was obtained by ﬁtting the data to a 1:2 binding model (K1 = 7.4 (
2.1)  108 M−1; K2 = 1.6 ( 0.8)  106 M−1).
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Fluorescence titration data for the Pd complex and Calcein
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Figure A.17 – Fluorescence emission spectra of a solution of Calcein (25 μM) upon
addition of complex [(en)PdCl2] (0 − 400 μM). The excitation wavelength was 493
nm. The spectra were recorded in H2O (100 mM phosphate buﬀer, pH 7.0) after
equilibration for two days in the dark.
Figure A.18 – Fluorescence emission intensity at 520 nm of a solution of Calcein (25
μM) upon addition of complex [(en)PdCl2] (0 − 400 μM). The curve was obtained
by ﬁtting the data to a 1:2 binding model (K1 = 6.2 ( 0.6)  105 M−1; K2 = 1.0 ( 0.8)
 104 M−1).
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Fluorescence titration data for the Pd complex and Calcein Blue
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Figure A.19 – Fluorescence emission spectra of a solution of Calcein Blue (25 μM)
upon addition of complex [(en)PdCl2] (0 − 400μM). The excitationwavelengthwas
336 nm. The spectrawere recorded inH2O (100mMphosphate buﬀer, pH 7.0) after
equilibration for two days in the dark.
Figure A.20 – Fluorescence emission intensity at 440 nm of a solution of Calcein
Blue (25 μM) upon addition of complex [(en)PdCl2] (0 − 400 μM). The curve was
obtained by ﬁtting the data to a 1:1 binding model (K1 = 1.2 ( 0.1)  105 M−1).
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Fluorescence titration data for the Pd complex and Methylcalcein Blue
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Figure A.21 – Fluorescence emission spectra of a solution of Methylcalcein Blue (25
μM)uponadditionof complex [(en)PdCl2] (0 − 400μM). The excitationwavelength
was 363 nm. The spectra were recorded in H2O (100mMphosphate buﬀer, pH 7.0)
after equilibration for two days in the dark.
Figure A.22 – Fluorescence emission intensity at 445 nm of a solution of
Methylcalcein Blue (25 μM) upon addition of complex [(en)PdCl2] (0 − 400 μM).
The curve was obtained by ﬁtting the data to a 1:1 binding model (K1 = 2.2( 0.2) 
105 M−1).
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Fluorescence titration data for the Pd complex and Nuclear Fast Red
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Figure A.23 – Fluorescence emission spectra of a solution of Nuclear Fast Red (25
μM) upon addition of complex [(en)PdCl2] (0 − 125 μM). The excitationwavelength
was 540 nm. The spectra were recorded in H2O (100mMphosphate buﬀer, pH 7.0)
after equilibration for two days in the dark.
Figure A.24 – Fluorescence emission intensity at 590 nm of a solution of Nuclear
Fast Red (25 μM) upon addition of complex [(en)PdCl2] (0 − 125 μM). The curve
was obtained by ﬁtting the data to a 1:1 binding model (K1 = 9.5( 9.5)  108 M−1).
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Fluorescence titration data for the Pd complex and Lumazine
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Figure A.25 – Fluorescence emission spectra of a solution of Lumazine (25 μM)
upon addition of complex [(en)PdCl2] (0 − 600μM). The excitationwavelengthwas
328 nm. The spectrawere recorded inH2O (100mMphosphate buﬀer, pH 7.0) after
equilibration for two days in the dark.
Figure A.26 – Fluorescence emission intensity at 460 nm of a solution of Lumazine
(25 μM) upon addition of complex [(en)PdCl2] (0 − 600 μM). The curve was
obtained by ﬁtting the data to a 1:1 binding model (K1 = 7.8 ( 0.8)  104 M−1).
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Fluorescence titration data for the Pd complex and N-Methylanthranilic Acid
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Figure A.27 – Fluorescence emission spectra of a solution of N-Methylanthranilic
Acid (25 μM) upon addition of complex [(en)PdCl2] (0 − 5000 μM). The excitation
wavelength was 325 nm. The spectra were recorded in H2O (100 mM phosphate
buﬀer, pH 7.0) after equilibration for two days in the dark.
Figure A.28 – Fluorescence emission intensity at 439 nm of a solution of N-
Methylanthranilic Acid (25 μM) upon addition of complex [(en)PdCl2] (0 − 5000
μM). The curve was obtained by ﬁtting the data to a 1:1 binding model (K1 = 8.6
( 0.9)  103 M−1).
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A.2 Multivariate Analyses
A.2.1 Sensing of Ten Dipeptides in Water
Principal Component Analysis (Figure 4.7)
Table A.1 – Correlation matrix
Eigenvalue 35.09 2.70 1.74 0.87 0.60
Variance explained by components 83.54 6.42 4.13 2.06 1.42
Total variance explained (%) 83.54 89.96 94.09 96.15 97.57
Table A.2 – Variables contributions to PC1, calculated as the square of the
corresponding component loading (only principal component 1 was taken into
account, since it represents more than 80% of the total variance) .
variable PC1 variable PC1
Ru/MCB, 5 min 0.687241 Rh/NFR, 5 min 0.877969
Ru/MCB, 20 min 0.749956 Rh/NFR, 20 min 0.857476
Ru/MCB, 60 min 0.748225 Rh/NFR, 60 min 0.861184
Rh/MCB, 5 min 0.802816 Pd/NFR, 5 min 0.795664
Rh/MCB, 20 min 0.833569 Pd/NFR, 20 min 0.956484
Rh/MCB, 60 min 0.833776 Pd/NFR, 60 min 0.923521
Ru/CAB, 5 min 0.624100 Pd/CAL, 5 min 0.588289
Ru/CAB, 20 min 0.801025 Pd/CAL, 20 min 0.904401
Ru/CAB, 60 min 0.872356 Pd/CAL, 60 min 0.972196
Rh/CAB, 5 min 0.937024 Pd/MCB, 5 min 0.859329
Rh/CAB, 20 min 0.940900 Pd/MCB, 20 min 0.958441
Rh/CAB, 60 min 0.933156 Pd/MCB, 60 min 0.940900
Ru/CAL, 5 min 0.603729 Pd/CAB, 5 min 0.724201
Ru/CAL, 20 min 0.783225 Pd/CAB, 20 min 0.958441
Ru/CAL, 60 min 0.877969 Pd/CAB, 60 min 0.946729
Rh/CAL, 5 min 0.889249 Pd/LUM, 5 min 0.698896
Rh/CAL, 20 min 0.912025 Pd/LUM, 20 min 0.859329
Rh/CAL, 60 min 0.925444 Pd/LUM, 60 min 0.727609
Ru/NFR, 5 min 0.777924 Pd/NMA, 5 min 0.826281
Ru/NFR, 20 min 0.831744 Pd/NMA, 20 min 0.919681
Ru/NFR, 60 min 0.863041 Pd/NMA, 60 min 0.680625
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Table A.3 – Sum of each metal-dye combination contributions to PC1 reported in
Table A.2. In bold, the 6 most important contributors which were selected to build
the reduced sensor array (see A.2.2 and A.2.4 for examples involving this reduced
array).
Metal/dye combination PC1 Metal/dye combination PC1
Ru/MCB 2.185422 Rh/NFR 2.596629
Rh/MCB 2.490161 Pd/NFR 2.675669
Ru/CAB 2.297481 Pd/CAL 2.464886
Rh/CAB 2.811080 Pd/MCB 2.758670
Ru/CAL 2.264923 Pd/CAB 2.629371
Rh/CAL 2.726718 Pd/LUM 2.285834
Ru/NFR 2.472709 Pd/NMA 2.426587
Linear Discriminant Analysis
The linear discriminant analysis was performed using a stepwise variable selection
algorithm based on the statistical signiﬁcance of each variable in the discrimination
between groups. Selected variables and related classiﬁcation function coeﬃcients are
shown in section A.3 (p. 181).
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Figure A.29 – Two-dimensional LDA score plot for the discrimination of 10
dipeptides. The peptide concentrations were 50 μM (ﬁlled symbols) or 20 μM
(open symbols). The input data for the LDA was obtained from a sensor array
composed of the 14 metal-dye combinations listed in Table 4.1 (p. 73), and was
the same as the input data used for the PCA analysis that produced Figure 4.7 of
Section 4.3.1.
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Table A.4 – Classiﬁcation matrix (cases in row categories classiﬁed into columns).
Unless otherwise indicated, the concentrations of peptides were 50 μM.
20 AA 20 VF AA AF DF HA KY ML FP SG WG VF Blank % correct
20 μM AA 6 0 0 0 0 0 0 0 0 0 0 0 0 100
20 μM VF 0 6 0 0 0 0 0 0 0 0 0 0 0 100
AA 0 0 4 0 0 0 0 0 0 0 0 0 0 100
AF 0 0 0 4 0 0 0 0 0 0 0 0 0 100
DF 0 0 0 0 4 0 0 0 0 0 0 0 0 100
HA 0 0 0 0 0 4 0 0 0 0 0 0 0 100
KY 0 0 0 0 0 0 4 0 0 0 0 0 0 100
ML 0 0 0 0 0 0 0 4 0 0 0 0 0 100
FP 0 0 0 0 0 0 0 0 4 0 0 0 0 100
SG 0 0 0 0 0 0 0 0 0 4 0 0 0 100
WG 0 0 0 0 0 0 0 0 0 0 4 0 0 100
VF 0 0 0 0 0 0 0 0 0 0 0 4 0 100
Blank 0 0 0 0 0 0 0 0 0 0 0 0 4 100
Total 6 6 4 4 4 4 4 4 4 4 4 4 4 100
Table A.5 – Jack-knifed classiﬁcation matrix (each measurement was omitted at
a time and then classiﬁed). Unless otherwise indicated, the concentrations of
peptides were 50 μM.
20 AA 20 VF AA AF DF HA KY ML FP SG WG VF Blank % correct
20 μM AA 6 0 0 0 0 0 0 0 0 0 0 0 0 100
20 μM VF 0 6 0 0 0 0 0 0 0 0 0 0 0 100
AA 0 0 4 0 0 0 0 0 0 0 0 0 0 100
AF 0 0 0 4 0 0 0 0 0 0 0 0 0 100
DF 0 0 0 0 4 0 0 0 0 0 0 0 0 100
HA 0 0 0 0 0 4 0 0 0 0 0 0 0 100
KY 0 0 0 0 0 0 4 0 0 0 0 0 0 100
ML 0 0 0 0 0 0 0 4 0 0 0 0 0 100
FP 0 0 0 0 0 0 0 0 4 0 0 0 0 100
SG 0 0 0 0 0 0 0 0 0 4 0 0 0 100
WG 0 0 0 0 0 0 0 0 0 0 4 0 0 100
VF 0 0 0 0 0 0 0 0 0 0 0 4 0 100
Blank 0 0 0 0 0 0 0 0 0 0 0 0 4 100
Total 6 6 4 4 4 4 4 4 4 4 4 4 4 100
Table A.6 – Correlation matrix
Eigenvalue 327940 34500 11492 8778 4808 917 ...
Variance explained 83.9 8.8 2.9 2.3 1.2 0.3 ...
Total variance explained (%) 83.9 92.7 95.6 97.9 99.1 99.4 ...
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A.2.2 Sensor Array Reduction
The following results were obtained by using the six metal/dye combination deter-
mined in table Table A.3 (Pd/NFR, Pd/CAB, Rh/NFR, Rh/CAL, Pd/MCB and Rh/CAB).
Principal Component Analysis
42.4
2
.03
Figure A.30 – Two-dimensional PCA score plots for the discrimination of 10
dipeptides. The input data for the PCAwas obtained froma sensor array composed
of the following six metal-dye combinations: Pd/NFR, Pd/CAB, Rh/NFR, Rh/CAL,
Pd/MCB, and Rh/CAB. The ﬂuorescence was measured after 5, 20 and 60 minutes
and the peptides concentrations were 50 μM (ﬁlled symbols) or 20 μM (open
symbols).
Table A.7 – Correlation matrix
Eigenvalue 16.63 0.77 0.37 0.09 0.05 ...
Variance explained by components 92.38 4.27 2.04 0.53 0.28 ...
Total variance explained (%) 92.38 96.65 98.69 99.22 99.50 ...
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Table A.8 – Variables contributions to PC1 and PC2, calculated as the square of the
corresponding component loadings.
variable PC1 PC2 variable PC1 PC2
Rh/CAB, 5 min 0.96236 0.02132 Pd/NFR, 5 min 0.82446 0.12745
Rh/CAB, 20 min 0.98605 0.00792 Pd/NFR, 20 min 0.97220 0.00160
Rh/CAB, 60 min 0.98406 0.00084 Pd/NFR, 60 min 0.92544 0.01563
Rh/CAL, 5 min 0.92544 0.04623 Pd/MCB, 5 min 0.86118 0.10304
Rh/CAL, 20 min 0.96432 0.02403 Pd/MCB, 20 min 0.92930 0.02856
Rh/CAL, 60 min 0.97812 0.00176 Pd/MCB, 60 min 0.89681 0.00020
Rh/NFR, 5 min 0.94090 0.04580 Pd/CAB, 5 min 0.75690 0.20160
Rh/NFR, 20 min 0.92737 0.05712 Pd/CAB, 20 min 0.95063 0.02822
Rh/NFR, 60 min 0.92930 0.05664 Pd/CAB, 60 min 0.91776 0.00063
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Linear Discriminant Analysis
The linear discriminant analysis was performed using a stepwise variable selection
algorithm based on the statistical signiﬁcance of each variable in the discrimination
between groups. Selected variables and related classiﬁcation function coeﬃcients are
shown in section A.3.
Figure A.31 – Two-dimensional LDA score plot for the discrimination of 10
dipeptides. The input data for the LDAwas obtained froma sensor array composed
of the following six metal-dye combinations: Pd/NFR, Pd/CAB, Rh/NFR, Rh/CAL,
Pd/MCB, and Rh/CAB. The ﬂuorescence was measured after 5, 20 and 60 minutes
and the peptides concentrations were 50 μM (ﬁlled symbols) or 20 μM (open
symbols).
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Table A.9 – Classiﬁcation matrix (cases in row categories classiﬁed into columns).
Unless otherwise indicated, the concentrations of peptides were 50 μM.
20 AA 20 VF AA AF DF HA KY ML FP SG WG VF Blank % correct
20 μM AA 6 0 0 0 0 0 0 0 0 0 0 0 0 100
20 μM VF 0 6 0 0 0 0 0 0 0 0 0 0 0 100
AA 0 0 4 0 0 0 0 0 0 0 0 0 0 100
AF 0 0 0 4 0 0 0 0 0 0 0 0 0 100
DF 0 0 0 0 4 0 0 0 0 0 0 0 0 100
HA 0 0 0 0 0 4 0 0 0 0 0 0 0 100
KY 0 0 0 0 0 0 4 0 0 0 0 0 0 100
ML 0 0 0 0 0 0 0 4 0 0 0 0 0 100
FP 0 0 0 0 0 0 0 0 4 0 0 0 0 100
SG 0 0 0 0 0 0 0 0 0 4 0 0 0 100
WG 0 0 0 0 0 0 0 0 0 0 4 0 0 100
VF 0 0 0 0 0 0 0 0 0 0 0 4 0 100
Blank 0 0 0 0 0 0 0 0 0 0 0 0 4 100
Total 6 6 4 4 4 4 4 4 4 4 4 4 4 100
Table A.10 – Jack-knifed classiﬁcation matrix (each measurement was omitted at
a time and then classiﬁed). Unless otherwise indicated, the concentrations of
peptides were 50 μM.
20 AA 20 VF AA AF DF HA KY ML FP SG WG VF Blank % correct
20 μM AA 6 0 0 0 0 0 0 0 0 0 0 0 0 100
20 μM VF 0 6 0 0 0 0 0 0 0 0 0 0 0 100
AA 0 0 4 0 0 0 0 0 0 0 0 0 0 100
AF 0 0 0 4 0 0 0 0 0 0 0 0 0 100
DF 0 0 0 0 4 0 0 0 0 0 0 0 0 100
HA 0 0 0 0 0 4 0 0 0 0 0 0 0 100
KY 0 0 0 0 0 0 4 0 0 0 0 0 0 100
ML 0 0 0 0 0 0 0 4 0 0 0 0 0 100
FP 0 0 0 0 0 0 0 0 4 0 0 0 0 100
SG 0 0 0 0 0 0 0 0 0 4 0 0 0 100
WG 0 0 0 0 0 0 0 0 0 0 4 0 0 100
VF 0 0 0 0 0 0 0 0 0 0 0 4 0 100
Blank 0 0 0 0 0 0 0 0 0 0 0 0 4 100
Total 6 6 4 4 4 4 4 4 4 4 4 4 4 100
Table A.11 – Correlation matrix
Eigenvalue 59247 3244 2400 158 110 84 ...
Variance explained 90.8 4.9 3.7 0.2 0.2 0.1 ...
Total variance explained (%) 90.8 95.7 99.4 99.6 99.8 99.9 ...
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Cross-validation
The data from the previous experiment were used but this time 40% of the data was
takenout randomly (not involved in building the linear discriminant functions) and then
reclassiﬁed.
Table A.12 – Classiﬁcation matrix (cases used to build the discriminant functions).
Unless otherwise indicated, the concentrations of peptides were 50 μM.
20 AA 20 VF AA AF DF HA KY ML FP SG WG VF Blank % correct
20 μM AA 3 0 0 0 0 0 0 0 0 0 0 0 0 100
20 μM VF 0 5 0 0 0 0 0 0 0 0 0 0 0 100
AA 0 0 1 0 0 0 0 0 0 0 0 0 0 100
AF 0 0 0 3 0 0 0 0 0 0 0 0 0 100
DF 0 0 0 0 3 0 0 0 0 0 0 0 0 100
HA 0 0 0 0 0 3 0 0 0 0 0 0 0 100
KY 0 0 0 0 0 0 2 0 0 0 0 0 0 100
ML 0 0 0 0 0 0 0 3 0 0 0 0 0 100
FP 0 0 0 0 0 0 0 0 3 0 0 0 0 100
SG 0 0 0 0 0 0 0 0 0 3 0 0 0 100
WG 0 0 0 0 0 0 0 0 0 0 2 0 0 100
VF 0 0 0 0 0 0 0 0 0 0 0 2 0 100
Blank 0 0 0 0 0 0 0 0 0 0 0 0 1 100
Total 3 5 1 3 3 3 2 3 3 3 2 2 1 100
A.2 Multivariate Analyses 173
Table A.13 – Classiﬁcation of cases with zero weight or frequency: these observa-
tions were not used to determine discriminant functions but were classiﬁed into
groups afterwards. Unless otherwise indicated, the concentrations of peptides
were 50 μM.
20 AA 20 VF AA AF DF HA KY ML FP SG WG VF Blank % correct
20 μM AA 3 0 0 0 0 0 0 0 0 0 0 0 0 100
20 μM VF 0 1 0 0 0 0 0 0 0 0 0 0 0 100
AA 0 0 3 0 0 0 0 0 0 0 0 0 0 100
AF 0 0 0 1 0 0 0 0 0 0 0 0 0 100
DF 0 0 0 0 1 0 0 0 0 0 0 0 0 100
HA 0 0 0 0 0 1 0 0 0 0 0 0 0 100
KY 0 0 0 0 0 0 2 0 0 0 0 0 0 100
ML 0 0 0 0 0 0 0 1 0 0 0 0 0 100
FP 0 0 0 0 0 0 0 0 1 0 0 0 0 100
SG 0 0 0 0 0 0 0 0 0 1 0 0 0 100
WG 0 0 0 0 0 0 0 0 0 0 2 0 0 100
VF 0 0 0 0 0 0 0 0 0 0 0 2 0 100
Blank 0 0 0 0 0 0 0 0 0 0 0 0 3 100
Total 3 1 3 1 1 1 1 2 1 1 2 2 3 100
Table A.14 – Correlation matrix
Eigenvalue 57281 4239 2321 123 74 ...
Variance explained 89.3 6.6 3.7 0.2 0.1 ...
Total variance explained (%) 89.3 95.9 99.6 99.8 99.9 ...
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A.2.3 Sensing of Bradykinin and Kallidin
Principal Component Analysis (see also Figure 4.8)
Allmeasurementswere performedwith the sixmetal-dye combinations determined by
pre-screening (Rh/MCB, Rh/CAB, Rh/CAL, Pd/CAB, Pd/NFR, and Pd/LUM), see 7.5.4, p.
144.
Table A.15 – Correlation matrix
Eigenvalue 10.85 6.22 0.58 0.14 0.05 ...
Variance explained by components 60.25 34.54 3.22 0.80 0.28 ...
Total variance explained (%) 60.25 94.79 98.01 98.81 99.09 ...
Table A.16 – Variables contributions to PC1 and PC2, calculated as the square of the
corresponding component loadings.
variable PC1 PC2 variable PC1 PC2
Rh/MCB, 2.5 min 0.85008 0.14063 Pd/LUM, 40 min 0.40323 0.55950
Rh/MCB, 5 min 0.83723 0.15288 Pd/LUM, 50 min 0.27248 0.70224
Rh/MCB, 10 min 0.81000 0.17223 Pd/LUM, 60 min 0.23232 0.74304
Rh/CAL, 2.5 min 0.78410 0.20430 Pd/NFR, 40 min 0.35522 0.60996
Rh/CAL, 5 min 0.70224 0.27353 Pd/NFR, 50 min 0.00230 0.47197
Rh/CAL, 10 min 0.62410 0.33408 Pd/NFR, 60 min 0.35760 0.60528
Rh/CAB, 2.5 min 0.76738 0.19184 Pd/CAB, 40 min 0.79388 0.18318
Rh/CAB, 5 min 0.78146 0.19536 Pd/CAB, 50 min 0.76913 0.22278
Rh/CAB, 10 min 0.77440 0.18576 Pd/CAB, 60 min 0.72420 0.26729
A.2 Multivariate Analyses 175
Linear Discriminant Analysis
Linear discriminant analysis was performed using a stepwise variable selection al-
gorithm based on the statistical signiﬁcance of each variable in the discrimination
between groups. Selected variables and related classiﬁcation function coeﬃcients are
shown in section A.3.
Figure A.32 – Two-dimensional LDA score plot for the discrimination of various
mixtures of kallidin (KD) and bradykinin (BK). The input data for the LDA
was obtained from a sensor array composed of the following six metal-dye
combinations: Rh/MCB, Rh/CAB, Rh/CAL, Pd/CAB, Pd/NFR, and Pd/LUM. The
ﬂuorescence was measured after 2.5, 5, and 10 minutes (Rh-based sensors) or 40,
50 and 60 minutes (Pd-based sensors) and the total peptide concentrations were
50 μM.
Table A.17 – Classiﬁcation matrix (cases in row categories classiﬁed into columns).
0 KD 10 KD 20 KD 30 KD 40 KD 50 KD Blank %
50 BK 40 BK 30 BK 20 BK 10 BK 0 BK correct
0 KD 50 BK 4 0 0 0 0 0 0 100
10 KD 40 BK 0 4 0 0 0 0 0 100
20 KD 30 BK 0 0 4 0 0 0 0 100
30 KD 20 BK 0 0 0 4 0 0 0 100
40 KD 10 BK 0 0 0 0 4 0 0 100
50 KD 0 BK 0 0 0 0 0 4 0 100
Blank 0 0 0 0 0 0 4 100
Total 4 4 4 4 4 4 4 100
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Table A.18 – Jack-knifed classiﬁcation matrix (each measurement was omitted at a
time and then classiﬁed).
0 KD 10 KD 20 KD 30 KD 40 KD 50 KD Blank %
50 BK 40 BK 30 BK 20 BK 10 BK 0 BK correct
0 KD 50 BK 4 0 0 0 0 0 0 100
10 KD 40 BK 0 4 0 0 0 0 0 100
20 KD 30 BK 0 0 4 0 0 0 0 100
30 KD 20 BK 0 0 0 4 0 0 0 100
40 KD 10 BK 0 0 0 0 4 0 0 100
50 KD 0 BK 0 0 0 0 0 4 0 100
Blank 0 0 0 0 0 0 4 100
Total 4 4 4 4 4 4 4 100
Table A.19 – Correlation matrix.
Eigenvalue 1078 467 4.39 2.00 1.85 0.10
Variance explained 69.4 30.1 0.2 0.2 0.1 0.0
Total variance explained (%) 69.4 99.5 99.7 99.9 100 100
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A.2.4 Sensing of Carnosine and Homocarnosine in Serum
The following results were obtained by using the six metal-dye combination deter-
mined in section A.2.2. (Pd/NFR, Pd/CAB, Rh/NFR, Rh/CAL, Pd/MCB and Rh/CAB) with
modiﬁed metal concentrations ([Metal] = 500 μM for Pd/NFR, Pd/CAB, Rh/NFR, and
Rh/CAL mixtures, 300 μM for Pd/MCB mixtures, and 200 μM for Rh/CAB mixtures).
Principal Component Analysis (see also Figure 4.9)
Table A.20 – Correlation matrix.
Eigenvalue 8.84 6.64 1.08 0.56 0.42 0.26 ...
Variance explained by components 49.1 36.9 6.0 3.1 2.3 1.4 ...
Total variance explained (%) 49.1 86.0 92.0 95.1 97.4 98.8 ...
Table A.21 – Variables contributions to PC1 and PC2, calculated as the square of the
corresponding component loadings.
variable PC1 PC2 variable PC1 PC2
Rh/CAB, 5 min 0.32262 0.44622 Pd/MCB, 5 min 0.48025 0.40323
Rh/CAB, 20 min 0.47886 0.41990 Pd/MCB, 20 min 0.56250 0.27144
Rh/CAB, 60 min 0.32718 0.61152 Pd/MCB, 60 min 0.53582 0.26112
Rh/CAL, 5 min 0.54908 0.26832 Pd/CAB, 40 min 0.51840 0.38564
Rh/CAL, 20 min 0.68228 0.20521 Pd/CAB, 50 min 0.54170 0.30914
Rh/CAL, 60 min 0.70896 0.16403 Pd/CAB, 60 min 0.55354 0.25402
Rh/NFR, 5 min 0.64642 0.11903 Pd/NFR, 5 min 0.20160 0.72250
Rh/NFR, 20 min 0.77792 0.10049 Pd/NFR, 20 min 0.15445 0.77088
Rh/NFR, 60 min 0.78500 0.13323 Pd/NFR, 60 min 0.01082 0.79388
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Linear Discriminant Analysis
The linear discriminant analysis was performed using a stepwise variable selection
algorithm based on the statistical signiﬁcance of each variable in the discrimination
between groups. Selected variables and related classiﬁcation function coeﬃcients are
shown in section A.3.
Figure A.33 – Two-dimensional LDA score plot for the discrimination of carnosine
(C) and homocarnosine (HC). The input data for the LDA was obtained from a
sensor array composed of the following six metal-dye combinations: Pd/NFR,
Pd/CAB, Rh/NFR, Rh/CAL, Pd/MCB, and Rh/CAB. The ﬂuorescence was measured
after 5, 20, and 60 minutes of reaction time.
Table A.22 – Classiﬁcation matrix (cases in row categories classiﬁed into columns).
100 100 75 75 50 50 25 25 Blank %
Car HCar Car HCar Car HCar Car HCAr correct
100 Car 4 0 0 0 0 0 0 0 0 100
100 HCar 0 4 0 0 0 0 0 0 0 100
75 Car 0 0 4 0 0 0 0 0 0 100
75 HCar 0 0 0 4 0 0 0 0 0 100
50 Car 0 0 0 0 4 0 0 0 0 100
50 HCar 0 0 0 0 0 4 0 0 0 100
25 Car 0 0 0 0 0 0 4 0 0 100
25 HCar 0 0 0 0 0 0 0 4 0 100
Blank 0 0 0 0 0 0 0 0 4 100
Total 4 4 4 4 4 4 4 4 4 100
A.2 Multivariate Analyses 179
Table A.23 – Jack-knifed classiﬁcation matrix (each measurement was omitted at a
time and then classiﬁed).
100 100 75 75 50 50 25 25 Blank %
Car HCar Car HCar Car HCar Car HCAr correct
100 Car 4 0 0 0 0 0 0 0 0 100
100 HCar 0 4 0 0 0 0 0 0 0 100
75 Car 0 0 4 0 0 0 0 0 0 100
75 HCar 0 0 0 4 0 0 0 0 0 100
50 Car 0 0 0 0 4 0 0 0 0 100
50 HCar 0 0 0 0 0 4 0 0 0 100
25 Car 0 0 0 0 0 0 4 0 0 100
25 HCar 0 0 0 0 0 0 0 4 0 100
Blank 0 0 0 0 0 0 0 0 4 100
Total 4 4 4 4 4 4 4 4 4 100
Table A.24 – Correlation matrix.
Eigenvalue 1083 191.7 169.4 20.33 6.38 3.57 1.37
Variance explained 73.4 13.0 11.4 1.4 0.4 0.3 0.1
Total variance explained (%) 73.4 86.4 97.8 99.2 99.6 99.9 100
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Cross-validation
The data from the previous experiment were used but this time 20% of the data was
takenout randomly (not involved in building the linear discriminant functions) and then
reclassiﬁed.
Table A.25 – Classiﬁcation matrix (cases used to build the discriminant functions).
100 100 75 75 50 50 25 25 Blank %
Car HCar Car HCar Car HCar Car HCAr correct
100 Car 3 0 0 0 0 0 0 0 0 100
100 HCar 0 3 0 0 0 0 0 0 0 100
75 Car 0 0 2 0 0 0 0 0 0 100
75 HCar 0 0 0 4 0 0 0 0 0 100
50 Car 0 0 0 0 3 0 0 0 0 100
50 HCar 0 0 0 0 0 2 0 0 0 100
25 Car 0 0 0 0 0 0 4 0 0 100
25 HCar 0 0 0 0 0 0 0 3 0 100
Blank 0 0 0 0 0 0 0 0 4 100
Total 3 3 2 4 3 2 4 3 4 100
Table A.26 – Classiﬁcation of cases with zero weight or frequency: these
observations were not used to determine discriminant functions but were
classiﬁed into groups afterwards.
100 100 75 75 50 50 25 25 Blank %
Car HCar Car HCar Car HCar Car HCAr correct
100 Car 1 0 0 0 0 0 0 0 0 100
100 HCar 0 1 0 0 0 0 0 0 0 100
75 Car 0 0 2 0 0 0 0 0 0 100
75 HCar 0 0 0 0 0 0 0 0 0 -
50 Car 0 0 0 0 1 0 0 0 0 100
50 HCar 0 0 0 0 0 2 0 0 0 100
25 Car 0 0 0 0 0 0 0 0 0 -
25 HCar 0 0 0 0 0 0 0 1 0 100
Blank 0 0 0 0 0 0 0 0 0 -
Total 1 1 2 0 1 2 0 1 0 100
Table A.27 – Correlation matrix.
Eigenvalue 671.7 114.8 55.8 21.3 2.5 ...
Variance explained 77.5 13.2 6.5 2.4 0.3 ...
Total variance explained (%) 77.5 90.7 97.2 99.6 99.9 ...
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A.3 Linear Discriminant Functions provided by the LDAs
Linear Discriminant Functions, also called canonical roots, are created as a linear
combination of discriminating (independent) variables, such as:
Fz = A+
pX
b=1
cb  Zb (A.1)
WhereA represents a constant, c the classiﬁcation coeﬃcients andZ the variables
(in the case where p variables are used).
Linear discriminant functions describe the best ﬁt parameters to separate diﬀerent
clusters (analytes). The cross-validation (jack-knifed matrix) routine is then used to
test the predictability of the sensor array by leaving one observation out of the set
at the time, and uses the rest of the data as a training set to generate the linear
discriminant functions. The linear discriminant functions are then used to place the
excludedobservation (data point)within the correct cluster. This is performed for each
observation, and the overall ability to classify the observations describes the quality
and predictability of the array.
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Table A.30 – Linear discrimination functions for the analysis of kallidin and
bradykinin (cf. section A.2.3, p. 175).
50 μM KD40 μM KD30 μM KD20 μM KD 10 μM KD Blank
+ + + +
10 μM BK 20 μM BK 30 μM BK40 μM BK50 μM BK
Constant 108996 111945 115779 119795 124859 -126886 -93646
Rh/MCB, 2.5 min 183145 186226 191548 198828 203999 204401 198426
Rh/MCB, 5 min 67737 63905 54917 46425 39482 35516 23659
Rh/MCB, 10 min -181545 -182939 -182597 -183118 -184309 -182129 -166274
Rh/CAL, 2.5 min
Rh/CAL, 5 min
Rh/CAL, 10 min
Rh/CAB, 2.5 min -74667 -73953 -72922 -73190 -72432 -71669 -68473
Rh/CAB, 5 min
Rh/CAB, 10 min 138783 137670 136444 137568 136665 135547 124908
Pd/LUM, 40 min 59795 60995 62152 62389 64265 65289 50962
Pd/LUM, 50 min
Pd/LUM, 60 min 74228 75970 78183 80578 83424 84265 75798
Pd/NFR, 40 min
Pd/NFR, 50 min
Pd/NFR, 60 min -17780 -16317 -14111 -13462 -12021 -10744 -16522
Pd/CAB, 40 min
Pd/CAB, 50 min 51839 51606 51495 52794 52497 52236 47673
Pd/CAB, 60 min 54442 57658 62219 64591 68887 71394 50495
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A.4 Kinetic Proﬁles
Figure A.34 – Relative ﬂuorescence emission intensity at 590 nm for the reaction
of [(p-cymene)RuCl2]2 (25 μM) and Nuclear Fast Red (25 μM) in the presence of
diﬀerent dipeptides. The data were obtained at 25C in H2O (100 mM phosphate
buﬀer, pH 7.0). The excitation wavelength was 540 nm.
Figure A.35 – Relative ﬂuorescence emission intensity at 440 nm for the reaction
of [Cp*RhCl2]2 (25 μM) and Calcein Blue (25 μM) in the presence of diﬀerent
dipeptides. The data were obtained at 25C in H2O (100 mM phosphate buﬀer, pH
7.0). The excitation wavelength was 336 nm.
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B.1 LDA Score Plots
Here are presented the linear discriminant analysis score plots not displayed in Chapter
5. They appear by order of decreasing quality of discrimination, as classiﬁed in Table 5.1,
p. 94.
In all cases, the concentration of analytewas [peptide] = 1.0mM, the concentration
of the dyes were [MCB] = 50 μM, [AI] = 25 μM, [XO] = 12.5 μM, and the concentration
of metal cations were [Cu 2+] = [Ni 2+] = 100 μM.When one or several of themembers of
the DCL was/were omitted, bidistilled water was used instead. The pHwasmaintained
at 8.4 (100 mM of a CHES buﬀer).
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Figure B.1 – LDA score plot generated from the data of a sensor made from AI,
XO, CuCl2 and NiCl2. The sensor was used for the diﬀerentiation of 13 di- and
tripeptides in buﬀered aqueous solution at a concentration of 1.0 mM. Cross-
validation aﬀorded 100% correct classiﬁcation, and the F-value associated to the
LDA model is 510.
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Figure B.2 – LDA score plot generated from the data of a sensor made from
MCB, AI, XO, and NiCl2. The sensor was used for the diﬀerentiation of 13 di-
and tripeptides in buﬀered aqueous solution at a concentration of 1.0 mM. Cross-
validation aﬀorded 100% correct classiﬁcation, and the F-value associated to the
LDA model is 423.
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Figure B.3 – LDA score plot generated from the data of a sensor made from
MCB, XO, CuCl2 and NiCl2. The sensor was used for the diﬀerentiation of 13 di-
and tripeptides in buﬀered aqueous solution at a concentration of 1.0 mM. Cross-
validation aﬀorded 100% correct classiﬁcation, and the F-value associated to the
LDA model is 325.
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Figure B.4 – LDA score plot generated from the data of a sensor made from MCB,
XO, andCuCl2. The sensorwasused for thediﬀerentiationof 13 di- and tripeptides in
buﬀered aqueous solution at a concentration of 1.0 mM. Cross-validation aﬀorded
100% correct classiﬁcation, and the F-value associated to the LDA model is 220.
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FigureB.5–LDAscoreplot generated fromthedataof a sensormade fromAI, CuCl2
and NiCl2. The sensor was used for the diﬀerentiation of 13 di- and tripeptides in
buﬀered aqueous solution at a concentration of 1.0 mM. Cross-validation aﬀorded
100% correct classiﬁcation, and the F-value associated to the LDA model is 209.
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Figure B.6 – LDA score plot generated from the data of a sensor made from MCB,
AI and NiCl2. The sensor was used for the diﬀerentiation of 13 di- and tripeptides in
buﬀered aqueous solution at a concentration of 1.0 mM. Cross-validation aﬀorded
100% correct classiﬁcation, and the F-value associated to the LDA model is 154.
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Figure B.7 – LDA score plot generated from the data of a sensor made from AI, XO
and NiCl2. The sensor was used for the diﬀerentiation of 13 di- and tripeptides in
buﬀered aqueous solution at a concentration of 1.0 mM. Cross-validation aﬀorded
100% correct classiﬁcation, and the F-value associated to the LDA model is 154.
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Figure B.8 – LDA score plot generated from the data of a sensor made from AI
and NiCl2. The sensor was used for the diﬀerentiation of 13 di- and tripeptides in
buﬀered aqueous solution at a concentration of 1.0 mM. Cross-validation aﬀorded
100% correct classiﬁcation, and the F-value associated to the LDA model is 141.
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Figure B.9 – LDA score plot generated from the data of a sensor made from MCB,
XO andNiCl2. The sensor was used for the diﬀerentiation of 13 di- and tripeptides in
buﬀered aqueous solution at a concentration of 1.0 mM. Cross-validation aﬀorded
100% correct classiﬁcation, and the F-value associated to the LDA model is 133.
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Figure B.10 – LDA score plot generated from the data of a sensor made from
MCB, AI, CuCl2 and NiCl2. The sensor was used for the diﬀerentiation of 13 di-
and tripeptides in buﬀered aqueous solution at a concentration of 1.0 mM. Cross-
validation aﬀorded 99% correct classiﬁcation, and the F-value associated to the LDA
model is 661.
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Figure B.11 – LDA score plot generated from the data of a sensor made from
MCB, AI, XO and CuCl2. The sensor was used for the diﬀerentiation of 13 di-
and tripeptides in buﬀered aqueous solution at a concentration of 1.0 mM. Cross-
validation aﬀorded 99% correct classiﬁcation, and the F-value associated to the LDA
model is 230.
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Figure B.12 – LDA score plot generated from the data of a sensor made fromMCB,
AI and CuCl2. The sensor was used for the diﬀerentiation of 13 di- and tripeptides in
buﬀered aqueous solution at a concentration of 1.0 mM. Cross-validation aﬀorded
99% correct classiﬁcation, and the F-value associated to the LDA model is 190.
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Figure B.13 – LDA score plot generated from the data of a sensor made fromMCB
and CuCl2. The sensor was used for the diﬀerentiation of 13 di- and tripeptides in
buﬀered aqueous solution at a concentration of 1.0 mM. Cross-validation aﬀorded
99% correct classiﬁcation, and the F-value associated to the LDA model is 121.
198 Sensor Arrays vs. Dynamic Combinatorial Libraries
-50 -25 0 25 50
-20
-10
0
10
 GF
 GG
 GL
 GM
 LG
 LM
 MF
 MG
 ML
 GGM
 GMG
 MFG
 MLG
SC
O
R
E 
2 
(1
2%
)
SCORE 1 (86%)
Figure B.14 – LDA score plot generated from the data of a sensor made from AI
and CuCl2. The sensor was used for the diﬀerentiation of 13 di- and tripeptides in
buﬀered aqueous solution at a concentration of 1.0 mM. Cross-validation aﬀorded
98% correct classiﬁcation, and the F-value associated to the LDA model is 209.
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Figure B.15 – LDA score plot generated from the data of a sensor made from
XO, CuCl2 and NiCl2. The sensor was used for the diﬀerentiation of 13 di- and
tripeptides in buﬀered aqueous solution at a concentration of 1.0 mM. Cross-
validation aﬀorded 98% correct classiﬁcation, and the F-value associated to the LDA
model is 194.
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Figure B.16 – LDA score plot generated from the data of a sensormade fromAI, XO
and CuCl2. The sensor was used for the diﬀerentiation of 13 di- and tripeptides in
buﬀered aqueous solution at a concentration of 1.0 mM. Cross-validation aﬀorded
98% correct classiﬁcation, and the F-value associated to the LDA model is 105.
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Figure B.17 – LDA score plot generated from the data of a sensor made from
MCB, CuCl2 and NiCl2. The sensor was used for the diﬀerentiation of 13 di- and
tripeptides in buﬀered aqueous solution at a concentration of 1.0 mM. Cross-
validation aﬀorded 96% correct classiﬁcation, and the F-value associated to the LDA
model is 161.
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Figure B.18 – LDA score plot generated from the data of a sensor made from XO
and CuCl2. The sensor was used for the diﬀerentiation of 13 di- and tripeptides in
buﬀered aqueous solution at a concentration of 1.0 mM. Cross-validation aﬀorded
87% correct classiﬁcation, and the F-value associated to the LDA model is 63.
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Figure B.19 – LDA score plot generated from the data of a sensor made fromMCB
and NiCl2. The sensor was used for the diﬀerentiation of 13 di- and tripeptides in
buﬀered aqueous solution at a concentration of 1.0 mM. Cross-validation aﬀorded
81% correct classiﬁcation, and the F-value associated to the LDA model is 60.
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